Integra LifeSciences Holdings
Buy, Hold or Sell?

Let's analyse Integra LifeSciences Holdings together

Penke I guess you are interested in Integra LifeSciences Holdings. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Integra LifeSciences Holdings. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Integra LifeSciences Holdings

I send you an email if I find something interesting about Integra LifeSciences Holdings.

Quick analysis of Integra LifeSciences Holdings (30 sec.)

What can you expect buying and holding a share of Integra LifeSciences Holdings? (30 sec.)

How much money do you get?

$0.05

When do you have the money?

1 year

How often do you get paid?

17.5%

What is your share worth?

Current worth

$20.27

Expected worth in 1 year

$18.98

How sure are you?

80.0%

+ What do you gain per year?

Total Gains per Share

$-1.25

Return On Investment

-4.2%

For what price can you sell your share?

Current Price per Share

$29.38

Expected price per share

$0 - $35.57

How sure are you?

50%

1. Valuation of Integra LifeSciences Holdings (5 min.)

Live pricePrice per Share (EOD)

$29.38

Book Value per Share

$20.27

Intrinsic Value Per Share

$-26.00 - $26.04

Total Value Per Share

$-5.73 - $46.31

My calculation of the intrinsic value of Integra LifeSciences Holdings is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.39) 3Y: ($0.55) TTM: ($0.23)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($-0.07) TTM: ($-0.10)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.85	$2.27	$0.47 - $2.37
2	$0.67	$4.63	$-0.61 - $2.54
3	$-0.43	$7.07	$-1.69 - $2.71
4	$-2.33	$9.60	$-2.76 - $2.87
5	$-4.96	$12.19	$-3.84 - $3.04
6	$-8.21	$14.85	$-4.92 - $3.21
7	$-12.01	$17.58	$-6.00 - $3.37
8	$-16.28	$20.35	$-7.08 - $3.54
9	$-20.97	$23.17	$-8.15 - $3.71
10	$-26.00	$26.04	$-9.23 - $3.87

2. Growth of Integra LifeSciences Holdings (5 min.)

Is Integra LifeSciences Holdings growing?

	Current year	Previous year	Grow	Grow %
How rich?	$1.5b	$1.7b	-$69.9m	-4.3%

How much money is Integra LifeSciences Holdings making?

	Current year	Previous year	Grow	Grow %
Making money	$16.9m	$45.1m	-$28.2m	-166.5%
Net Profit Margin	4.4%	11.6%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Integra LifeSciences Holdings (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

Richest
#20 / 334

Most Revenue
#39 / 334

Most Profit
#48 / 334

Most Efficient
#90 / 334

What can you expect buying and holding a share of Integra LifeSciences Holdings? (5 min.)

Welcome investor! Integra LifeSciences Holdings's management wants to use your money to grow the business. In return you get a share of Integra LifeSciences Holdings.

What can you expect buying and holding a share of Integra LifeSciences Holdings?

First you should know what it really means to hold a share of Integra LifeSciences Holdings. And how you can make/lose money.

Speculation

The Price per Share of Integra LifeSciences Holdings is $29.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Integra LifeSciences Holdings.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Integra LifeSciences Holdings, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $20.27. Based on the TTM, the Book Value Change Per Share is $-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $0.48 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Integra LifeSciences Holdings.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.25	0.9%	0.21	0.7%	0.54	1.8%	0.36	1.2%	0.25	0.9%
Usd Book Value Change Per Share	0.49	1.7%	-0.32	-1.1%	0.48	1.6%	0.22	0.7%	0.29	1.0%
Usd Dividend Per Share	0.00	0.0%	0.01	0.0%	0.01	0.0%	0.59	2.0%	0.31	1.1%
Usd Total Gains Per Share	0.49	1.7%	-0.31	-1.1%	0.49	1.7%	0.81	2.8%	0.60	2.1%
Usd Price Per Share	43.55	-	45.07	-	54.18	-	55.18	-	56.67	-
Price to Earnings Ratio	43.00	-	82.57	-	26.55	-	-92.87	-	13.93	-
Price-to-Total Gains Ratio	89.69	-	25.55	-	13.52	-	99.73	-	122.75	-
Price to Book Ratio	2.15	-	2.22	-	2.68	-	3.03	-	4.21	-
Price-to-Total Gains Ratio	89.69	-	25.55	-	13.52	-	99.73	-	122.75	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	29.38
Number of shares	34

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.01	0.59
Usd Book Value Change Per Share	-0.32	0.22
Usd Total Gains Per Share	-0.31	0.81
Gains per Quarter (34 shares)	-10.61	27.68
Gains per Year (34 shares)	-42.45	110.71

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	2	-44	-52	81	30	101
2	3	-88	-94	162	60	212
3	5	-132	-136	242	90	323
4	7	-176	-178	323	120	434
5	8	-221	-220	404	150	545
6	10	-265	-262	485	180	656
7	12	-309	-304	565	209	767
8	13	-353	-346	646	239	878
9	15	-397	-388	727	269	989
10	17	-441	-430	808	299	1100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	18.0	2.0	0.0	90.0%	37.0	3.0	0.0	92.5%	88.0	25.0	0.0	77.9%
Book Value Change Per Share	2.0	2.0	0.0	50.0%	9.0	3.0	0.0	75.0%	15.0	5.0	0.0	75.0%	31.0	9.0	0.0	77.5%	76.0	35.0	2.0	67.3%
Dividend per Share	3.0	0.0	1.0	75.0%	4.0	0.0	8.0	33.3%	6.0	0.0	14.0	30.0%	7.0	0.0	33.0	17.5%	14.0	0.0	99.0	12.4%
Total Gains per Share	2.0	2.0	0.0	50.0%	9.0	3.0	0.0	75.0%	16.0	4.0	0.0	80.0%	32.0	8.0	0.0	80.0%	80.0	33.0	0.0	70.8%

Fundamentals of Integra LifeSciences Holdings

About Integra LifeSciences Holdings

https://www.integralife.com
Medical Devices
3946
1100 Campus Road, Princeton, NJ, United States, 08540
Google Maps Bing Maps

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 11:18:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Integra LifeSciences Holdings.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Integra LifeSciences Holdings earns for each $1 of revenue.

Above 10% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
A Net Profit Margin of 5.0% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Integra LifeSciences Holdings:

The MRQ is 5.0%. The company is making a profit. +1
The TTM is 4.4%. The company is making a profit. +1

Trends

Current period		Compared to		+/-
MRQ	5.0%	TTM	4.4%	+0.6%
TTM	4.4%	YOY	11.6%	-7.2%
TTM	4.4%	5Y	7.8%	-3.4%
5Y	7.8%	10Y	5.8%	+2.0%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	5.0%	-12.4%	+17.4%
TTM	4.4%	-20.4%	+24.8%
YOY	11.6%	-14.8%	+26.4%
5Y	7.8%	-21.3%	+29.1%
10Y	5.8%	-25.0%	+30.8%

Measures how much net profit Integra LifeSciences Holdings earns for each $1 of revenue.

Revenue is the amount of profit Integra LifeSciences Holdings generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Integra LifeSciences Holdings earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be used to compare companies within the Medical Devices industry.

You typically want a high profit margin. This means that for each $1 in sales, Integra LifeSciences Holdings makes more profit. This shows the investor how efficiently Integra LifeSciences Holdings is operating in general and compared to other companies in the same industry. Integra LifeSciences Holdings operates in the Medical Devices industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Integra LifeSciences Holdings. If profit margins remain low (compared to the Medical Devices industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Integra LifeSciences Holdings is 0.05. This means that Integra LifeSciences Holdings earned $0.05 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Devices industry is -12.4%.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Integra LifeSciences Holdings with other companies in the same industry (Medical Devices).
Net profit margin should rise over the years.
Can be influenced when Integra LifeSciences Holdings sells assets (profit will increase while costs remain the same).
It won’t show what part of Integra LifeSciences Holdings is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Integra LifeSciences Holdings

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Integra LifeSciences Holdings = 19,834
Total revenue MRQ Integra LifeSciences Holdings = 397,039
$19,834 / $397,039 = 0.05 or 5.0%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Integra LifeSciences Holdings is using its assets to generate profit.

Above 5% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
0.5% Return on Assets means that Integra LifeSciences Holdings generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Integra LifeSciences Holdings:

The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	0.5%	TTM	0.5%	+0.1%
TTM	0.5%	YOY	1.2%	-0.7%
TTM	0.5%	5Y	0.9%	-0.5%
5Y	0.9%	10Y	0.7%	+0.2%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.5%	-4.1%	+4.6%
TTM	0.5%	-4.7%	+5.2%
YOY	1.2%	-4.8%	+6.0%
5Y	0.9%	-4.0%	+4.9%
10Y	0.7%	-5.2%	+5.9%

Shows how efficient Integra LifeSciences Holdings is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Integra LifeSciences Holdings is using its resources to generate profit. If the return on assets (0.5%) from Integra LifeSciences Holdings are higher than the Medical Devices mean (-4.1%) that means Integra LifeSciences Holdings is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Integra LifeSciences Holdings is 0.5%. This means the company generated $0.01 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Devices industry is -4.1%.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Integra LifeSciences Holdings

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Integra LifeSciences Holdings = 19,834
Total assets MRQ (balance sheet) from Integra LifeSciences Holdings = 3,781,988
19,834 / 3,781,988 = 0.01 or 0.5%

ROA is an important ratio as it will tell you how effectively Integra LifeSciences Holdings is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Integra LifeSciences Holdings is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
1.2% Return on Equity means Integra LifeSciences Holdings generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Integra LifeSciences Holdings:

The MRQ is 1.2%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 1.0%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	1.2%	TTM	1.0%	+0.2%
TTM	1.0%	YOY	2.6%	-1.6%
TTM	1.0%	5Y	1.9%	-0.9%
5Y	1.9%	10Y	1.6%	+0.3%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	1.2%	-4.2%	+5.4%
TTM	1.0%	-5.8%	+6.8%
YOY	2.6%	-5.7%	+8.3%
5Y	1.9%	-6.3%	+8.2%
10Y	1.6%	-7.1%	+8.7%

Shows how efficient Integra LifeSciences Holdings is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Devices industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Integra LifeSciences Holdings is 1.2%. This means Integra LifeSciences Holdings generated $0.01 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Devices industry is -4.2%.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if Integra LifeSciences Holdings existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Integra LifeSciences Holdings

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Integra LifeSciences Holdings = 19,834
Shareholders equity (balance sheet) MRQ Integra LifeSciences Holdings = 1,587,884
19,834 / 1,587,884 = 0.01 or 1.2%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Integra LifeSciences Holdings.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Integra LifeSciences Holdings is operating .

Measures how much profit Integra LifeSciences Holdings makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
An Operating Margin of 14.1% means the company generated $0.14 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Integra LifeSciences Holdings:

The MRQ is 14.1%. The company is operating less efficient.
The TTM is 9.0%. The company is operating less efficient.

Trends

Current period		Compared to		+/-
MRQ	14.1%	TTM	9.0%	+5.0%
TTM	9.0%	YOY	15.3%	-6.3%
TTM	9.0%	5Y	12.4%	-3.4%
5Y	12.4%	10Y	10.0%	+2.4%

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	14.1%	-24.3%	+38.4%
TTM	9.0%	-16.4%	+25.4%
YOY	15.3%	-13.7%	+29.0%
5Y	12.4%	-19.9%	+32.3%
10Y	10.0%	-24.5%	+34.5%

Measures how efficient Integra LifeSciences Holdings is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Integra LifeSciences Holdings is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Integra LifeSciences Holdings is 14.1%. This means that Integra LifeSciences Holdings earned $0.14 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Devices industry is -24.3%.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Integra LifeSciences Holdings

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Integra LifeSciences Holdings = 55,880
Total revenue MRQ Integra LifeSciences Holdings = 397,039
$55,880 / $397,039 = 0.14 or 14.1%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Integra LifeSciences Holdings is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Devices industry mean).
An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Integra LifeSciences Holdings:

The MRQ is 0.859. The company is less efficient in keeping operating costs low.
The TTM is 0.915. The company is less efficient in keeping operating costs low.

Trends

Current period		Compared to		+/-
MRQ	0.859	TTM	0.915	-0.056
TTM	0.915	YOY	0.847	+0.068
TTM	0.915	5Y	0.885	+0.030
5Y	0.885	10Y	0.906	-0.021

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.859	1.442	-0.583
TTM	0.915	1.439	-0.524
YOY	0.847	1.431	-0.584
5Y	0.885	1.436	-0.551
10Y	0.906	1.374	-0.468

Measures how efficient Integra LifeSciences Holdings is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Integra LifeSciences Holdings is 85.9%. This means that Integra LifeSciences Holdings earned $0.86 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Devices industry is 1.44.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Integra LifeSciences Holdings

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(163,061 +178,098) \ 397,039 = 0.86

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Integra LifeSciences Holdings.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Integra LifeSciences Holdings is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
A Current Ratio of 3.45 means the company has $3.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Integra LifeSciences Holdings:

The MRQ is 3.447. The company is very able to pay all its short-term debts. +2
The TTM is 3.192. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	3.447	TTM	3.192	+0.255
TTM	3.192	YOY	3.693	-0.502
TTM	3.192	5Y	3.324	-0.132
5Y	3.324	10Y	3.450	-0.127

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	3.447	2.726	+0.721
TTM	3.192	2.732	+0.460
YOY	3.693	3.510	+0.183
5Y	3.324	3.617	-0.293
10Y	3.450	3.499	-0.049

Measures if Integra LifeSciences Holdings is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Integra LifeSciences Holdings if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Integra LifeSciences Holdings is 3.45. This means Integra LifeSciences Holdings has $3.45 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 2.73.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Integra LifeSciences Holdings

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
1,058,036 \ 306,980) = 3.45

The current ratio measures if Integra LifeSciences Holdings is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Integra LifeSciences Holdings is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Integra LifeSciences Holdings does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Integra LifeSciences Holdings is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Integra LifeSciences Holdings is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
A Quick Ratio of 1.96 means the company can pay off $1.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Integra LifeSciences Holdings:

The MRQ is 1.958. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 1.777. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	1.958	TTM	1.777	+0.182
TTM	1.777	YOY	2.299	-0.523
TTM	1.777	5Y	1.964	-0.187
5Y	1.964	10Y	1.851	+0.113

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	1.958	1.491	+0.467
TTM	1.777	1.633	+0.144
YOY	2.299	2.113	+0.186
5Y	1.964	2.295	-0.331
10Y	1.851	2.255	-0.404

Measures if Integra LifeSciences Holdings is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Integra LifeSciences Holdings can pay off its short term debts. This shows if Integra LifeSciences Holdings can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Integra LifeSciences Holdings is 1.96. This means that Integra LifeSciences Holdings can pay off $1.96 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is 1.49.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Integra LifeSciences Holdings

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Integra LifeSciences Holdings: (309,096 + 32,694 +259,327) / 306,980 = 1.96

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of Integra LifeSciences Holdings.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Integra LifeSciences Holdings assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Integra LifeSciences Holdings to Medical Devices industry mean.
A Debt to Asset Ratio of 0.58 means that Integra LifeSciences Holdings assets are financed with 58.0% credit (debt) and the remaining percentage (100% - 58.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Integra LifeSciences Holdings:

The MRQ is 0.580. The company is able to pay all its debts by selling its assets. +1
The TTM is 0.566. The company is able to pay all its debts by selling its assets. +1

Trends

Current period		Compared to		+/-
MRQ	0.580	TTM	0.566	+0.014
TTM	0.566	YOY	0.550	+0.016
TTM	0.566	5Y	0.516	+0.050
5Y	0.516	10Y	0.543	-0.027

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	0.580	0.389	+0.191
TTM	0.566	0.386	+0.180
YOY	0.550	0.335	+0.215
5Y	0.516	0.442	+0.074
10Y	0.543	0.461	+0.082

Measures how much % of Integra LifeSciences Holdings assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Integra LifeSciences Holdings than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Integra LifeSciences Holdings to Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Integra LifeSciences Holdings is 0.58. This means means that Integra LifeSciences Holdings is financed with 58.0% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Devices industry is 272.6%.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Integra LifeSciences Holdings has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Integra LifeSciences Holdings

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
2,194,104 \ 3,781,988 = 58.0% or 0.58.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Integra LifeSciences Holdings is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
A Debt to Equity ratio of 138.2% means that company has $1.38 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Integra LifeSciences Holdings:

The MRQ is 1.382. The company is able to pay all its debts with equity. +1
The TTM is 1.307. The company is able to pay all its debts with equity. +1

Trends

Current period		Compared to		+/-
MRQ	1.382	TTM	1.307	+0.075
TTM	1.307	YOY	1.224	+0.083
TTM	1.307	5Y	1.249	+0.058
5Y	1.249	10Y	1.318	-0.069

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
MRQ	1.382	0.551	+0.831
TTM	1.307	0.554	+0.753
YOY	1.224	0.479	+0.745
5Y	1.249	0.622	+0.627
10Y	1.318	0.674	+0.644

Measures if Integra LifeSciences Holdings is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Integra LifeSciences Holdings is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Integra LifeSciences Holdings is 1.38. This means that Integra LifeSciences Holdings can pay off $1.38 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is 0.55.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Integra LifeSciences Holdings

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
2,194,104 \ 1,587,884 = 1.38 or 138.2%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Integra LifeSciences Holdings

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Integra LifeSciences Holdings generates.

Above 15 is considered overpriced but always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
A PE ratio of 43.00 means the investor is paying $43.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Integra LifeSciences Holdings:

The EOD is 29.006. Based on the earnings, the company is overpriced. -1
The MRQ is 42.996. Based on the earnings, the company is overpriced. -1
The TTM is 82.571. Based on the earnings, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	29.006	MRQ	42.996	-13.990
MRQ	42.996	TTM	82.571	-39.575
TTM	82.571	YOY	26.553	+56.018
TTM	82.571	5Y	-92.868	+175.439
5Y	-92.868	10Y	13.935	-106.802

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	29.006	-1.077	+30.083
MRQ	42.996	-1.704	+44.700
TTM	82.571	-2.081	+84.652
YOY	26.553	-2.978	+29.531
5Y	-92.868	-2.379	-90.489
10Y	13.935	-1.726	+15.661

Measures how much money you pay for each share for every $1 in earnings Integra LifeSciences Holdings generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Integra LifeSciences Holdings to the Medical Devices industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Integra LifeSciences Holdings is 43.00. This means the investor is paying $43.00 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Devices industry is -1.70.
What is the trend?
The trend is important because it shows you how Integra LifeSciences Holdings is performing over time. The most recent quarter might be important if Integra LifeSciences Holdings released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Integra LifeSciences Holdings up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Integra LifeSciences Holdings

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 78,327 = EPS
PE ratio MRQ = 43.00

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Integra LifeSciences Holdings:

The EOD is 16.815. Based on how much money comes from the company's main activities, the company is underpriced. +1
The MRQ is 24.924. Based on how much money comes from the company's main activities, the company is underpriced. +1
The TTM is 60.252. Based on how much money comes from the company's main activities, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	16.815	MRQ	24.924	-8.110
MRQ	24.924	TTM	60.252	-35.328
TTM	60.252	YOY	23.996	+36.256
TTM	60.252	5Y	-36.978	+97.230
5Y	-36.978	10Y	-250.529	+213.551

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	16.815	-0.932	+17.747
MRQ	24.924	-1.578	+26.502
TTM	60.252	-2.973	+63.225
YOY	23.996	-6.318	+30.314
5Y	-36.978	-5.307	-31.671
10Y	-250.529	-5.171	-245.358

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Integra LifeSciences Holdings is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Devices industry mean).
A PB ratio of 2.15 means the investor is paying $2.15 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Integra LifeSciences Holdings:

The EOD is 1.449. Based on the equity, the company is underpriced. +1
The MRQ is 2.148. Based on the equity, the company is underpriced. +1
The TTM is 2.221. Based on the equity, the company is underpriced. +1

Trends

Current period		Compared to		+/-
EOD	1.449	MRQ	2.148	-0.699
MRQ	2.148	TTM	2.221	-0.073
TTM	2.221	YOY	2.680	-0.460
TTM	2.221	5Y	3.029	-0.808
5Y	3.029	10Y	4.212	-1.183

Compared to industry (Medical Devices)

Period	Company	Industry (mean)	+/-
EOD	1.449	1.876	-0.427
MRQ	2.148	2.372	-0.224
TTM	2.221	2.434	-0.213
YOY	2.680	3.217	-0.537
5Y	3.029	3.893	-0.864
10Y	4.212	4.245	-0.033

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Integra LifeSciences Holdings.

3.1. Institutions holding Integra LifeSciences Holdings

Institutions are holding 88.908% of the shares of Integra LifeSciences Holdings.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Vanguard Group Inc	8.9655	0.0067	7012793	-147061	-2.054
2023-12-31	BlackRock Inc	8.4913	0.0074	6641845	-192342	-2.8144
2023-12-31	Morgan Stanley - Brokerage Accounts	6.7383	0.0202	5270697	-677945	-11.3966
2023-12-31	Capital Research Global Investors	5.4939	0.046	4297326	1228996	40.0542
2023-12-31	Wellington Management Company LLP	4.0722	0.0259	3185293	151344	4.9884
2023-12-31	Cooke & Bieler LP	3.6239	1.0881	2834604	120410	4.4363
2023-12-31	AllianceBernstein L.P.	3.4844	0.0457	2725502	-67329	-2.4108
2023-12-31	ClearBridge Advisors, LLC	3.1632	0.0927	2474249	-267673	-9.7622
2023-12-31	Champlain Investment Partners, LLC	3.1142	0.629	2435957	-2872	-0.1178
2023-12-31	State Street Corporation	2.7049	0.0045	2115767	-21794	-1.0196
2023-12-31	Dimensional Fund Advisors, Inc.	2.0648	0.0205	1615112	63323	4.0806
2023-12-31	Goldman Sachs Group Inc	1.6675	0.0051	1304308	621015	90.8856
2023-12-31	Geode Capital Management, LLC	1.6059	0.0057	1256108	-6080	-0.4817
2023-09-30	Deerfield Management Co	1.4406	0.9481	1126827	1126827	0
2023-12-31	Madison Avenue Partners, LP	1.3323	6.408	1042156	77489	8.0327
2023-09-30	Point72 Asset Management, L.P.	1.1572	0.1009	905126	904626	180925.2
2023-12-31	Macquarie Group Ltd	1.1371	0.0448	889429	-575696	-39.2933
2023-12-31	Fuller & Thaler Asset Management Inc	1.0753	0.1856	841059	235565	38.9046
2023-12-31	Manufacturers Life Insurance Co	0.9145	0.0186	715294	191529	36.5677
2023-12-31	GW&K Investment Management, LLC	0.8867	0.2816	693553	-64611	-8.522
Total		63.1337	9.9851	49383005	+2697721	+5.5%

3.2. Funds holding Integra LifeSciences Holdings

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	American Funds SMALLCAP World A	4.8294	0.2297	3796022	1046794	38.0759
2024-02-29	Aviva Investors GlConvtAbsRet I USD Acc	3.6847	0	2896250	-1485871	-33.9076
2024-03-28	iShares Core S&P Mid-Cap ETF	2.6939	0.0883	2117438	0	0
2024-02-29	Vanguard Total Stock Mkt Idx Inv	2.6163	0.0049	2056472	-5708	-0.2768
2024-02-29	Champlain Small Company Fund, LLC	2.5992	1.6281	2043037	213220	11.6525
2024-02-29	Vanguard Small Cap Index	2.1793	0.045	1712942	15906	0.9373
2023-12-31	ClearBridge Small Cap Growth A	1.7547	1.4418	1379240	-237897	-14.711
2024-02-29	ClearBridge Small Cap Growth	1.6058	1.1374	1262158	0	0
2024-02-29	Vanguard Small Cap Value Index Inv	1.4836	0.0809	1166153	4848	0.4175
2023-12-31	Vanguard Selected Value Inv	1.279	0.6374	1005332	0	0
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.2762	0.0363	1003110	2549	0.2548
2023-12-31	Champlain Small Company Adv	1.2595	1.7605	990000	-25000	-2.4631
2023-12-31	FullerThaler Behavioral Small-Cap Equity	1.0132	0.4361	796433	226600	39.766
2023-12-31	FullerThaler Behavioral Sm-Cp Eq R6	1.0132	0.4362	796433	226600	39.766
2024-02-29	AB Discovery Value Advisor	0.9837	1.0874	773220	35010	4.7426
2023-12-31	Vanguard Explorer Inv	0.8938	0.1431	702569	0	0
2024-01-31	JHancock Small Cap Core NAV	0.7512	1.2518	590455	0	0
2024-02-29	Hartford Capital Appreciation Y	0.7387	0.3414	580623	82233	16.4997
2024-01-31	Old Westbury Small & Mid Cap Strategies	0.7315	0.3129	575000	30000	5.5046
2024-02-29	SPDR® S&P MIDCAP 400 ETF Trust	0.6911	0.0954	543225	2046	0.3781
Total		34.078	11.1946	26786112	+131330	+0.5%

3.3. Insider Transactions

Insiders are holding 13.911% of the shares of Integra LifeSciences Holdings.

Date	Owner	Type	Amount	Price	Post Transaction Amount	Link
2023-06-01	Witte Jan De	BUY	7792	38.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Integra LifeSciences Holdings compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.486	-0.324	+167%	0.482	+1%	0.220	+121%	0.293	+66%
Book Value Per Share	-	-	20.273	20.287	0%	20.319	0%	18.429	+10%	14.925	+36%
Current Ratio	-	-	3.447	3.192	+8%	3.693	-7%	3.324	+4%	3.450	0%
Debt To Asset Ratio	-	-	0.580	0.566	+2%	0.550	+5%	0.516	+12%	0.543	+7%
Debt To Equity Ratio	-	-	1.382	1.307	+6%	1.224	+13%	1.249	+11%	1.318	+5%
Dividend Per Share	-	-	-	0.012	-100%	0.012	-100%	0.594	-100%	0.312	-100%
Eps	-	-	0.253	0.211	+20%	0.539	-53%	0.357	-29%	0.250	+1%
Free Cash Flow Per Share	-	-	0.437	0.229	+91%	0.650	-33%	0.551	-21%	0.387	+13%
Free Cash Flow To Equity Per Share	-	-	0.349	-0.475	+236%	-0.101	+129%	0.310	+12%	0.737	-53%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	0.998	+0%	0.999	+0%
Intrinsic Value_10Y_max	-	-	26.041	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-26.002	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	2.267	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.848	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	7.073	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-0.428	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	12.193	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-4.956	-	-	-	-	-	-	-	-
Market Cap	2298097724.000	-48%	3411131791.600	3630754485.400	-6%	4539233460.000	-25%	4657635493.580	-27%	4652616190.362	-27%
Net Profit Margin	-	-	0.050	0.044	+14%	0.116	-57%	0.078	-36%	0.058	-14%
Operating Margin	-	-	0.141	0.090	+56%	0.153	-8%	0.124	+13%	0.100	+41%
Operating Ratio	-	-	0.859	0.915	-6%	0.847	+1%	0.885	-3%	0.906	-5%
Pb Ratio	1.449	-48%	2.148	2.221	-3%	2.680	-20%	3.029	-29%	4.212	-49%
Pe Ratio	29.006	-48%	42.996	82.571	-48%	26.553	+62%	-92.868	+316%	13.935	+209%
Price Per Share	29.380	-48%	43.550	45.070	-3%	54.180	-20%	55.176	-21%	56.666	-23%
Price To Free Cash Flow Ratio	16.815	-48%	24.924	60.252	-59%	23.996	+4%	-36.978	+248%	-250.529	+1105%
Price To Total Gains Ratio	60.510	-48%	89.693	25.555	+251%	13.522	+563%	99.728	-10%	122.753	-27%
Quick Ratio	-	-	1.958	1.777	+10%	2.299	-15%	1.964	0%	1.851	+6%
Return On Assets	-	-	0.005	0.005	+16%	0.012	-56%	0.009	-45%	0.007	-29%
Return On Equity	-	-	0.012	0.010	+20%	0.026	-53%	0.019	-34%	0.016	-21%
Total Gains Per Share	-	-	0.486	-0.312	+164%	0.494	-2%	0.814	-40%	0.605	-20%
Usd Book Value	-	-	1587884000.000	1631300750.000	-3%	1701232750.000	-7%	1548714550.000	+3%	1233772000.000	+29%
Usd Book Value Change Per Share	-	-	0.486	-0.324	+167%	0.482	+1%	0.220	+121%	0.293	+66%
Usd Book Value Per Share	-	-	20.273	20.287	0%	20.319	0%	18.429	+10%	14.925	+36%
Usd Dividend Per Share	-	-	-	0.012	-100%	0.012	-100%	0.594	-100%	0.312	-100%
Usd Eps	-	-	0.253	0.211	+20%	0.539	-53%	0.357	-29%	0.250	+1%
Usd Free Cash Flow	-	-	34215000.000	18272500.000	+87%	54346000.000	-37%	46695650.000	-27%	32352750.000	+6%
Usd Free Cash Flow Per Share	-	-	0.437	0.229	+91%	0.650	-33%	0.551	-21%	0.387	+13%
Usd Free Cash Flow To Equity Per Share	-	-	0.349	-0.475	+236%	-0.101	+129%	0.310	+12%	0.737	-53%
Usd Market Cap	2298097724.000	-48%	3411131791.600	3630754485.400	-6%	4539233460.000	-25%	4657635493.580	-27%	4652616190.362	-27%
Usd Price Per Share	29.380	-48%	43.550	45.070	-3%	54.180	-20%	55.176	-21%	56.666	-23%
Usd Profit	-	-	19834000.000	16935250.000	+17%	45137500.000	-56%	30072950.000	-34%	20757025.000	-4%
Usd Revenue	-	-	397039000.000	385393250.000	+3%	389416500.000	+2%	376555600.000	+5%	326435950.000	+22%
Usd Total Gains Per Share	-	-	0.486	-0.312	+164%	0.494	-2%	0.814	-40%	0.605	-20%
	EOD	+4 -4	MRQ	TTM	+25 -10	YOY	+8 -27	5Y	+14 -22	10Y	+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Integra LifeSciences Holdings based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	29.006
Price to Book Ratio (EOD)	Between	0-1	1.449
Net Profit Margin (MRQ)	Greater than	0	0.050
Operating Margin (MRQ)	Greater than	0	0.141
Quick Ratio (MRQ)	Greater than	1	1.958
Current Ratio (MRQ)	Greater than	1	3.447
Debt to Asset Ratio (MRQ)	Less than	1	0.580
Debt to Equity Ratio (MRQ)	Less than	1	1.382
Return on Equity (MRQ)	Greater than	0.15	0.012
Return on Assets (MRQ)	Greater than	0.05	0.005
Total			5/10 (50.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Integra LifeSciences Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	25.938
Ma 20	Greater than	Ma 50	32.877
Ma 50	Greater than	Ma 100	36.405
Ma 100	Greater than	Ma 200	39.234
Open	Greater than	Close	29.050
Total			0/5 (0.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

		2022-12-31		2023-03-31		2023-06-30		2023-09-30		2023-12-31
Accumulated Other Comprehensive Income		10,265	-3,198	7,067	-2,237	4,830	-3,085	1,745	-16,851	-15,106

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	3,781,988
Total Liabilities	2,194,104
Total Stockholder Equity	1,587,884

	As reported
Total Liabilities	2,194,104
Total Stockholder Equity	+ 1,587,884
Total Assets	= 3,781,988

Assets

Total Assets	3,781,988
Total Current Assets	1,058,036
Long-term Assets	2,723,952

Total Current Assets

Total Current Assets (as reported)	1,058,036
Cash And Cash Equivalents	276,402
Short-term Investments	32,694
Net Receivables	259,327
Inventory	389,608
Other Current Assets	100,005
Total Current Assets (calculated)	1,058,036
+/-	0

Long-term Assets

Long-term Assets (as reported)	2,723,952
Property Plant Equipment	496,383
Goodwill	1,055,462
Intangible Assets	1,067,833
Long-term Assets Other	26,014
Long-term Assets (calculated)	2,645,692
+/-	78,260

Liabilities & Shareholders' Equity

Total Current Liabilities	306,980
Long-term Liabilities	1,887,124
Total Stockholder Equity	1,587,884

Total Current Liabilities

Total Current Liabilities (as reported)	306,980
Short-term Debt	29,815
Short Long Term Debt	14,531
Accounts payable	92,326
Other Current Liabilities	176,299
Total Current Liabilities (calculated)	312,971
+/-	5,991

Long-term Liabilities

Long-term Liabilities (as reported)	1,887,124
Long term Debt	1,485,018
Capital Lease Obligations	182,133
Long-term Liabilities Other	199,940
Long-term Liabilities (calculated)	1,867,091
+/-	20,033

Total Stockholder Equity

Total Stockholder Equity (as reported)	1,587,884
Common Stock	909
Retained Earnings	946,859
Accumulated Other Comprehensive Income	-15,106
Other Stockholders Equity	655,222
Total Stockholder Equity (calculated)	1,587,884
+/-	0

Other

Capital Stock	909
Cash and Short Term Investments	309,096
Common Stock Shares Outstanding	78,327
Current Deferred Revenue	8,540
Liabilities and Stockholders Equity	3,781,988
Net Debt	1,405,280
Net Invested Capital	3,087,433
Net Working Capital	751,056
Property Plant and Equipment Gross	863,830
Short Long Term Debt Total	1,681,682

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

1997-06-30

1997-03-31

1996-12-31

1996-09-30

1996-06-30

1996-03-31

1995-12-31

1995-09-30

1995-06-30

1995-03-31

> Total Assets

0
0
22,200
19,400
53,700
52,600
50,900
48,700
47,000
45,200
43,500
38,400
36,100
37,400
38,500
34,700
66,700
66,800
64,000
66,300
73,693
76,289
85,760
86,514
86,514
94,193
206,556
227,588
226,767
234,390
242,573
274,668
356,755
392,533
402,529
412,526
421,139
435,400
440,187
456,713
470,407
451,686
465,881
448,432
491,631
566,219
604,460
613,618
623,074
776,490
810,077
818,012
818,012
862,454
960,745
1,034,431
995,417
946,372
973,236
940,102
937,997
941,795
959,276
1,017,308
1,007,028
1,153,856
1,174,666
1,144,109
1,158,370
1,161,817
1,185,506
1,163,599
1,156,491
1,187,501
1,184,072
1,196,229
1,555,923
1,563,023
1,545,734
1,578,625
1,550,807
1,637,894
1,827,620
1,774,704
1,830,262
1,814,162
1,827,424
1,807,954
2,049,015
2,101,131
2,418,187
3,211,257
3,247,693
3,185,773
3,178,642
3,107,887
3,205,711
3,290,410
3,346,580
3,303,240
3,447,565
3,391,759
922,302
3,615,136
3,741,554
3,712,787
3,774,465
3,782,383
3,671,997
3,752,862
3,807,013
3,889,758
3,742,399
3,777,601
3,739,371
3,781,988

3,781,988

3,739,371

3,777,601

3,742,399

3,889,758

3,807,013

3,752,862

3,671,997

3,782,383

3,774,465

3,712,787

3,741,554

3,615,136

922,302

3,391,759

3,447,565

3,303,240

3,346,580

3,290,410

3,205,711

3,107,887

3,178,642

3,185,773

3,247,693

3,211,257

2,418,187

2,101,131

2,049,015

1,807,954

1,827,424

1,814,162

1,830,262

1,774,704

1,827,620

1,637,894

1,550,807

1,578,625

1,545,734

1,563,023

1,555,923

1,196,229

1,184,072

1,187,501

1,156,491

1,163,599

1,185,506

1,161,817

1,158,370

1,144,109

1,174,666

1,153,856

1,007,028

1,017,308

959,276

941,795

937,997

940,102

973,236

946,372

995,417

1,034,431

960,745

862,454

818,012

810,077

776,490

623,074

613,618

604,460

566,219

491,631

448,432

465,881

451,686

470,407

456,713

440,187

435,400

421,139

412,526

402,529

392,533

356,755

274,668

242,573

234,390

226,767

227,588

206,556

94,193

86,514

85,760

76,289

73,693

66,300

64,000

66,800

66,700

34,700

38,500

37,400

36,100

38,400

43,500

45,200

47,000

48,700

50,900

52,600

53,700

19,400

22,200

> Total Current Assets

0
0
12,300
9,300
34,300
39,400
38,000
40,200
38,800
37,400
35,800
31,800
29,600
31,100
30,500
26,900
42,900
43,200
40,100
42,800
43,653
36,643
46,602
46,217
46,217
50,444
104,491
108,232
131,247
145,082
153,328
152,273
196,278
213,178
186,573
187,893
189,740
164,187
174,060
216,238
204,958
225,172
269,659
265,952
242,826
226,463
219,499
221,761
229,800
352,983
380,359
339,931
339,931
379,561
436,282
497,392
477,567
423,249
395,795
365,363
372,844
387,631
386,295
444,849
425,185
495,784
476,328
452,257
459,743
477,323
493,562
453,051
447,059
477,736
510,583
525,242
539,746
564,161
562,589
529,321
521,950
608,247
504,912
438,495
494,565
493,986
511,877
495,170
568,919
616,166
944,943
822,146
848,650
821,322
827,983
775,082
822,686
868,672
883,813
858,168
1,008,672
966,222
922,302
1,237,202
1,039,075
1,032,382
1,103,785
1,153,716
1,066,053
1,137,414
1,196,453
1,161,498
1,029,482
1,051,260
1,027,229
1,058,036

1,058,036

1,027,229

1,051,260

1,029,482

1,161,498

1,196,453

1,137,414

1,066,053

1,153,716

1,103,785

1,032,382

1,039,075

1,237,202

922,302

966,222

1,008,672

858,168

883,813

868,672

822,686

775,082

827,983

821,322

848,650

822,146

944,943

616,166

568,919

495,170

511,877

493,986

494,565

438,495

504,912

608,247

521,950

529,321

562,589

564,161

539,746

525,242

510,583

477,736

447,059

453,051

493,562

477,323

459,743

452,257

476,328

495,784

425,185

444,849

386,295

387,631

372,844

365,363

395,795

423,249

477,567

497,392

436,282

379,561

339,931

380,359

352,983

229,800

221,761

219,499

226,463

242,826

265,952

269,659

225,172

204,958

216,238

174,060

164,187

189,740

187,893

186,573

213,178

196,278

152,273

153,328

145,082

131,247

108,232

104,491

50,444

46,217

46,602

36,643

43,653

42,800

40,100

43,200

42,900

26,900

30,500

31,100

29,600

31,800

35,800

37,400

38,800

40,200

38,000

39,400

34,300

9,300

12,300

Cash And Cash Equivalents

0
0
7,200
4,500
12,000
9,700
8,000
11,800
8,800
4,300
8,200
2,100
5,900
4,700
2,600
5,300
7,600
12,000
12,900
19,300
23,366
5,676
13,011
14,086
14,086
8,602
59,333
44,518
46,764
51,195
50,142
43,583
105,089
116,153
83,951
78,979
76,052
42,540
34,912
69,855
32,763
29,020
37,352
46,889
22,393
27,533
24,322
22,697
29,329
120,838
129,498
57,339
57,339
77,338
109,339
183,546
185,630
138,717
106,747
71,891
81,674
93,618
82,832
128,763
104,354
137,279
110,991
100,808
58,642
75,470
125,718
96,938
89,691
98,636
118,868
120,614
129,038
137,160
140,231
71,994
79,871
131,296
79,311
48,132
77,086
86,803
107,598
102,055
124,113
154,600
481,943
174,935
189,396
183,771
205,991
138,838
157,025
176,084
207,981
198,911
357,712
360,981
396,279
470,166
408,976
397,414
470,231
513,448
407,092
447,152
511,937
456,661
307,367
309,192
273,732
276,402

276,402

273,732

309,192

307,367

456,661

511,937

447,152

407,092

513,448

470,231

397,414

408,976

470,166

396,279

360,981

357,712

198,911

207,981

176,084

157,025

138,838

205,991

183,771

189,396

174,935

481,943

154,600

124,113

102,055

107,598

86,803

77,086

48,132

79,311

131,296

79,871

71,994

140,231

137,160

129,038

120,614

118,868

98,636

89,691

96,938

125,718

75,470

58,642

100,808

110,991

137,279

104,354

128,763

82,832

93,618

81,674

71,891

106,747

138,717

185,630

183,546

109,339

77,338

57,339

129,498

120,838

29,329

22,697

24,322

27,533

22,393

46,889

37,352

29,020

32,763

69,855

34,912

42,540

76,052

78,979

83,951

116,153

105,089

43,583

50,142

51,195

46,764

44,518

59,333

8,602

14,086

13,011

5,676

23,366

19,300

12,900

12,000

7,600

5,300

2,600

4,700

5,900

2,100

8,200

4,300

8,800

11,800

8,000

9,700

12,000

4,500

7,200

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,900
4,300
206
3,575
4,043
1,052
1,052
3,053
4,074
22,183
42,952
50,512
54,173
55,278
24,063
29,516
31,523
29,567
30,118
25,841
38,479
30,955
43,705
69,434
98,430
80,327
63,787
6,417
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,780
39,315
0
0
0
0
0
0
0
0
0
0
0
0
0
4,073
0
0
0
0
11,286
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,369
13,111
16,682
15,659
20,200
19,938
32,694

32,694

19,938

20,200

15,659

16,682

13,111

4,369

11,286

4,073

39,315

53,780

6,417

63,787

80,327

98,430

69,434

43,705

30,955

38,479

25,841

30,118

29,567

31,523

29,516

24,063

55,278

54,173

50,512

42,952

22,183

4,074

3,053

1,052

4,043

3,575

206

4,300

7,900

Net Receivables

0
0
1,800
1,800
2,000
2,700
2,200
2,900
2,400
2,800
3,000
2,800
3,100
3,200
2,900
3,100
8,800
8,000
7,800
8,400
8,719
10,908
12,402
13,087
13,087
15,032
14,454
14,024
14,828
15,642
17,724
19,412
24,065
23,722
26,961
28,936
30,322
35,651
38,028
46,765
51,261
46,275
46,786
49,007
56,607
74,135
76,715
85,018
85,884
95,267
92,313
103,539
103,539
108,126
111,081
112,417
101,610
101,462
101,379
103,228
98,532
97,779
107,150
106,005
106,117
116,179
117,777
118,129
113,996
115,571
119,527
114,916
111,944
114,749
113,538
118,145
112,521
118,262
120,741
131,918
126,785
134,546
125,465
132,241
151,607
145,571
140,750
148,186
158,234
171,323
171,126
251,799
272,260
258,380
248,738
265,737
279,072
296,507
281,119
275,296
245,546
179,143
218,184
225,532
223,542
229,823
222,232
231,831
234,010
237,361
248,268
263,465
253,995
258,663
256,270
259,327

259,327

256,270

258,663

253,995

263,465

248,268

237,361

234,010

231,831

222,232

229,823

223,542

225,532

218,184

179,143

245,546

275,296

281,119

296,507

279,072

265,737

248,738

258,380

272,260

251,799

171,126

171,323

158,234

148,186

140,750

145,571

151,607

132,241

125,465

134,546

126,785

131,918

120,741

118,262

112,521

118,145

113,538

114,749

111,944

114,916

119,527

115,571

113,996

118,129

117,777

116,179

106,117

106,005

107,150

97,779

98,532

103,228

101,379

101,462

101,610

112,417

111,081

108,126

103,539

92,313

95,267

85,884

85,018

76,715

74,135

56,607

49,007

46,786

46,275

51,261

46,765

38,028

35,651

30,322

28,936

26,961

23,722

24,065

19,412

17,724

15,642

14,828

14,024

14,454

15,032

13,087

12,402

10,908

8,719

8,400

7,800

8,000

8,800

3,100

2,900

3,200

3,100

2,800

3,000

2,800

2,400

2,900

2,200

2,700

2,000

1,800

Other Current Assets

0
0
1,900
1,600
18,200
24,200
24,700
22,900
24,800
28,300
22,700
24,500
18,200
20,600
21,600
15,800
13,400
12,000
700
700
695
753
805
1,484
1,484
1,106
2,517
2,898
2,690
2,708
4,718
5,498
5,667
4,710
5,743
9,365
8,354
9,646
10,241
12,716
11,894
11,237
18,077
22,253
22,886
25,397
24,689
19,659
18,996
22,789
32,177
34,518
34,518
44,752
60,247
55,326
48,745
43,751
47,128
50,004
50,525
52,981
48,340
63,153
60,113
67,866
66,130
62,059
60,856
74,426
78,941
30,291
27,396
30,774
30,739
26,752
34,496
36,758
26,886
29,632
23,958
42,397
39,361
42,620
43,894
41,170
43,858
27,666
35,477
55,563
59,534
99,080
96,520
88,654
82,408
90,160
99,627
99,576
92,091
67,907
67,332
67,342
69,817
69,282
78,508
81,527
84,155
91,051
96,946
132,693
125,188
116,789
116,845
129,112
130,976
100,005

100,005

130,976

129,112

116,845

116,789

125,188

132,693

96,946

91,051

84,155

81,527

78,508

69,282

69,817

67,342

67,332

67,907

92,091

99,576

99,627

90,160

82,408

88,654

96,520

99,080

59,534

55,563

35,477

27,666

43,858

41,170

43,894

42,620

39,361

42,397

23,958

29,632

26,886

36,758

34,496

26,752

30,739

30,774

27,396

30,291

78,941

74,426

60,856

62,059

66,130

67,866

60,113

63,153

48,340

52,981

50,525

50,004

47,128

43,751

48,745

55,326

60,247

44,752

34,518

32,177

22,789

18,996

19,659

24,689

25,397

22,886

22,253

18,077

11,237

11,894

12,716

10,241

9,646

8,354

9,365

5,743

4,710

5,667

5,498

4,718

2,708

2,690

2,898

2,517

1,106

1,484

805

753

695

700

12,000

13,400

15,800

21,600

20,600

18,200

24,500

22,700

28,300

24,800

22,900

24,700

24,200

18,200

1,600

1,900

> Long-term Assets

0
0
9,900
10,100
19,400
13,200
12,900
8,500
8,200
7,800
7,700
6,600
6,500
6,300
8,000
7,800
23,800
23,600
23,900
23,500
30,040
39,646
39,158
40,297
40,297
43,749
102,065
119,356
95,520
89,308
89,245
122,395
160,477
179,355
215,956
224,633
231,399
271,213
266,127
240,475
265,449
226,514
196,222
182,480
248,805
339,756
384,961
391,857
393,274
423,507
429,718
0
478,081
482,893
524,463
537,039
517,850
523,123
577,441
574,739
565,153
554,164
572,981
572,459
581,843
658,072
698,338
691,852
698,627
684,494
691,944
710,548
709,432
709,765
673,489
670,987
1,016,177
998,862
983,145
1,049,304
1,028,857
1,029,647
1,322,708
1,336,209
1,335,697
1,320,176
1,315,547
1,312,784
1,480,096
1,484,965
1,473,244
2,389,111
2,399,043
2,364,451
2,350,659
2,332,805
2,383,025
2,421,738
2,462,767
2,445,072
2,438,893
2,425,537
2,301,425
2,377,934
2,702,479
2,680,405
2,670,680
2,628,667
2,605,944
2,615,448
2,610,560
2,728,260
2,712,917
2,726,341
2,712,142
2,723,952

2,723,952

2,712,142

2,726,341

2,712,917

2,728,260

2,610,560

2,615,448

2,605,944

2,628,667

2,670,680

2,680,405

2,702,479

2,377,934

2,301,425

2,425,537

2,438,893

2,445,072

2,462,767

2,421,738

2,383,025

2,332,805

2,350,659

2,364,451

2,399,043

2,389,111

1,473,244

1,484,965

1,480,096

1,312,784

1,315,547

1,320,176

1,335,697

1,336,209

1,322,708

1,029,647

1,028,857

1,049,304

983,145

998,862

1,016,177

670,987

673,489

709,765

709,432

710,548

691,944

684,494

698,627

691,852

698,338

658,072

581,843

572,459

572,981

554,164

565,153

574,739

577,441

523,123

517,850

537,039

524,463

482,893

478,081

429,718

423,507

393,274

391,857

384,961

339,756

248,805

182,480

196,222

226,514

265,449

240,475

266,127

271,213

231,399

224,633

215,956

179,355

160,477

122,395

89,245

89,308

95,520

119,356

102,065

43,749

40,297

39,158

39,646

30,040

23,500

23,900

23,600

23,800

7,800

8,000

6,300

6,500

6,600

7,700

7,800

8,200

8,500

12,900

13,200

19,400

10,100

9,900

Property Plant Equipment

0
0
9,500
9,600
9,300
9,100
8,800
8,600
8,200
7,800
7,600
6,400
6,400
6,200
6,500
6,300
10,100
9,400
9,600
9,700
10,547
12,060
11,789
11,599
11,599
11,537
11,567
11,662
11,436
11,273
16,424
16,556
17,608
17,757
17,873
20,072
20,213
22,540
22,433
25,461
27,685
27,691
27,511
27,451
29,079
35,791
40,659
42,559
43,702
50,632
55,262
61,730
61,730
63,437
69,999
70,382
69,783
70,777
70,834
83,526
83,418
84,644
87,293
99,456
102,478
115,667
122,435
131,383
136,770
146,928
161,189
177,898
179,352
184,537
192,724
200,310
205,667
206,668
203,882
209,986
210,111
215,460
197,200
205,181
210,330
208,648
212,195
222,369
229,110
232,074
232,241
269,251
274,029
277,025
287,000
300,112
306,350
414,228
417,122
431,934
431,793
427,714
379,355
371,164
387,367
384,933
381,521
396,246
390,853
447,558
448,999
459,586
461,689
466,222
475,478
496,383

496,383

475,478

466,222

461,689

459,586

448,999

447,558

390,853

396,246

381,521

384,933

387,367

371,164

379,355

427,714

431,793

431,934

417,122

414,228

306,350

300,112

287,000

277,025

274,029

269,251

232,241

232,074

229,110

222,369

212,195

208,648

210,330

205,181

197,200

215,460

210,111

209,986

203,882

206,668

205,667

200,310

192,724

184,537

179,352

177,898

161,189

146,928

136,770

131,383

122,435

115,667

102,478

99,456

87,293

84,644

83,418

83,526

70,834

70,777

69,783

70,382

69,999

63,437

61,730

55,262

50,632

43,702

42,559

40,659

35,791

29,079

27,451

27,511

27,691

27,685

25,461

22,433

22,540

20,213

20,072

17,873

17,757

17,608

16,556

16,424

11,273

11,436

11,662

11,567

11,537

11,599

11,789

12,060

10,547

9,700

9,600

9,400

10,100

6,300

6,500

6,200

6,400

7,600

7,800

8,200

8,600

8,800

9,100

9,300

9,600

9,500

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,525
15,835
16,502
17,102
22,073
21,704
22,028
22,566
26,683
28,135
37,843
38,309
39,237
71,789
69,817
69,737
68,364
94,075
147,316
158,243
162,414
163,719
174,507
179,260
207,438
207,438
214,478
210,503
212,094
207,705
211,767
264,605
261,941
257,789
252,143
262,433
261,928
267,426
285,376
294,529
292,980
295,232
292,085
292,426
294,067
292,278
292,881
248,824
249,764
367,649
354,977
349,574
363,888
354,202
357,022
505,727
512,389
516,103
514,023
515,636
510,571
578,229
585,410
587,943
937,905
944,495
927,148
926,369
926,475
922,508
926,732
945,282
954,280
951,554
956,207
919,556
932,367
1,010,072
1,015,638
1,012,081
1,013,458
1,008,928
990,406
977,860
1,038,881
1,041,606
1,043,273
1,036,146
1,055,462

1,055,462

1,036,146

1,043,273

1,041,606

1,038,881

977,860

990,406

1,008,928

1,013,458

1,012,081

1,015,638

1,010,072

932,367

919,556

956,207

951,554

954,280

945,282

926,732

922,508

926,475

926,369

927,148

944,495

937,905

587,943

585,410

578,229

510,571

515,636

514,023

516,103

512,389

505,727

357,022

354,202

363,888

349,574

354,977

367,649

249,764

248,824

292,881

292,278

294,067

292,426

292,085

295,232

292,980

294,529

285,376

267,426

261,928

262,433

252,143

257,789

261,941

264,605

211,767

207,705

212,094

210,503

214,478

207,438

179,260

174,507

163,719

162,414

158,243

147,316

94,075

68,364

69,737

69,817

71,789

39,237

38,309

37,843

28,135

26,683

22,566

22,028

21,704

22,073

17,102

16,502

15,835

31,525

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,629
0
0
0
2,491
13,647
17,527
20,246
5,350
346
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

346

5,350

20,246

17,527

13,647

2,491

1,629

Intangible Assets

0
0
0
0
200
100
100
0
0
0
0
0
0
0
0
1,400
13,200
13,700
13,400
13,200
18,809
26,393
25,296
25,299
25,299
29,558
29,191
31,525
31,016
15,247
16,846
45,164
73,349
51,518
73,636
79,118
81,109
99,435
98,711
99,054
142,336
137,556
135,920
132,933
108,069
140,552
178,354
179,716
177,467
183,775
181,194
195,766
195,766
188,130
209,337
225,998
220,225
217,447
214,432
211,117
206,344
201,174
198,711
194,904
191,210
230,935
243,934
237,122
230,920
224,308
218,345
212,267
212,274
206,884
202,410
197,163
429,446
422,009
413,906
459,459
447,424
440,583
606,420
603,740
594,856
583,569
573,687
561,175
654,408
648,744
634,052
1,159,627
1,147,954
1,121,845
1,097,259
1,079,496
1,058,630
1,041,620
1,040,350
1,031,591
1,014,227
998,686
973,685
989,436
1,193,681
1,178,884
1,155,795
1,145,573
1,121,971
1,082,275
1,054,035
1,126,609
1,108,759
1,093,596
1,067,023
1,067,833

1,067,833

1,067,023

1,093,596

1,108,759

1,126,609

1,054,035

1,082,275

1,121,971

1,145,573

1,155,795

1,178,884

1,193,681

989,436

973,685

998,686

1,014,227

1,031,591

1,040,350

1,041,620

1,058,630

1,079,496

1,097,259

1,121,845

1,147,954

1,159,627

634,052

648,744

654,408

561,175

573,687

583,569

594,856

603,740

606,420

440,583

447,424

459,459

413,906

422,009

429,446

197,163

202,410

206,884

212,274

212,267

218,345

224,308

230,920

237,122

243,934

230,935

191,210

194,904

198,711

201,174

206,344

211,117

214,432

217,447

220,225

225,998

209,337

188,130

195,766

181,194

183,775

177,467

179,716

178,354

140,552

108,069

132,933

135,920

137,556

142,336

99,054

98,711

99,435

81,109

79,118

73,636

51,518

73,349

45,164

16,846

15,247

31,016

31,525

29,191

29,558

25,299

25,296

26,393

18,809

13,200

13,400

13,700

13,200

1,400

100

200

Other Assets

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,493
27,586
27,369
28,698
27,439
32,212
90,498
107,694
84,084
78,035
72,821
105,839
142,869
161,598
198,083
204,561
211,186
248,673
243,694
215,014
237,764
198,823
168,711
155,029
219,726
303,965
344,302
349,298
349,572
372,875
374,456
416,351
419,989
419,456
454,464
466,657
448,067
452,346
506,607
491,213
481,735
469,520
485,688
473,003
479,365
542,405
575,903
560,469
561,857
537,566
530,755
532,650
530,080
525,228
480,765
470,677
810,510
792,194
779,263
839,318
818,746
814,187
1,125,508
1,131,028
1,125,367
1,111,528
1,103,352
1,090,415
1,250,986
1,252,891
1,241,003
2,119,860
2,125,014
20,906
19,785
21,372
30,538
39,158
60,013
27,267
41,319
42,930
-2,301,425
168,602
96,852
96,032
114,485
3,782,383
67,799
70,590
82,173
63,154
72,002
0
0
0

72,002

63,154

82,173

70,590

67,799

3,782,383

114,485

96,032

96,852

168,602

-2,301,425

42,930

41,319

27,267

60,013

39,158

30,538

21,372

19,785

20,906

2,125,014

2,119,860

1,241,003

1,252,891

1,250,986

1,090,415

1,103,352

1,111,528

1,125,367

1,131,028

1,125,508

814,187

818,746

839,318

779,263

792,194

810,510

470,677

480,765

525,228

530,080

532,650

530,755

537,566

561,857

560,469

575,903

542,405

479,365

473,003

485,688

469,520

481,735

491,213

506,607

452,346

448,067

466,657

454,464

419,456

419,989

416,351

374,456

372,875

349,572

349,298

344,302

303,965

219,726

155,029

168,711

198,823

237,764

215,014

243,694

248,673

211,186

204,561

198,083

161,598

142,869

105,839

72,821

78,035

84,084

107,694

90,498

32,212

27,439

28,698

27,369

27,586

19,493

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,657
8,028
15,957
15,743
14,988
19,545
15,412
5,645
6,422
6,259
5,603
5,684
5,689
4,955
6,932
7,128
7,062
7,376
6,935
4,757
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

4,757

6,935

7,376

7,062

7,128

6,932

4,955

5,689

5,684

5,603

6,259

6,422

5,645

15,412

19,545

14,988

15,743

15,957

8,028

8,657

> Total Liabilities

0
0
2,600
2,000
1,800
2,100
2,300
2,300
2,200
2,300
3,000
2,600
3,700
4,100
4,400
3,300
25,000
28,600
27,400
28,300
30,211
32,834
34,633
32,733
32,733
31,671
23,990
23,531
18,304
19,242
24,967
27,071
135,343
154,446
155,474
143,996
143,124
147,128
147,552
148,890
156,062
156,990
158,279
158,614
182,583
254,173
298,979
317,456
317,528
552,976
559,680
557,583
557,583
538,366
639,151
684,225
621,148
543,597
542,814
495,217
480,077
481,419
488,476
517,345
479,442
635,039
673,145
651,471
649,919
654,605
658,805
645,824
646,602
670,912
684,595
526,049
876,723
873,793
859,756
874,303
862,708
926,171
1,097,520
1,023,261
1,053,875
1,019,375
1,003,997
968,287
1,196,524
1,206,576
1,505,071
2,248,951
1,832,027
1,843,868
1,432,251
1,732,091
1,808,681
1,869,459
1,961,606
1,886,504
2,105,762
2,042,663
-475,595
2,100,269
2,212,223
2,137,806
2,142,778
2,097,579
2,056,800
2,091,945
2,082,599
2,085,355
2,067,461
2,094,441
2,160,150
2,194,104

2,194,104

2,160,150

2,094,441

2,067,461

2,085,355

2,082,599

2,091,945

2,056,800

2,097,579

2,142,778

2,137,806

2,212,223

2,100,269

-475,595

2,042,663

2,105,762

1,886,504

1,961,606

1,869,459

1,808,681

1,732,091

1,432,251

1,843,868

1,832,027

2,248,951

1,505,071

1,206,576

1,196,524

968,287

1,003,997

1,019,375

1,053,875

1,023,261

1,097,520

926,171

862,708

874,303

859,756

873,793

876,723

526,049

684,595

670,912

646,602

645,824

658,805

654,605

649,919

651,471

673,145

635,039

479,442

517,345

488,476

481,419

480,077

495,217

542,814

543,597

621,148

684,225

639,151

538,366

557,583

559,680

552,976

317,528

317,456

298,979

254,173

182,583

158,614

158,279

156,990

156,062

148,890

147,552

147,128

143,124

143,996

155,474

154,446

135,343

27,071

24,967

19,242

18,304

23,531

23,990

31,671

32,733

34,633

32,834

30,211

28,300

27,400

28,600

25,000

3,300

4,400

4,100

3,700

2,600

3,000

2,300

2,200

2,300

2,100

1,800

2,000

2,600

> Total Current Liabilities

0
0
2,400
1,800
1,700
1,900
2,200
2,200
2,000
2,200
2,900
2,400
3,400
3,800
4,200
3,000
11,800
12,000
11,000
14,800
16,379
18,300
20,841
21,040
21,040
22,145
17,036
19,146
14,086
15,124
21,018
21,921
25,451
29,539
32,443
20,618
19,694
23,184
23,766
24,234
30,979
32,263
33,536
31,287
53,768
113,619
255,456
274,017
273,744
181,025
188,185
191,671
191,671
189,235
280,602
174,751
170,671
216,834
215,320
156,730
159,180
85,639
102,704
200,032
163,316
118,008
104,433
101,868
104,586
112,247
112,574
106,929
105,780
109,339
122,278
119,382
116,831
126,902
130,123
126,025
126,805
155,753
139,947
139,127
156,630
149,827
161,397
123,601
188,083
177,877
210,234
348,911
336,020
233,342
258,340
262,552
288,106
315,111
302,641
331,309
246,485
212,415
255,146
401,013
412,301
318,756
332,858
340,021
315,833
295,596
304,452
320,906
282,293
377,496
355,712
306,980

306,980

355,712

377,496

282,293

320,906

304,452

295,596

315,833

340,021

332,858

318,756

412,301

401,013

255,146

212,415

246,485

331,309

302,641

315,111

288,106

262,552

258,340

233,342

336,020

348,911

210,234

177,877

188,083

123,601

161,397

149,827

156,630

139,127

139,947

155,753

126,805

126,025

130,123

126,902

116,831

119,382

122,278

109,339

105,780

106,929

112,574

112,247

104,586

101,868

104,433

118,008

163,316

200,032

102,704

85,639

159,180

156,730

215,320

216,834

170,671

174,751

280,602

189,235

191,671

188,185

181,025

273,744

274,017

255,456

113,619

53,768

31,287

33,536

32,263

30,979

24,234

23,766

23,184

19,694

20,618

32,443

29,539

25,451

21,921

21,018

15,124

14,086

19,146

17,036

22,145

21,040

20,841

18,300

16,379

14,800

11,000

12,000

11,800

3,000

4,200

3,800

3,400

2,400

2,900

2,200

2,000

2,200

1,900

1,700

1,800

2,400

Short-term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,800
2,000
2,300
4,051
5,028
6,671
8,872
8,872
7,189
6,619
3,576
4,920
5,441
9,567
9,433
11,009
13,381
11,561
0
0
0
0
0
0
0
0
0
16,000
64,000
202,205
219,542
220,000
119,964
119,962
119,962
119,962
120,000
200,000
100,000
100,000
150,443
94,233
76,760
77,470
0
7,500
108,438
69,375
0
0
0
0
0
0
0
0
0
0
0
0
0
1,875
3,750
5,625
10,403
10,938
14,375
17,813
21,250
28,750
665,000
6,250
12,500
18,750
60,000
60,000
1,476,488
11,250
22,500
33,750
58,448
56,835
57,253
12,964
24,403
35,018
159,068
169,800
58,987
58,526
59,775
59,300
63,368
69,738
52,749
14,792
110,262
24,148
29,815

29,815

24,148

110,262

14,792

52,749

69,738

63,368

59,300

59,775

58,526

58,987

169,800

159,068

35,018

24,403

12,964

57,253

56,835

58,448

33,750

22,500

11,250

1,476,488

60,000

18,750

12,500

6,250

665,000

28,750

21,250

17,813

14,375

10,938

10,403

5,625

3,750

1,875

69,375

108,438

7,500

77,470

76,760

94,233

150,443

100,000

200,000

120,000

119,962

119,964

220,000

219,542

202,205

64,000

16,000

11,561

13,381

11,009

9,433

9,567

5,441

4,920

3,576

6,619

7,189

8,872

6,671

5,028

4,051

2,300

2,000

1,800

1,500

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,648
0
0
0
14,375
0
21,250
28,750
665,000
6,250
881,018
19,934
61,845
60,451
1,476,488
11,250
22,500
33,750
45,000
45,000
45,000
0
11,250
22,500
146,250
155,900
45,000
45,000
45,000
45,000
50,625
56,250
38,125
0
95,644
85,387
14,531

14,531

85,387

95,644

38,125

56,250

50,625

45,000

155,900

146,250

22,500

11,250

45,000

33,750

22,500

11,250

1,476,488

60,451

61,845

19,934

881,018

6,250

665,000

28,750

21,250

14,375

4,648

Accounts payable

0
0
700
300
400
400
300
100
400
200
1,100
500
300
400
500
600
2,400
1,700
1,300
1,000
1,717
2,489
3,710
3,363
3,363
3,601
3,698
2,924
2,995
2,989
3,737
3,764
4,313
4,621
6,604
7,947
6,878
6,630
8,332
10,160
14,543
12,788
9,118
8,978
10,054
16,192
16,255
20,329
19,255
25,827
26,928
23,232
23,232
26,029
26,083
22,964
22,834
19,899
20,345
24,598
25,403
32,906
34,719
27,783
35,311
47,894
35,475
27,656
35,580
43,190
43,239
36,742
43,875
44,767
54,466
50,752
46,428
47,004
45,935
34,060
42,630
58,197
38,587
34,772
53,993
43,954
38,932
29,057
45,594
42,193
40,740
93,967
86,995
84,037
86,380
76,050
100,553
107,191
94,158
113,090
97,061
58,291
50,254
54,608
61,500
65,512
59,600
61,837
88,371
69,498
80,732
102,100
112,785
99,766
93,550
92,326

92,326

93,550

99,766

112,785

102,100

80,732

69,498

88,371

61,837

59,600

65,512

61,500

54,608

50,254

58,291

97,061

113,090

94,158

107,191

100,553

76,050

86,380

84,037

86,995

93,967

40,740

42,193

45,594

29,057

38,932

43,954

53,993

34,772

38,587

58,197

42,630

34,060

45,935

47,004

46,428

50,752

54,466

44,767

43,875

36,742

43,239

43,190

35,580

27,656

35,475

47,894

35,311

27,783

34,719

32,906

25,403

24,598

20,345

19,899

22,834

22,964

26,083

26,029

23,232

26,928

25,827

19,255

20,329

16,255

16,192

10,054

8,978

9,118

12,788

14,543

10,160

8,332

6,630

6,878

7,947

6,604

4,621

4,313

3,764

3,737

2,989

2,995

2,924

3,698

3,601

3,363

3,710

2,489

1,717

1,000

1,300

1,700

2,400

600

500

400

300

500

1,100

200

400

100

300

400

300

700

Other Current Liabilities

0
0
1,700
1,500
1,300
1,500
1,900
2,100
1,600
2,000
1,800
1,900
3,100
3,400
3,700
2,400
7,900
8,500
7,700
11,500
10,611
10,783
10,460
7,605
8,805
10,388
5,701
11,874
5,303
5,765
6,390
7,908
9,183
10,574
10,961
12,671
12,816
16,554
15,434
14,074
16,436
19,475
24,418
22,309
21,922
25,147
32,010
29,827
31,088
32,371
38,509
48,477
45,576
40,551
51,030
48,734
44,664
43,167
96,659
51,295
52,370
48,732
56,158
59,367
54,794
66,747
65,329
69,669
64,979
64,796
65,690
66,682
58,037
60,824
63,338
64,433
66,183
75,487
77,130
83,039
74,247
82,850
85,491
84,314
77,602
76,472
86,718
87,732
128,151
114,760
143,076
183,893
24,215
149,305
5,000
160,238
150,053
145,965
147,664
156,194
131,600
125,004
164,999
182,062
175,601
188,367
209,344
213,114
162,819
157,305
147,618
158,804
146,973
159,193
229,875
176,299

176,299

229,875

159,193

146,973

158,804

147,618

157,305

162,819

213,114

209,344

188,367

175,601

182,062

164,999

125,004

131,600

156,194

147,664

145,965

150,053

160,238

5,000

149,305

24,215

183,893

143,076

114,760

128,151

87,732

86,718

76,472

77,602

84,314

85,491

82,850

74,247

83,039

77,130

75,487

66,183

64,433

63,338

60,824

58,037

66,682

65,690

64,796

64,979

69,669

65,329

66,747

54,794

59,367

56,158

48,732

52,370

51,295

96,659

43,167

44,664

48,734

51,030

40,551

45,576

48,477

38,509

32,371

31,088

29,827

32,010

25,147

21,922

22,309

24,418

19,475

16,436

14,074

15,434

16,554

12,816

12,671

10,961

10,574

9,183

7,908

6,390

5,765

5,303

11,874

5,701

10,388

8,805

7,605

10,460

10,783

10,611

11,500

7,700

8,500

7,900

2,400

3,700

3,400

3,100

1,900

1,800

2,000

1,600

2,100

1,900

1,500

1,300

1,500

1,700

> Long-term Liabilities

0
0
200
200
100
200
100
100
200
100
100
200
300
300
200
300
13,200
16,600
16,400
13,500
13,832
14,534
13,792
11,693
11,693
9,526
6,954
4,385
4,218
4,118
3,949
5,150
109,892
124,907
123,031
123,378
123,430
123,944
123,786
124,656
125,083
124,727
124,743
127,327
128,815
140,554
43,523
43,439
43,784
371,951
371,495
0
365,912
349,131
358,549
509,474
450,477
326,763
327,494
338,487
320,897
395,780
385,772
317,313
316,126
517,031
568,712
549,603
545,333
542,358
546,231
538,895
540,822
561,573
562,317
406,667
759,892
746,891
729,633
748,278
735,903
770,418
957,573
884,134
897,245
869,548
842,600
844,686
1,008,441
1,028,699
1,294,837
1,900,040
1,913,233
1,610,526
1,555,221
1,469,539
1,520,575
1,554,348
1,658,965
1,555,195
1,859,277
1,830,248
1,528,800
1,699,256
1,799,922
1,819,050
1,809,920
1,757,558
1,740,967
1,796,349
1,778,147
1,764,449
1,785,168
1,716,945
1,804,438
1,887,124

1,887,124

1,804,438

1,716,945

1,785,168

1,764,449

1,778,147

1,796,349

1,740,967

1,757,558

1,809,920

1,819,050

1,799,922

1,699,256

1,528,800

1,830,248

1,859,277

1,555,195

1,658,965

1,554,348

1,520,575

1,469,539

1,555,221

1,610,526

1,913,233

1,900,040

1,294,837

1,028,699

1,008,441

844,686

842,600

869,548

897,245

884,134

957,573

770,418

735,903

748,278

729,633

746,891

759,892

406,667

562,317

561,573

540,822

538,895

546,231

542,358

545,333

549,603

568,712

517,031

316,126

317,313

385,772

395,780

320,897

338,487

327,494

326,763

450,477

509,474

358,549

349,131

365,912

371,495

371,951

43,784

43,439

43,523

140,554

128,815

127,327

124,743

124,727

125,083

124,656

123,786

123,944

123,430

123,378

123,031

124,907

109,892

5,150

3,949

4,118

4,218

4,385

6,954

9,526

11,693

13,792

14,534

13,832

13,500

16,400

16,600

13,200

300

200

300

200

100

200

100

200

100

200

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
371,900
366,014
294,842
293,699
490,062
541,604
532,264
522,978
515,947
517,735
519,547
521,386
543,250
545,140
392,057
629,000
630,971
621,095
626,246
611,427
643,733
718,792
700,595
712,189
684,291
658,998
665,000
848,750
867,500
1,152,633
1,781,142
1,772,027
1,476,488
1,421,001
1,210,513
1,205,025
1,204,537
1,274,049
1,198,561
1,478,191
1,472,323
1,414,000
1,408,221
1,484,912
1,386,176
1,387,433
1,388,683
1,389,927
1,385,537
1,381,142
1,300,490
1,337,212
1,333,414
0
0

1,333,414

1,337,212

1,300,490

1,381,142

1,385,537

1,389,927

1,388,683

1,387,433

1,386,176

1,484,912

1,408,221

1,414,000

1,472,323

1,478,191

1,198,561

1,274,049

1,204,537

1,205,025

1,210,513

1,421,001

1,476,488

1,772,027

1,781,142

1,152,633

867,500

848,750

665,000

658,998

684,291

712,189

700,595

718,792

643,733

611,427

626,246

621,095

630,971

629,000

392,057

545,140

543,250

521,386

519,547

517,735

515,947

522,978

532,264

541,604

490,062

293,699

294,842

366,014

371,900

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,657
8,028
15,957
15,743
14,988
19,545
15,412
5,645
6,422
6,259
5,603
5,684
5,689
4,955
6,932
7,128
7,062
7,376
6,935
4,757
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

4,757

6,935

7,376

7,062

7,128

6,932

4,955

5,689

5,684

5,603

6,259

6,422

5,645

15,412

19,545

14,988

15,743

15,957

8,028

8,657

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,628
4,932
4,932
5,147
4,892
4,734
4,548
4,386
4,218
4,118
3,949
5,150
5,211
5,254
3,120
4,121
3,688
5,608
4,566
5,756
6,452
5,568
6,275
6,429
6,700
7,537
5,540
11,575
14,478
14,541
14,667
19,860
20,057
19,131
18,311
19,474
19,170
21,051
20,274
20,414
17,132
16,225
12,485
11,826
11,608
16,652
18,494
11,613
16,857
17,087
13,603
13,955
14,039
12,927
12,023
12,527
36,280
34,380
31,756
30,409
32,045
31,984
29,274
28,648
28,607
28,920
30,230
30,745
28,855
29,944
13,576
53,768
68,327
134,038
134,220
128,441
108,167
112,804
126,218
116,108
106,299
110,968
127,254
131,181
172,744
178,527
175,430
135,903
144,818
142,296
133,472
201,839
187,466
0
0
0

187,466

201,839

133,472

142,296

144,818

135,903

175,430

178,527

172,744

131,181

127,254

110,968

106,299

116,108

126,218

112,804

108,167

128,441

134,220

134,038

68,327

53,768

13,576

29,944

28,855

30,745

30,230

28,920

28,607

28,648

29,274

31,984

32,045

30,409

31,756

34,380

36,280

12,527

12,023

12,927

14,039

13,955

13,603

17,087

16,857

11,613

18,494

16,652

11,608

11,826

12,485

16,225

17,132

20,414

20,274

21,051

19,170

19,474

18,311

19,131

20,057

19,860

14,667

14,541

14,478

11,575

5,540

7,537

6,700

6,429

6,275

5,568

6,452

5,756

4,566

5,608

3,688

4,121

3,120

5,254

5,211

5,150

3,949

4,118

4,218

4,386

4,548

4,734

4,892

5,147

4,932

5,628

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,324
14,893
5,393
5,397
5,396
5,154
2,083
94,612
81,540
76,782
91,623
92,431
94,701
209,507
154,891
156,449
156,337
153,372
148,941
130,836
131,255
128,628
65,130
72,879
73,311
72,997
57,778
57,660
53,086
59,730
36,553
24,221
21,260
27,780
16,190
65,282
63,447
70,325
45,788
56,633
61,287
69,743
63,338
61,693
70,653
0
0

70,653

61,693

63,338

69,743

61,287

56,633

45,788

70,325

63,447

65,282

16,190

27,780

21,260

24,221

36,553

59,730

53,086

57,660

57,778

72,997

73,311

72,879

65,130

128,628

131,255

130,836

148,941

153,372

156,337

156,449

154,891

209,507

94,701

92,431

91,623

76,782

81,540

94,612

2,083

5,154

5,396

5,397

5,393

14,893

9,324

> Total Stockholder Equity

0
0
19,600
17,400
51,900
50,500
48,600
46,400
44,800
42,900
40,500
35,800
32,400
33,300
34,100
31,400
41,700
38,200
36,600
38,000
43,482
43,455
51,127
53,781
53,781
62,522
182,566
204,057
208,463
215,148
217,606
247,597
221,412
238,087
247,055
268,530
278,015
288,272
292,635
307,823
314,345
294,696
307,602
289,818
309,048
312,046
305,481
296,162
305,546
223,514
250,397
260,429
260,429
324,088
321,594
350,206
374,269
402,775
430,422
444,885
457,920
460,376
470,800
499,963
527,586
518,817
501,521
492,638
508,451
507,212
526,701
517,775
509,889
516,589
499,477
670,180
679,200
689,230
685,978
704,322
688,099
711,723
730,100
751,443
776,387
794,787
823,427
839,667
852,491
894,555
913,116
962,306
998,440
1,341,905
1,365,081
1,375,796
1,397,030
1,420,951
1,384,974
1,416,736
1,341,803
1,349,096
1,397,897
1,514,867
1,529,331
1,574,981
1,631,687
1,684,804
1,615,197
1,660,917
1,724,414
1,804,403
1,674,938
1,683,160
1,579,221
1,587,884

1,587,884

1,579,221

1,683,160

1,674,938

1,804,403

1,724,414

1,660,917

1,615,197

1,684,804

1,631,687

1,574,981

1,529,331

1,514,867

1,397,897

1,349,096

1,341,803

1,416,736

1,384,974

1,420,951

1,397,030

1,375,796

1,365,081

1,341,905

998,440

962,306

913,116

894,555

852,491

839,667

823,427

794,787

776,387

751,443

730,100

711,723

688,099

704,322

685,978

689,230

679,200

670,180

499,477

516,589

509,889

517,775

526,701

507,212

508,451

492,638

501,521

518,817

527,586

499,963

470,800

460,376

457,920

444,885

430,422

402,775

374,269

350,206

321,594

324,088

260,429

250,397

223,514

305,546

296,162

305,481

312,046

309,048

289,818

307,602

294,696

314,345

307,823

292,635

288,272

278,015

268,530

247,055

238,087

221,412

247,597

217,606

215,148

208,463

204,057

182,566

62,522

53,781

51,127

43,455

43,482

38,000

36,600

38,200

41,700

31,400

34,100

33,300

32,400

35,800

40,500

42,900

44,800

46,400

48,600

50,500

51,900

17,400

19,600

Common Stock

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
163
164
169
173
173
207
256
261
263
269
270
272
276
276
276
286
287
290
290
292
293
295
296
298
310
311
312
315
318
320
322
323
323
337
340
344
345
347
348
350
353
353
354
359
359
360
359
357
358
359
359
369
370
370
370
410
415
415
415
416
418
420
458
459
460
462
463
777
782
804
813
813
817
877
880
880
882
883
886
887
889
892
892
893
894
895
896
896
900
903
903
905
908
909
909
909

909

908

905

903

900

896

895

894

893

892

889

887

886

883

882

880

877

817

813

804

782

777

463

462

460

459

458

420

418

416

415

410

370

369

359

358

357

359

360

359

354

353

350

348

347

345

344

340

337

323

322

320

318

315

312

311

310

298

296

295

293

292

290

287

286

276

272

270

269

263

261

256

207

173

169

164

163

200

Retained Earnings Total Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
197,540
214,024
232,830
244,317
245,018
256,259
260,819
267,512
276,026
289,237
302,023
297,973
301,413
272,863
285,046
283,162
287,987
297,794
314,960
323,344
328,341
128,038
145,879
157,563
172,052
192,195
220,443
226,837
237,673
240,831
285,186
297,500
309,941
323,236
348,373
381,129
410,865
383,255
398,574
407,553
407,184
439,521
532,265
574,888
609,955
653,184
698,568
731,469
776,257
826,172
879,118
903,344
907,528
0
0

907,528

903,344

879,118

826,172

776,257

731,469

698,568

653,184

609,955

574,888

532,265

439,521

407,184

407,553

398,574

383,255

410,865

381,129

348,373

323,236

309,941

297,500

285,186

240,831

237,673

226,837

220,443

192,195

172,052

157,563

145,879

128,038

328,341

323,344

314,960

297,794

287,987

283,162

285,046

272,863

301,413

297,973

302,023

289,237

276,026

267,512

260,819

256,259

245,018

244,317

232,830

214,024

197,540

Accumulated Other Comprehensive Income

0
0
-1,000
-2,300
-2,300
-2,300
-2,300
-3,700
-3,700
-3,700
-4,700
-4,500
-4,800
-5,100
-5,500
-5,800
-6,500
-6,900
-200
-200
-68
-362
-786
-10,684
-619
-1,242
-277
-576
-1,247
641
1,118
1,453
967
2,271
2,274
4,226
4,368
2,991
4,206
6,668
1,957
-3,224
-3,456
-4,773
-2,910
1,647
3,189
8,080
9,625
12,287
20,677
19,000
19,045
31,287
15,999
5,355
-2,599
10,928
18,639
8,905
-2,284
-19,000
1,429
-1,795
12,361
15,857
-3,280
-9,093
-2,147
-13,389
-9,495
-4,797
-11,281
-9,404
-713
927
1,927
1,853
-14,318
-23,488
-47,616
-40,288
-41,723
-47,902
-36,665
-43,576
-40,310
-57,154
-51,453
-34,158
-23,783
-23,807
-1,663
-25,306
-26,271
-45,443
-56,679
-68,700
-87,615
-76,402
-104,588
-103,124
-91,913
-74,059
-43,627
-49,963
-46,774
-45,155
-21,025
-13,215
-7,439
10,265
7,067
4,830
1,745
-15,106

-15,106

1,745

4,830

7,067

10,265

-7,439

-13,215

-21,025

-45,155

-46,774

-49,963

-43,627

-74,059

-91,913

-103,124

-104,588

-76,402

-87,615

-68,700

-56,679

-45,443

-26,271

-25,306

-1,663

-23,807

-23,783

-34,158

-51,453

-57,154

-40,310

-43,576

-36,665

-47,902

-41,723

-40,288

-47,616

-23,488

-14,318

1,853

1,927

927

-713

-9,404

-11,281

-4,797

-9,495

-13,389

-2,147

-9,093

-3,280

15,857

12,361

-1,795

1,429

-19,000

-2,284

8,905

18,639

10,928

-2,599

5,355

15,999

31,287

19,045

19,000

20,677

12,287

9,625

8,080

3,189

1,647

-2,910

-4,773

-3,456

-3,224

1,957

6,668

4,206

2,991

4,368

4,226

2,274

2,271

967

1,453

1,118

641

-1,247

-576

-277

-1,242

-619

-10,684

-786

-362

-68

-200

-6,900

-6,500

-5,800

-5,500

-5,100

-4,800

-4,500

-4,700

-3,700

-2,300

-1,000

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
533,863
538,651
552,227
558,527
598,249
600,852
607,676
609,849
611,337
613,721
587,301
589,948
591,331
594,078
750,918
760,817
766,096
769,208
779,555
779,074
790,371
1,010,448
1,020,128
1,022,150
1,032,970
1,038,200
798,652
799,376
812,250
817,071
821,758
822,520
1,177,125
1,187,963
1,192,601
1,191,807
1,198,010
1,208,549
1,213,620
1,240,455
1,279,370
1,284,711
1,290,909
1,231,637
1,248,555
1,258,830
1,264,943
1,266,739
1,259,852
1,267,641
1,276,977
1,245,297
1,283,675
0
0

1,283,675

1,245,297

1,276,977

1,267,641

1,259,852

1,266,739

1,264,943

1,258,830

1,248,555

1,231,637

1,290,909

1,284,711

1,279,370

1,240,455

1,213,620

1,208,549

1,198,010

1,191,807

1,192,601

1,187,963

1,177,125

822,520

821,758

817,071

812,250

799,376

798,652

1,038,200

1,032,970

1,022,150

1,020,128

1,010,448

790,371

779,074

779,555

769,208

766,096

760,817

750,918

594,078

591,331

589,948

587,301

613,721

611,337

609,849

607,676

600,852

598,249

558,527

552,227

538,651

533,863

Treasury Stock

-481,678

-362,862

-362,863

-362,880

-362,886

-234,448

-234,449

-234,461

-235,141

-235,224

-235,226

-202,506

-119,943

-120,101

-120,107

-120,109

-120,615

-120,727

-120,732

-120,734

-121,644

-121,816

-122,014

-123,051

-367,121

-352,669

-340,667

-287,978

-283,658

-252,380

-231,914

-156,921

-145,846

-107,640

-91,002

-75,815

-44,124

-19,474

-5,236

-17,955

-21,204

-37,137

-1,812

-51

-180

-7

Other Stockholders Equity

0
0
69,900
71,200
107,200
107,400
107,500
109,100
109,300
109,500
110,500
116,200
116,400
120,900
125,000
125,500
136,100
136,600
137,300
140,100
138,747
138,929
145,303
0
144,038
164,527
279,812
283,971
284,955
285,497
300,753
290,195
259,054
269,007
271,139
281,480
283,384
287,497
298,243
301,128
303,917
281,792
284,448
257,364
266,014
256,477
245,775
221,431
221,851
127,813
136,630
0
142,886
169,798
197,881
212,288
250,750
254,502
260,005
268,469
277,468
281,483
254,993
268,569
270,549
257,582
248,183
240,555
242,728
244,216
246,600
220,180
222,827
224,210
226,957
383,797
393,696
398,975
402,087
412,434
411,953
423,250
643,327
653,007
655,029
665,849
671,079
675,601
676,325
690,236
695,255
700,114
701,786
1,056,393
1,067,236
1,071,986
1,071,698
1,077,903
1,088,448
1,093,677
1,037,949
1,044,144
1,049,487
1,055,768
997,176
1,014,094
1,024,381
1,729,959
903,853
896,972
904,778
914,115
763,619
769,893
649,542
655,222

655,222

649,542

769,893

763,619

914,115

904,778

896,972

903,853

1,729,959

1,024,381

1,014,094

997,176

1,055,768

1,049,487

1,044,144

1,037,949

1,093,677

1,088,448

1,077,903

1,071,698

1,071,986

1,067,236

1,056,393

701,786

700,114

695,255

690,236

676,325

675,601

671,079

665,849

655,029

653,007

643,327

423,250

411,953

412,434

402,087

398,975

393,696

383,797

226,957

224,210

222,827

220,180

246,600

244,216

242,728

240,555

248,183

257,582

270,549

268,569

254,993

281,483

277,468

268,469

260,005

254,502

250,750

212,288

197,881

169,798

142,886

136,630

127,813

221,851

221,431

245,775

256,477

266,014

257,364

284,448

281,792

303,917

301,128

298,243

287,497

283,384

281,480

271,139

269,007

259,054

290,195

300,753

285,497

284,955

283,971

279,812

164,527

144,038

145,303

138,929

138,747

140,100

137,300

136,600

136,100

125,500

125,000

120,900

116,400

116,200

110,500

109,500

109,300

109,100

107,500

107,400

107,200

71,200

69,900

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Accounts Payable	92,326	102,100	61,837	54,608	113,090	76,050	93,967	29,057	34,772	34,060	50,752	36,742	27,656	27,783	24,598	22,964	23,232	20,329	8,978	10,160	7,947	3,764	2,924	3,363	1,000	600	500	100	300
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-15,106	10,265	-45,155	-74,059	-76,402	-45,443	-23,807	-57,154	-47,902	-23,488	927	-4,797	-9,093	-1,795	8,905	5,355	19,045	8,080	-4,773	6,668	4,226	1,453	-576	-619	-200	-5,800	-4,500	-3,700	-2,300
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	182,133	172,044	105,104	100,936	109,757	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	909	905	896	893	887	880	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	1,276,977	1,264,943	1,290,909	1,213,620	1,192,601	821,758	798,652	1,020,128	779,555	750,918	587,301	607,676	552,227	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	276,402	456,661	513,448	470,166	198,911	138,838	174,935	102,055	48,132	71,994	120,614	96,938	100,808	128,763	71,891	183,546	57,339	22,697	46,889	69,855	78,979	43,583	44,518	14,086	19,300	5,300	2,100	11,800	4,500
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	309,096	456,661	513,448	470,166	198,911	138,838	174,935	102,055	48,132	71,994	120,614	96,938	100,808	128,763	71,891	183,546	57,339	22,697	127,216	100,810	108,546	98,861	66,701	15,138	23,600	5,300	2,100	11,800	4,500
Common Stock	909	905	896	893	887	880	813	777	459	416	410	369	357	359	350	344	323	315	298	292	286	272	261	173	200	0	0	0	0
Common Stock Shares Outstanding	80,337	83,516	85,485	85,228	86,494	84,446	79,121	79,194	73,884	65,920	57,604	57,032	58,990	60,298	58,584	56,756	59,156	65,494	69,130	62,204	66,208	61,790	55,592	35,106	34,118	32,278	29,565	28,114	20,992
Common Stock Total Equity	0	905	896	893	887	880	813	777	459	416	410	369	357	359	350	344	323	315	298	292	286	272	261	173	200	0	0	0	0
Current Deferred Revenue	8,540	7,253	5,295	5,275	4,772	3,764	11,051	6,812	5,666	5,176	4,197	3,505	4,543	4,444	4,077	3,053	2,901	4,319	0	0	0	816	772	0	0	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	6,935	6,932	5,603	15,412	15,957	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	63,338	45,788	16,190	36,553	57,778	65,130	148,941	154,891	91,623	2,083	5,393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	1,055,462	1,038,881	1,013,458	932,367	954,280	926,475	937,905	510,571	512,389	363,888	249,764	294,067	292,980	261,928	261,941	212,094	207,438	162,414	68,364	39,237	26,683	22,073	31,525	0	0	0	0	0	0
Intangible Assets	1,067,833	1,126,609	1,145,573	989,436	1,031,591	1,079,496	1,159,627	561,175	603,740	459,459	197,163	212,267	237,122	194,904	211,117	225,998	195,766	179,716	132,933	99,054	79,118	45,164	31,525	25,299	13,200	1,400	0	0	0
Inventory	389,608	324,583	317,386	310,117	316,054	280,347	296,332	217,263	211,429	237,114	213,431	171,806	171,261	146,928	140,240	146,103	144,535	94,387	67,476	55,947	41,046	28,502	24,609	16,508	10,100	2,700	2,400	2,600	1,400
Liabilities And Stockholders Equity	3,781,988	3,889,758	3,782,383	3,615,136	3,303,240	3,107,887	3,211,257	1,807,954	1,774,704	1,578,625	1,196,229	1,163,599	1,144,109	1,017,308	940,102	1,034,431	818,012	613,618	448,432	456,713	412,526	274,668	227,588	86,514	66,300	34,700	38,400	48,700	19,400
Long Term Debt	1,485,018	1,300,490	1,388,683	1,408,221	1,198,561	1,210,513	1,781,142	665,000	700,595	626,246	392,057	519,547	532,264	294,842	308,754	490,000	330,000	508	118,378	118,900	119,257	0	0	4,758	0	0	0	0	0
Long Term Debt Total	0	1,300,490	1,388,683	1,408,221	1,198,561	1,210,513	1,781,142	665,000	700,595	626,246	392,057	519,547	532,264	294,842	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	5,350	2,491	1,629	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	1,405,280	1,158,698	1,137,839	1,185,241	1,258,907	1,215,375	1,666,207	562,945	666,838	558,002	271,443	422,609	431,456	274,517	313,623	406,454	392,623	197,353	71,489	49,045	40,278	-43,583	-40,942	-456	-9,400	-5,300	-2,100	-11,800	-4,500
Net Invested Capital	3,087,433	3,247,718	3,230,987	3,069,338	2,764,797	2,730,009	2,803,448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	259,327	263,465	231,831	225,532	275,296	265,737	251,799	148,186	132,241	131,918	118,145	114,916	118,129	106,005	103,228	112,417	103,539	85,018	49,007	46,765	28,936	19,412	14,024	13,087	8,400	3,100	2,800	2,900	1,800
Net Tangible Assets	0	-361,087	-474,227	-406,936	-569,135	-630,175	-1,135,226	-232,079	-364,686	-119,025	223,253	11,441	-37,464	43,131	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	751,056	840,592	813,695	836,189	526,859	512,530	473,235	371,569	299,368	403,296	405,860	346,122	350,389	244,817	208,633	322,641	148,260	-52,256	234,665	192,004	167,275	130,352	89,086	25,177	28,000	23,900	29,400	38,000	7,500
Non Current Assets Total	2,723,952	2,728,260	2,628,667	2,377,934	2,445,072	2,332,805	2,389,111	1,312,784	1,336,209	1,049,304	670,987	710,548	691,852	572,459	574,739	537,039	478,081	391,857	182,480	240,475	224,633	122,395	119,356	40,297	23,500	7,800	6,600	8,500	10,100
Non Current Liabilities Other	199,940	400,621	323,087	274,845	320,081	201,248	53,768	30,745	28,648	30,409	12,527	13,955	11,613	11,826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	1,887,124	1,764,449	1,757,558	1,699,256	1,555,195	1,469,539	1,900,040	844,686	884,134	748,278	406,667	538,895	549,603	317,313	338,487	509,474	365,912	43,439	127,327	124,656	123,378	5,150	4,385	11,693	13,500	300	200	100	200
Non Currrent Assets Other	26,014	-510,151	9,963	11,277	11,179	19,917	16,078	11,734	7,967	10,368	8,338	10,359	13,128	8,277	2,314	28,565	13,147	7,168	22,096	100,173	104,074	35,457	65,926	3,399	600	100	200	-100	500
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	63,154	3,782,383	168,602	27,267	21,372	19,837	17,040	14,419	15,971	23,750	26,316	30,367	16,171	18,155	28,565	13,147	7,168	5,928	20,788	27,246	27,225	11,834	28,698	0	0	0	0	0
Other Current Assets	100,005	116,789	91,051	231,387	67,907	90,160	99,080	27,666	42,620	29,632	26,752	30,291	62,059	63,153	50,004	55,326	34,518	19,659	22,253	12,716	9,365	5,498	2,898	1,484	700	15,800	24,500	22,900	1,600
Other Current Liab	176,299	158,804	213,114	182,062	156,194	160,238	183,893	87,732	168,628	166,078	64,433	66,682	69,669	118,734	102,590	97,468	91,152	59,654	22,309	14,074	12,671	17,341	11,874	8,805	11,500	2,400	1,900	2,100	1,500
Other Liab	0	201,839	135,903	131,181	116,108	128,441	117,323	179,686	183,539	30,409	12,527	13,955	11,613	11,826	20,414	19,474	19,860	11,575	6,429	5,756	4,121	5,150	4,386	5,147	0	0	0	0	0
Other Stockholder Equity	655,222	914,115	1,030,495	1,055,768	1,093,677	1,071,986	700,114	675,601	653,007	412,434	383,797	220,180	240,555	268,569	268,469	212,288	142,886	221,431	257,364	301,128	281,480	290,195	567,942	288,076	132,300	119,700	111,700	105,400	68,900
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0
Property Plant And Equipment Gross	863,830	789,315	711,120	371,164	431,934	300,112	269,251	222,369	205,181	209,986	200,310	177,898	131,383	99,456	83,526	70,382	61,730	42,559	27,451	25,461	20,072	16,556	11,662	11,599	9,700	6,300	6,400	8,600	9,600
Property Plant And Equipment Net	496,383	459,586	396,246	371,164	431,934	300,112	269,251	222,369	205,181	209,986	200,310	177,898	131,383	99,456	83,526	70,382	61,730	42,559	27,451	25,461	20,072	16,556	11,662	11,599	9,700	6,300	6,400	8,600	9,600
Property Plant Equipment	0	311,302	311,703	287,529	337,404	300,112	269,251	222,369	205,181	209,986	200,310	177,898	131,383	99,456	83,526	70,382	61,730	42,559	27,451	25,461	20,072	16,556	11,662	11,599	0	0	0	0	0
Retained Earnings	946,859	879,118	698,568	532,265	398,574	348,373	285,186	220,443	145,879	314,960	285,046	302,023	260,819	232,830	167,161	132,219	98,175	66,336	36,929	-265	-17,462	-44,323	-79,600	-105,729	-94,300	-88,300	-75,900	-59,000	-51,500
Retained Earnings Total Equity	0	879,118	698,568	532,265	398,574	348,373	285,186	220,443	145,879	314,960	285,046	302,023	260,819	232,830	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	14,531	38,125	45,000	146,250	45,000	22,500	60,000	665,000	14,375	4,648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	1,681,682	1,615,359	1,651,287	1,655,407	1,457,818	1,354,213	1,841,142	665,000	714,970	629,996	392,057	519,547	532,264	403,280	385,514	590,000	449,962	220,050	118,378	118,900	119,257	0	3,576	13,630	9,900	0	0	0	0
Short Term Debt	29,815	52,749	59,775	159,068	57,253	22,500	60,000	665,000	14,375	3,750	0	0	0	108,438	76,760	100,000	119,962	219,542	0	0	0	9,433	3,576	8,872	2,300	0	0	0	0
Short Term Investments	32,694	16,682	0	0	12	0	0	0	4,073	0	0	0	0	0	0	0	0	0	80,327	30,955	29,567	55,278	22,183	1,052	4,300	0	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	3,781,988	3,889,758	3,782,383	3,615,136	3,303,240	3,107,887	3,211,257	1,807,954	1,774,704	1,578,625	1,196,229	1,163,599	1,144,109	1,017,308	940,102	1,034,431	818,012	613,618	448,432	456,713	412,526	274,668	227,588	86,514	66,300	34,700	38,400	48,700	19,400
Total Current Assets	1,058,036	1,161,498	1,153,716	1,237,202	858,168	775,082	822,146	495,170	438,495	529,321	525,242	453,051	452,257	444,849	365,363	497,392	339,931	221,761	265,952	216,238	187,893	152,273	108,232	46,217	42,800	26,900	31,800	40,200	9,300
Total Current Liabilities	306,980	320,906	340,021	401,013	331,309	262,552	348,911	123,601	139,127	126,025	119,382	106,929	101,868	200,032	156,730	174,751	191,671	274,017	31,287	24,234	20,618	21,921	19,146	21,040	14,800	3,000	2,400	2,200	1,800
Total Liab	2,194,104	2,085,355	2,097,579	2,100,269	1,886,504	1,732,091	2,248,951	968,287	1,023,261	874,303	526,049	645,824	651,471	517,345	495,217	684,225	557,583	317,456	158,614	148,890	143,996	27,071	23,531	32,733	28,300	3,300	2,600	2,300	2,000
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	1,587,884	1,804,403	1,684,804	1,514,867	1,416,736	1,375,796	962,306	839,667	751,443	704,322	670,180	517,775	492,638	499,963	444,885	350,206	260,429	296,162	289,818	307,823	268,530	247,597	204,057	53,781	38,000	31,400	35,800	46,400	17,400
Treasury Stock	0	-362,862	-234,448	-235,141	-119,943	-120,615	-121,644	-123,051	-367,121	-367,121	-367,121	-367,121	-367,121	-283,658	-252,380	-252,380	-252,380	-145,846	-75,815	-19,474	-5,236	-1,812	-51	-180	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31
Accounts Payable	92,326	93,550	99,766	112,785	102,100	80,732	69,498	88,371	61,837	59,600	65,512	61,500	54,608	50,254	58,291	97,061	113,090	94,158	107,191	100,553	76,050	86,380	84,037	86,995	93,967	40,740	42,193	45,594	29,057	38,932	43,954	53,993	34,772	38,587	58,197	42,630	34,060	45,935	47,004	46,428	50,752	54,466	44,767	43,875	36,742	43,239	43,190	35,580	27,656	35,475	47,894	35,311	27,783	34,719	32,906	25,403	24,598	20,345	19,899	22,834	22,964	26,083	26,029	23,232	23,232	26,928	25,827	19,255	20,329	16,255	16,192	10,054	8,978	9,118	12,788	14,543	10,160	8,332	6,630	6,878	7,947	6,604	4,621	4,313	3,764	3,737	2,989	2,995	2,924	3,698	3,601	3,363	3,363	3,710	2,489	1,717	1,000	1,300	1,700	2,400	600	500	400	300	500	1,100	200	400	100	300	400	400	300	700	-	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Other Comprehensive Income	-15,106	1,745	4,830	7,067	10,265	-7,439	-13,215	-21,025	-45,155	-46,774	-49,963	-43,627	-74,059	-91,913	-103,124	-104,588	-76,402	-87,615	-68,700	-56,679	-45,443	-26,271	-25,306	-1,663	-23,807	-23,783	-34,158	-51,453	-57,154	-40,310	-43,576	-36,665	-47,902	-41,723	-40,288	-47,616	-23,488	-14,318	1,853	1,927	927	-713	-9,404	-11,281	-4,797	-9,495	-13,389	-2,147	-9,093	-3,280	15,857	12,361	-1,795	1,429	-19,000	-2,284	8,905	18,639	10,928	-2,599	5,355	15,999	31,287	19,045	19,000	20,677	12,287	9,625	8,080	3,189	1,647	-2,910	-4,773	-3,456	-3,224	1,957	6,668	4,206	2,991	4,368	4,226	2,274	2,271	967	1,453	1,118	641	-1,247	-576	-277	-1,242	-619	-10,684	-786	-362	-68	-200	-200	-6,900	-6,500	-5,800	-5,500	-5,100	-4,800	-4,500	-4,700	-3,700	-3,700	-3,700	-2,300	-2,300	-2,300	-2,300	-1,000	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Lease Obligations	182,133	182,478	174,156	171,702	172,044	171,021	166,772	102,106	105,104	108,366	109,183	109,449	100,936	101,296	111,984	113,292	109,757	108,655	107,645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Stock	909	909	909	908	905	903	903	900	896	896	895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Surpluse	0	0	1,283,675	1,245,297	1,276,977	1,267,641	1,259,852	1,266,739	1,264,943	1,258,830	1,248,555	1,231,637	1,290,909	1,284,711	1,279,370	1,240,455	1,213,620	1,208,549	1,198,010	1,191,807	1,192,601	1,187,963	1,177,125	822,520	821,758	817,071	812,250	799,376	798,652	1,038,200	1,032,970	1,022,150	1,020,128	1,010,448	790,371	779,074	779,555	769,208	766,096	760,817	750,918	594,078	591,331	589,948	587,301	613,721	611,337	609,849	607,676	600,852	598,249	558,527	552,227	538,651	533,863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash	276,402	273,732	309,192	307,367	456,661	511,937	447,152	407,092	513,448	470,231	397,414	408,976	470,166	396,279	360,981	357,712	198,911	207,981	176,084	157,025	138,838	205,991	183,771	189,396	174,935	481,943	154,600	124,113	102,055	107,598	86,803	77,086	48,132	79,311	131,296	79,871	71,994	140,231	137,160	129,038	120,614	118,868	98,636	89,691	96,938	125,718	75,470	58,642	100,808	110,991	137,279	104,354	128,763	82,832	93,618	81,674	71,891	106,747	138,717	185,630	183,546	109,339	77,338	57,339	57,339	129,498	120,838	29,329	22,697	24,322	27,533	22,393	46,889	37,352	29,020	32,763	69,855	34,912	42,540	76,052	78,979	83,951	116,153	105,089	43,583	50,142	51,195	46,764	44,518	59,333	8,602	14,086	14,086	13,011	5,676	23,366	19,300	12,900	12,000	7,600	5,300	2,600	4,700	5,900	2,100	8,200	4,300	8,800	11,800	8,000	9,700	12,000	4,500	7,200	-	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash And Short Term Investments	309,096	273,732	309,192	307,367	456,661	511,937	447,152	407,092	513,448	470,231	397,414	408,976	470,166	396,279	360,981	357,712	198,911	207,981	176,084	157,025	138,838	205,991	183,771	189,396	174,935	481,943	154,600	135,399	102,055	107,598	86,803	77,086	48,132	79,311	131,296	79,871	71,994	140,231	137,160	129,038	120,614	118,868	98,636	89,691	96,938	125,718	114,785	112,422	100,808	110,991	137,279	104,354	128,763	82,832	93,618	81,674	71,891	106,747	138,717	185,630	183,546	109,339	77,338	57,339	0	129,498	120,838	29,329	22,697	24,322	33,950	86,180	127,216	135,782	98,454	76,468	100,810	73,391	68,381	106,170	108,546	115,474	145,669	129,152	98,861	104,315	101,707	89,716	66,701	63,407	11,655	15,138	0	17,054	9,251	23,572	23,600	20,800	12,000	7,600	5,300	2,600	4,700	5,900	2,100	8,200	4,300	8,800	11,800	8,000	9,700	12,000	4,500	7,200	-	-
Common Stock	909	909	909	908	905	903	903	900	896	896	895	894	893	892	892	889	887	886	883	882	880	880	877	817	813	813	804	782	777	463	462	460	459	458	420	418	416	415	415	415	410	370	370	370	369	359	359	358	357	359	360	359	359	354	353	353	350	348	347	345	344	340	337	323	323	322	320	318	315	312	311	310	298	296	295	293	292	290	290	287	286	276	276	276	272	270	269	263	261	256	207	173	173	169	164	163	200	200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Common Stock Shares Outstanding	78,327	79,811	81,151	82,323	83,654	83,399	83,622	84,276	85,780	85,447	85,340	85,258	84,929	84,752	84,706	85,892	86,773	85,688	86,257	86,258	86,683	86,299	83,513	79,834	79,684	79,455	78,963	78,394	80,286	81,032	78,710	76,466	76,370	73,864	67,878	66,684	66,314	65,812	65,608	65,536	64,550	55,792	56,236	56,112	56,128	57,554	57,218	56,976	53,692	58,058	60,356	60,370	59,124	60,144	60,798	59,964	58,976	58,800	58,404	58,504	57,886	56,242	57,160	53,778	53,778	58,628	60,338	59,930	56,742	59,734	67,608	67,656	59,170	68,594	69,478	70,288	61,122	60,652	68,958	68,746	59,408	60,572	60,122	61,738	58,876	61,308	61,698	61,434	56,920	56,944	50,098	39,236	39,236	39,068	34,682	34,448	34,448	32,857	33,913	40,000	40,000	32,222	32,000	33,000	33,000	31,250	28,571	30,000	30,000	30,000	30,000	26,667	21,649	21,649	12,222	12,222
Common Stock Total Equity	0	0	909	908	905	903	903	900	896	896	895	894	893	892	892	889	887	886	883	882	880	880	877	817	813	813	804	782	777	463	462	460	459	458	420	418	416	415	415	415	410	370	370	370	369	359	359	358	357	359	360	359	359	354	353	353	350	348	347	345	344	340	337	323	323	322	320	318	315	312	311	310	298	296	295	293	292	290	290	287	286	276	276	276	272	270	269	263	261	256	207	177	173	169	164	163	200	200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Current Deferred Revenue	8,540	8,139	8,275	7,743	7,253	6,364	5,425	5,343	5,295	5,388	5,890	5,400	5,275	4,875	4,717	4,860	4,772	3,984	3,507	3,750	3,764	155,710	0	164,810	11,051	7,668	8,424	8,088	6,812	6,997	8,151	7,222	5,666	4,931	4,303	4,303	5,176	5,183	4,411	4,220	4,197	4,474	3,748	3,868	3,505	3,645	4,261	4,027	4,543	3,629	3,367	3,836	4,444	4,327	4,001	3,937	4,077	4,083	3,325	3,173	3,053	3,489	2,655	2,901	0	2,786	2,863	3,401	4,319	4,986	8,280	5,792	0	0	0	0	0	0	0	0	0	3,317	963	946	816	1,324	929	868	772	1,018	967	1,879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,757	6,935	7,376	7,062	7,128	6,932	4,955	5,689	5,684	5,603	6,259	6,422	5,645	15,412	19,545	14,988	15,743	15,957	8,028	8,657	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Liab	0	0	70,653	61,693	63,338	69,743	61,287	56,633	45,788	70,325	63,447	65,282	16,190	27,780	21,260	24,221	36,553	59,730	53,086	57,660	57,778	72,997	73,311	72,879	65,130	128,628	131,255	130,836	148,941	153,372	156,337	156,449	154,891	209,507	94,701	92,431	91,623	76,782	81,540	94,612	2,083	5,154	5,396	5,397	5,393	14,893	9,324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Good Will	1,055,462	1,036,146	1,043,273	1,041,606	1,038,881	977,860	990,406	1,008,928	1,013,458	1,012,081	1,015,638	1,010,072	932,367	919,556	956,207	951,554	954,280	945,282	926,732	922,508	926,475	926,369	927,148	944,495	937,905	587,943	585,410	578,229	510,571	515,636	514,023	516,103	512,389	505,727	357,022	354,202	363,888	349,574	354,977	367,649	249,764	248,824	292,881	292,278	294,067	292,426	292,085	295,232	292,980	294,529	285,376	267,426	261,928	262,433	252,143	257,789	261,941	264,605	211,767	207,705	212,094	210,503	214,478	207,438	207,438	179,260	174,507	163,719	162,414	158,243	147,316	94,075	68,364	69,737	69,817	71,789	39,237	38,309	37,843	28,135	26,683	22,566	22,028	21,704	22,073	17,102	16,502	15,835	31,525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Intangible Assets	1,067,833	1,067,023	1,093,596	1,108,759	1,126,609	1,054,035	1,082,275	1,121,971	1,145,573	1,155,795	1,178,884	1,193,681	989,436	973,685	998,686	1,014,227	1,031,591	1,040,350	1,041,620	1,058,630	1,079,496	1,097,259	1,121,845	1,147,954	1,159,627	634,052	648,744	654,408	561,175	573,687	583,569	594,856	603,740	606,420	440,583	447,424	459,459	413,906	422,009	429,446	197,163	202,410	206,884	212,274	212,267	218,345	224,308	230,920	237,122	243,934	230,935	191,210	194,904	198,711	201,174	206,344	211,117	214,432	217,447	220,225	225,998	209,337	188,130	195,766	195,766	181,194	183,775	177,467	179,716	178,354	140,552	108,069	132,933	135,920	137,556	142,336	99,054	98,711	99,435	81,109	79,118	73,636	51,518	73,349	45,164	16,846	15,247	31,016	31,525	29,191	29,558	25,299	25,299	25,296	26,393	18,809	13,200	13,400	13,700	13,200	1,400	0	0	0	0	0	0	0	0	100	100	200	0	-	-	-
Inventory	389,608	366,251	354,293	351,275	324,583	311,060	320,208	328,005	317,386	327,167	323,618	328,049	310,117	307,839	358,756	338,082	316,054	302,622	296,505	286,962	280,347	290,846	290,517	290,474	296,332	232,340	234,680	239,809	217,263	219,671	220,442	221,978	211,429	213,878	241,835	233,043	237,114	230,455	223,632	215,232	213,431	207,389	195,457	179,558	171,806	169,376	172,541	172,469	171,261	181,430	174,460	154,601	146,928	147,973	143,253	142,113	140,240	140,541	139,319	141,582	146,103	155,615	149,345	144,535	144,535	126,371	114,089	95,591	94,387	93,773	92,981	77,153	67,476	69,014	69,206	65,335	55,947	52,400	50,509	44,894	41,046	38,395	39,077	37,394	28,502	26,571	25,025	24,013	24,609	24,113	22,651	16,508	16,508	16,341	15,731	10,667	10,100	10,800	11,200	13,100	2,700	3,400	2,600	2,400	2,400	1,900	2,000	2,800	2,600	3,100	2,800	2,100	1,400	1,400	-	-
Liabilities And Stockholders Equity	3,781,988	3,739,371	3,777,601	3,742,399	3,889,758	3,807,013	3,752,862	3,671,997	3,782,383	3,774,465	3,712,787	3,741,554	3,615,136	922,302	3,391,759	3,447,565	3,303,240	3,346,580	3,290,410	3,205,711	3,107,887	3,178,642	3,185,773	3,247,693	3,211,257	2,418,187	2,101,131	2,049,015	1,807,954	1,827,424	1,814,162	1,830,262	1,774,704	1,827,620	1,637,894	1,550,807	1,578,625	1,545,734	1,563,023	1,555,923	1,196,229	1,184,072	1,187,501	1,156,491	1,163,599	1,185,506	1,161,817	1,158,370	1,144,109	1,174,666	1,153,856	1,007,028	1,017,308	959,276	941,795	937,997	940,102	973,236	946,372	995,417	1,034,431	960,745	862,454	818,012	818,012	810,077	776,490	623,074	613,618	604,460	566,219	491,631	448,432	465,881	451,686	470,407	456,713	440,187	435,400	421,139	412,526	402,529	392,533	356,755	274,668	242,573	234,390	226,767	227,588	206,556	94,193	86,514	86,514	85,760	76,289	73,693	66,300	64,000	66,800	66,700	34,700	38,500	37,400	36,100	38,400	43,500	45,200	47,000	48,700	50,900	52,600	53,700	19,400	22,200	-	-
Long Term Debt	1,485,018	1,419,616	1,333,414	1,337,212	1,300,490	1,381,142	1,385,537	1,389,927	1,388,683	1,387,433	1,498,676	1,484,912	1,408,221	1,414,000	1,472,323	1,478,191	1,198,561	1,274,049	1,204,537	1,205,025	1,210,513	1,421,001	1,476,488	1,772,027	1,781,142	1,152,633	867,500	848,750	665,000	658,998	684,291	712,189	700,595	718,792	643,733	611,427	626,246	621,095	630,971	629,000	392,057	545,140	543,250	521,386	519,547	517,735	515,947	522,978	532,264	541,604	490,062	293,699	294,842	366,014	371,900	295,313	308,754	307,220	305,712	431,307	490,000	330,000	330,000	330,000	330,000	330,000	330,000	0	508	4,889	118,112	118,169	118,378	118,468	119,159	118,631	118,900	119,220	118,336	119,742	119,257	119,911	119,653	104,681	0	0	0	0	0	0	2,514	3,121	4,758	6,954	7,579	8,204	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Debt Total	0	0	1,333,414	1,337,212	1,300,490	1,381,142	1,385,537	1,389,927	1,388,683	1,387,433	1,386,176	1,484,912	1,408,221	1,414,000	1,472,323	1,478,191	1,198,561	1,274,049	1,204,537	1,205,025	1,210,513	1,421,001	1,476,488	1,772,027	1,781,142	1,152,633	867,500	848,750	665,000	658,998	684,291	712,189	700,595	718,792	643,733	611,427	626,246	621,095	630,971	629,000	392,057	545,140	543,250	521,386	519,547	517,735	515,947	522,978	532,264	541,604	490,062	293,699	294,842	366,014	371,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	346	5,350	20,246	17,527	13,647	2,491	0	0	0	1,629	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Debt	1,405,280	768,522	1,294,022	633,478	1,158,698	1,202,476	1,268,282	1,241,941	1,137,839	1,182,268	1,255,445	1,341,285	1,185,241	1,132,521	1,303,276	1,332,271	1,258,907	1,329,723	1,283,498	1,207,750	1,215,375	1,226,260	1,292,717	1,642,631	1,666,207	689,440	725,400	730,887	562,945	580,150	618,738	652,916	666,838	650,419	522,840	537,181	558,002	482,739	493,811	499,962	271,443	426,272	444,614	431,695	422,609	392,017	440,477	464,336	431,456	430,613	7,096	101,896	274,517	290,682	278,282	291,109	313,623	294,706	317,438	345,677	406,454	420,661	372,662	392,623	392,623	320,464	329,126	190,671	197,353	182,772	154,579	111,776	71,489	81,116	90,139	85,868	49,045	84,308	75,796	43,690	40,278	35,960	3,500	-408	-43,583	-50,142	-51,195	-46,764	-40,942	-59,333	1,101	-456	-456	614	6,931	-11,111	-9,400	-2,600	-1,300	3,400	-5,300	-2,600	-4,700	-5,900	-2,100	-8,200	-4,300	-8,800	-11,800	-8,000	-9,700	-12,000	-4,500	-7,200	-	-
Net Invested Capital	3,087,433	3,084,224	3,112,218	3,114,650	3,247,718	3,267,806	3,209,579	3,162,124	3,230,987	3,175,820	3,118,657	3,170,143	3,069,338	2,926,787	2,901,369	2,918,494	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Receivables	259,327	256,270	258,663	253,995	263,465	248,268	237,361	234,010	231,831	222,232	229,823	223,542	225,532	218,184	179,143	245,546	275,296	281,119	296,507	279,072	265,737	248,738	258,380	272,260	251,799	171,126	171,323	158,234	148,186	140,750	145,571	151,607	132,241	125,465	134,546	126,785	131,918	120,741	118,262	112,521	118,145	113,538	114,749	111,944	114,916	119,527	115,571	113,996	118,129	117,777	116,179	106,117	106,005	107,150	97,779	98,532	103,228	101,379	101,462	101,610	112,417	111,081	108,126	103,539	103,539	92,313	95,267	85,884	85,018	76,715	74,135	56,607	49,007	46,786	46,275	51,261	46,765	38,028	35,651	30,322	28,936	26,961	23,722	24,065	19,412	17,724	15,642	14,828	14,024	14,454	15,032	13,087	13,087	12,402	10,908	8,719	8,400	7,800	8,000	8,800	3,100	2,900	3,200	3,100	2,800	3,000	2,800	2,400	2,900	2,200	2,700	2,000	1,800	1,800	-	-
Net Tangible Assets	0	0	639,887	-475,427	-361,087	-411,764	-411,764	-515,702	-474,227	-619,541	-619,541	-674,422	-406,936	-495,254	-605,797	-623,978	-569,135	-600,658	-547,401	-584,108	-630,175	-658,547	-707,088	-1,094,009	-1,135,226	-308,879	-339,599	-380,146	-232,079	-265,896	-302,805	-334,572	-364,686	-382,047	-85,882	-113,527	-119,025	-77,502	-87,756	-117,895	223,253	48,243	16,824	5,337	11,441	15,930	-9,181	-17,701	-37,464	-36,942	2,506	68,950	43,131	9,656	7,059	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Working Capital	751,056	671,517	673,764	747,189	840,592	892,001	841,818	750,220	813,695	770,927	713,626	626,774	836,189	896,950	753,807	762,187	526,859	581,172	553,561	534,580	512,530	569,643	587,980	512,630	473,235	734,709	438,289	380,836	371,569	350,480	344,159	337,935	299,368	364,965	452,494	395,145	403,296	432,466	437,259	422,915	405,860	388,305	368,397	341,279	346,122	380,988	365,076	355,157	350,389	371,895	377,776	261,869	244,817	283,591	301,992	213,664	208,633	180,475	206,415	306,896	322,641	155,680	190,326	148,260	148,260	192,174	171,958	-43,944	-52,256	-35,957	112,844	189,058	234,665	236,123	192,909	173,979	192,004	150,294	141,003	170,046	167,275	154,130	183,639	170,827	130,352	132,310	129,958	117,161	89,086	87,455	28,299	25,177	25,177	25,761	18,343	27,274	28,000	29,100	31,200	31,100	23,900	26,300	27,300	26,200	29,400	32,900	35,200	36,800	38,000	35,800	37,500	32,600	7,500	-	-	-
Non Current Assets Total	2,723,952	2,712,142	2,726,341	2,712,917	2,728,260	2,610,560	2,615,448	2,605,944	2,628,667	2,670,680	2,680,405	2,702,479	2,377,934	2,301,425	2,425,537	2,438,893	2,445,072	2,462,767	2,421,738	2,383,025	2,332,805	2,350,659	2,364,451	2,399,043	2,389,111	1,473,244	1,484,965	1,480,096	1,312,784	1,315,547	1,320,176	1,335,697	1,336,209	1,322,708	1,029,647	1,028,857	1,049,304	983,145	998,862	1,016,177	670,987	673,489	709,765	709,432	710,548	691,944	684,494	698,627	691,852	698,338	658,072	581,843	572,459	572,981	554,164	565,153	574,739	577,441	523,123	517,850	537,039	524,463	482,893	478,081	0	429,718	423,507	393,274	391,857	384,961	339,756	248,805	182,480	196,222	226,514	265,449	240,475	266,127	271,213	231,399	224,633	215,956	179,355	160,477	122,395	89,245	89,308	95,520	119,356	102,065	43,749	40,297	40,297	39,158	39,646	30,040	23,500	23,900	23,600	23,800	7,800	8,000	6,300	6,500	6,600	7,700	7,800	8,200	8,500	12,900	13,200	19,400	10,100	9,900	-	-
Non Current Liabilities Other	199,940	142,352	153,340	386,263	400,621	327,262	349,525	294,407	323,087	352,162	161,731	249,728	274,845	358,608	336,665	356,865	320,081	325,186	296,725	257,890	201,248	61,223	60,727	68,327	53,768	13,576	29,944	28,855	30,745	30,230	28,920	28,607	28,648	29,274	31,984	32,045	30,409	31,756	34,380	36,280	12,527	12,023	12,927	14,039	13,955	13,603	17,087	16,857	11,613	18,494	16,652	11,608	11,826	12,485	16,225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Current Liabilities Total	1,887,124	1,804,438	1,716,945	1,785,168	1,764,449	1,778,147	1,796,349	1,740,967	1,757,558	1,809,920	1,819,050	1,799,922	1,699,256	1,528,800	1,830,248	1,859,277	1,555,195	1,658,965	1,554,348	1,520,575	1,469,539	1,555,221	1,610,526	1,913,233	1,900,040	1,294,837	1,028,699	1,008,441	844,686	842,600	869,548	897,245	884,134	957,573	770,418	735,903	748,278	729,633	746,891	759,892	406,667	562,317	561,573	540,822	538,895	546,231	542,358	545,333	549,603	568,712	517,031	316,126	317,313	385,772	395,780	320,897	338,487	327,494	326,763	450,477	509,474	358,549	349,131	365,912	0	371,495	371,951	43,784	43,439	43,523	140,554	128,815	127,327	124,743	124,727	125,083	124,656	123,786	123,944	123,430	123,378	123,031	124,907	109,892	5,150	3,949	4,118	4,218	4,385	6,954	9,526	11,693	11,693	13,792	14,534	13,832	13,500	16,400	16,600	13,200	300	200	300	300	200	100	100	200	100	100	200	100	200	200	-	-
Non Currrent Assets Other	26,014	25,448	26,284	24,382	-510,151	-488,714	-517,656	29,513	-547,986	29,486	20,864	36,733	-463,557	20,679	35,401	38,989	14,644	33,008	16,720	79,133	19,917	32,797	30,756	26,101	16,078	12,657	12,523	13,592	11,734	6,653	6,874	7,280	-210,753	8,406	10,893	11,436	-202,753	9,524	8,786	7,770	-196,844	9,986	10,475	9,785	-187,313	11,956	12,516	12,580	-339,448	12,674	13,630	10,302	-146,877	8,826	1,975	2,086	-146,440	27,570	23,132	20,137	28,565	34,624	16,848	13,147	13,147	14,002	14,593	8,386	7,168	7,705	16,097	17,582	22,096	5,609	5,017	5,173	100,173	123,182	131,359	111,606	104,074	99,788	61,143	45,334	35,457	33,799	39,827	44,611	65,926	-13	2,654	3,399	3,399	2,073	1,193	684	600	900	500	500	100	1,500	100	100	200	100	0	0	-100	4,000	4,000	9,900	500	400	-	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Assets	0	0	0	72,002	63,154	82,173	70,590	67,799	3,782,383	114,485	96,032	96,852	168,602	-2,301,425	42,930	41,319	27,267	60,013	39,158	30,538	21,372	19,785	20,906	2,125,014	2,119,860	1,241,003	1,252,891	1,250,986	1,090,415	1,103,352	1,111,528	1,125,367	1,131,028	1,125,508	814,187	818,746	839,318	779,263	792,194	810,510	470,677	480,765	525,228	530,080	532,650	530,755	537,566	561,857	560,469	575,903	542,405	479,365	473,003	485,688	469,520	481,735	491,213	506,607	452,346	448,067	466,657	454,464	419,456	419,989	416,351	374,456	372,875	349,572	349,298	344,302	303,965	219,726	155,029	168,711	198,823	237,764	215,014	243,694	248,673	211,186	204,561	198,083	161,598	142,869	105,839	72,821	78,035	84,084	107,694	90,498	32,212	27,439	28,698	27,369	27,586	19,493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Current Assets	100,005	130,976	129,112	116,845	116,789	125,188	132,693	96,946	91,051	84,155	81,527	78,508	69,282	69,817	67,342	67,332	67,907	92,091	99,576	99,627	90,160	82,408	88,654	96,520	99,080	59,534	55,563	35,477	27,666	43,858	41,170	43,894	42,620	39,361	42,397	23,958	29,632	26,886	36,758	34,496	26,752	30,739	30,774	27,396	30,291	78,941	74,426	60,856	62,059	66,130	67,866	60,113	63,153	48,340	52,981	50,525	50,004	47,128	43,751	48,745	55,326	60,247	44,752	34,518	34,518	32,177	22,789	18,996	19,659	24,689	25,397	22,886	22,253	18,077	11,237	11,894	12,716	10,241	9,646	8,354	9,365	5,743	4,710	5,667	5,498	4,718	2,708	2,690	2,898	2,517	1,106	1,484	1,484	805	753	695	700	700	12,000	13,400	15,800	21,600	20,600	18,200	24,500	22,700	28,300	24,800	22,900	24,700	24,200	18,200	1,600	1,900	-	-
Other Current Liab	176,299	229,875	159,193	146,973	158,804	147,618	157,305	162,819	213,114	209,344	188,367	175,601	182,062	164,999	125,004	131,600	156,194	147,664	145,965	150,053	160,238	5,000	149,305	24,215	183,893	143,076	114,760	128,151	87,732	86,718	76,472	77,602	84,314	85,491	82,850	74,247	83,039	77,130	75,487	66,183	64,433	63,338	60,824	58,037	66,682	65,690	64,796	64,979	69,669	65,329	66,747	54,794	59,367	56,158	48,732	52,370	51,295	96,659	43,167	44,664	48,734	51,030	40,551	45,576	48,477	38,509	32,371	31,088	29,827	32,010	25,147	21,922	22,309	24,418	19,475	16,436	14,074	15,434	16,554	12,816	12,671	10,961	10,574	9,183	7,908	6,390	5,765	5,303	11,874	5,701	10,388	8,805	7,605	10,460	10,783	10,611	11,500	7,700	8,500	7,900	2,400	3,700	3,400	3,100	1,900	1,800	2,000	1,600	2,100	1,900	1,500	1,300	1,500	1,700	-	-
Other Liab	0	0	0	187,466	201,839	133,472	142,296	144,818	135,903	175,430	178,527	172,744	131,181	127,254	110,968	106,299	116,108	126,218	112,804	108,167	128,441	134,220	134,038	68,327	53,768	13,576	29,944	28,855	30,745	30,230	28,920	28,607	28,648	29,274	31,984	32,045	30,409	31,756	34,380	36,280	12,527	12,023	12,927	14,039	13,955	13,603	17,087	16,857	11,613	18,494	16,652	11,608	11,826	12,485	16,225	17,132	20,414	20,274	21,051	19,170	19,474	18,311	19,131	20,057	19,860	14,667	14,541	14,478	11,575	5,540	7,537	6,700	6,429	6,275	5,568	6,452	5,756	4,566	5,608	3,688	4,121	3,120	5,254	5,211	5,150	3,949	4,118	4,218	4,386	4,548	4,734	4,892	5,147	4,932	4,932	5,628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Stockholder Equity	655,222	649,542	769,893	763,619	914,115	904,778	896,972	903,853	1,729,959	1,024,381	1,014,094	997,176	1,055,768	1,049,487	1,044,144	1,037,949	1,093,677	1,088,448	1,077,903	1,071,698	1,071,986	1,067,236	1,056,393	701,786	700,114	695,255	690,236	676,325	675,601	671,079	665,849	655,029	653,007	643,327	423,250	411,953	412,434	402,087	398,975	393,696	383,797	226,957	224,210	222,827	220,180	246,600	244,216	242,728	240,555	248,183	257,582	270,549	268,569	254,993	281,483	277,468	268,469	260,005	254,502	250,750	212,288	197,881	169,798	142,886	0	136,630	127,813	221,851	221,431	245,775	256,477	266,014	257,364	284,448	281,792	303,917	301,128	298,243	287,497	283,384	281,480	271,139	269,007	259,054	290,195	300,753	285,497	284,955	283,971	279,812	164,527	144,038	0	145,303	138,929	138,747	140,100	137,300	136,600	136,100	125,500	125,000	120,900	116,400	116,200	110,500	109,500	109,300	109,100	107,500	107,400	107,200	71,200	69,900	-	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	2	2	7	7	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Property Plant And Equipment Gross	863,830	475,478	317,571	461,689	789,315	448,999	0	0	0	0	384,933	387,367	371,164	379,355	427,714	431,793	431,934	417,122	414,228	306,350	300,112	287,000	277,025	274,029	269,251	232,241	232,074	229,110	222,369	212,195	208,648	210,330	205,181	197,200	215,460	210,111	209,986	203,882	206,668	205,667	200,310	192,724	184,537	179,352	177,898	161,189	146,928	136,770	131,383	122,435	115,667	102,478	99,456	87,293	84,644	83,418	83,526	70,834	70,777	69,783	70,382	69,999	63,437	61,730	61,730	55,262	50,632	43,702	42,559	40,659	35,791	29,079	27,451	27,511	27,691	27,685	25,461	22,433	22,540	20,213	20,072	17,873	17,757	17,608	16,556	16,424	11,273	11,436	11,662	11,567	11,537	11,173	11,599	11,789	12,060	10,547	9,700	9,600	9,400	10,100	6,300	6,500	6,200	6,400	6,400	7,600	7,800	8,200	8,600	8,800	9,100	9,300	9,600	9,500	-	-
Property Plant And Equipment Net	496,383	475,478	466,222	461,689	459,586	448,999	447,558	390,853	396,246	381,521	384,933	387,367	371,164	379,355	427,714	431,793	431,934	417,122	414,228	306,350	300,112	287,000	277,025	274,029	269,251	232,241	232,074	229,110	222,369	212,195	208,648	210,330	205,181	197,200	215,460	210,111	209,986	203,882	206,668	205,667	200,310	192,724	184,537	179,352	177,898	161,189	146,928	136,770	131,383	122,435	115,667	102,478	99,456	87,293	84,644	83,418	83,526	70,834	70,777	69,783	70,382	69,999	63,437	61,730	0	55,262	50,632	43,702	42,559	40,659	35,791	29,079	27,451	27,511	27,691	27,685	25,461	22,433	22,540	20,213	20,072	17,873	17,757	17,608	16,556	16,424	11,273	11,436	11,662	11,567	11,537	11,599	0	11,789	12,060	10,547	9,700	9,600	9,400	10,100	6,300	6,500	6,200	6,400	6,400	7,600	7,800	8,200	8,600	8,800	9,100	9,300	9,600	9,500	-	-
Property Plant Equipment	0	0	317,571	315,175	311,302	300,729	302,423	309,209	311,703	293,921	384,933	296,193	287,529	294,439	334,334	335,903	337,404	319,384	316,445	306,350	300,112	287,000	277,025	274,029	269,251	232,241	232,074	229,110	222,369	212,195	208,648	210,330	205,181	197,200	215,460	210,111	209,986	203,882	206,668	205,667	200,310	192,724	184,537	179,352	177,898	161,189	146,928	136,770	131,383	122,435	115,667	102,478	99,456	87,293	84,644	83,418	83,526	70,834	70,777	69,783	70,382	69,999	63,437	63,344	61,730	55,262	50,632	43,702	42,559	40,659	35,791	29,079	27,451	27,511	27,691	27,685	25,461	22,433	22,540	20,213	20,072	17,873	17,757	17,608	16,556	16,424	11,273	11,436	11,662	11,567	11,537	11,173	11,599	11,789	12,060	10,547	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Retained Earnings	946,859	927,025	907,528	903,344	879,118	826,172	776,257	731,469	698,568	653,184	609,955	574,888	532,265	439,521	407,184	407,553	398,574	383,255	410,865	381,129	348,373	323,236	309,941	297,500	285,186	240,831	237,673	226,837	220,443	192,195	172,052	157,563	145,879	128,038	328,341	323,344	314,960	297,794	287,987	283,162	285,046	272,863	301,413	297,973	302,023	289,237	276,026	267,512	260,819	256,259	245,018	244,317	232,830	214,024	197,540	182,383	167,161	151,430	136,998	125,773	132,219	107,374	122,666	98,175	98,175	92,768	83,094	73,752	66,336	56,205	53,611	45,634	36,929	26,314	15,833	8,178	-265	-10,104	-2,506	-10,024	-17,462	-26,634	-33,467	-38,885	-44,323	-69,697	-71,260	-75,509	-79,600	-97,226	-100,971	-105,729	-105,729	-93,566	-95,283	-95,367	-94,300	-93,600	-91,500	-87,900	-88,300	-85,400	-82,500	-79,200	-75,900	-65,300	-62,900	-60,800	-59,000	-56,600	-54,600	-53,000	-51,500	-49,300	-	-
Retained Earnings Total Equity	0	0	907,528	903,344	879,118	826,172	776,257	731,469	698,568	653,184	609,955	574,888	532,265	439,521	407,184	407,553	398,574	383,255	410,865	381,129	348,373	323,236	309,941	297,500	285,186	240,831	237,673	226,837	220,443	192,195	172,052	157,563	145,879	128,038	328,341	323,344	314,960	297,794	287,987	283,162	285,046	272,863	301,413	297,973	302,023	289,237	276,026	267,512	260,819	256,259	245,018	244,317	232,830	214,024	197,540	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt	14,531	85,387	95,644	0	38,125	56,250	50,625	45,000	45,000	45,000	45,000	155,900	146,250	22,500	11,250	0	45,000	45,000	45,000	33,750	22,500	11,250	1,476,488	60,451	61,845	19,934	881,018	6,250	665,000	28,750	21,250	0	14,375	0	0	0	4,648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt Total	1,681,682	1,042,254	1,603,214	940,845	1,615,359	1,714,413	1,715,434	1,649,033	1,651,287	1,652,499	1,652,859	1,750,261	1,655,407	1,528,800	1,664,257	1,689,983	1,457,818	1,537,704	1,459,582	1,364,775	1,354,213	1,432,251	1,476,488	1,832,027	1,841,142	1,171,383	880,000	855,000	665,000	687,748	705,541	730,002	714,970	729,730	654,136	617,052	629,996	622,970	630,971	629,000	392,057	545,140	543,250	521,386	519,547	517,735	515,947	522,978	532,264	541,604	144,375	206,250	403,280	373,514	371,900	372,783	385,514	401,453	456,155	531,307	590,000	530,000	450,000	449,962	449,962	449,962	449,964	220,000	220,050	207,094	182,112	134,169	118,378	118,468	119,159	118,631	118,900	119,220	118,336	119,742	119,257	119,911	119,653	104,681	0	0	0	0	3,576	0	9,703	13,630	13,630	13,625	12,607	12,255	9,900	10,300	10,700	11,000	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Term Debt	29,815	24,148	110,262	14,792	52,749	69,738	63,368	59,300	59,775	58,526	58,987	169,800	159,068	35,018	24,403	12,964	57,253	56,835	58,448	33,750	22,500	11,250	1,476,488	60,000	60,000	18,750	12,500	6,250	665,000	28,750	21,250	17,813	14,375	10,938	10,403	5,625	3,750	1,875	0	0	0	0	0	0	0	0	0	0	0	0	0	69,375	108,438	7,500	0	77,470	76,760	94,233	150,443	100,000	100,000	200,000	120,000	119,962	119,962	119,962	119,964	220,000	219,542	202,205	64,000	16,000	0	0	0	0	0	0	0	0	0	11,561	13,381	11,009	9,433	9,567	5,441	4,920	3,576	6,619	7,189	8,872	8,872	6,671	5,028	4,051	2,300	2,000	1,800	1,500	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Term Investments	32,694	19,938	20,200	15,659	16,682	13,111	4,369	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11,286	0	0	0	0	4,073	0	0	0	0	0	0	0	0	0	0	0	0	0	39,315	53,780	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6,417	63,787	80,327	98,430	69,434	43,705	30,955	38,479	25,841	30,118	29,567	31,523	29,516	24,063	55,278	54,173	50,512	42,952	22,183	4,074	3,053	1,052	1,052	4,043	3,575	206	4,300	7,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Assets	3,781,988	3,739,371	3,777,601	3,742,399	3,889,758	3,807,013	3,752,862	3,671,997	3,782,383	3,774,465	3,712,787	3,741,554	3,615,136	922,302	3,391,759	3,447,565	3,303,240	3,346,580	3,290,410	3,205,711	3,107,887	3,178,642	3,185,773	3,247,693	3,211,257	2,418,187	2,101,131	2,049,015	1,807,954	1,827,424	1,814,162	1,830,262	1,774,704	1,827,620	1,637,894	1,550,807	1,578,625	1,545,734	1,563,023	1,555,923	1,196,229	1,184,072	1,187,501	1,156,491	1,163,599	1,185,506	1,161,817	1,158,370	1,144,109	1,174,666	1,153,856	1,007,028	1,017,308	959,276	941,795	937,997	940,102	973,236	946,372	995,417	1,034,431	960,745	862,454	818,012	818,012	810,077	776,490	623,074	613,618	604,460	566,219	491,631	448,432	465,881	451,686	470,407	456,713	440,187	435,400	421,139	412,526	402,529	392,533	356,755	274,668	242,573	234,390	226,767	227,588	206,556	94,193	86,514	86,514	85,760	76,289	73,693	66,300	64,000	66,800	66,700	34,700	38,500	37,400	36,100	38,400	43,500	45,200	47,000	48,700	50,900	52,600	53,700	19,400	22,200	-	-
Total Current Assets	1,058,036	1,027,229	1,051,260	1,029,482	1,161,498	1,196,453	1,137,414	1,066,053	1,153,716	1,103,785	1,032,382	1,039,075	1,237,202	922,302	966,222	1,008,672	858,168	883,813	868,672	822,686	775,082	827,983	821,322	848,650	822,146	944,943	616,166	568,919	495,170	511,877	493,986	494,565	438,495	504,912	608,247	521,950	529,321	562,589	564,161	539,746	525,242	510,583	477,736	447,059	453,051	493,562	477,323	459,743	452,257	476,328	495,784	425,185	444,849	386,295	387,631	372,844	365,363	395,795	423,249	477,567	497,392	436,282	379,561	339,931	339,931	380,359	352,983	229,800	221,761	219,499	226,463	242,826	265,952	269,659	225,172	204,958	216,238	174,060	164,187	189,740	187,893	186,573	213,178	196,278	152,273	153,328	145,082	131,247	108,232	104,491	50,444	46,217	46,217	46,602	36,643	43,653	42,800	40,100	43,200	42,900	26,900	30,500	31,100	29,600	31,800	35,800	37,400	38,800	40,200	38,000	39,400	34,300	9,300	12,300	-	-
Total Current Liabilities	306,980	355,712	377,496	282,293	320,906	304,452	295,596	315,833	340,021	332,858	318,756	412,301	401,013	255,146	212,415	246,485	331,309	302,641	315,111	288,106	262,552	258,340	233,342	336,020	348,911	210,234	177,877	188,083	123,601	161,397	149,827	156,630	139,127	139,947	155,753	126,805	126,025	130,123	126,902	116,831	119,382	122,278	109,339	105,780	106,929	112,574	112,247	104,586	101,868	104,433	118,008	163,316	200,032	102,704	85,639	159,180	156,730	215,320	216,834	170,671	174,751	280,602	189,235	191,671	191,671	188,185	181,025	273,744	274,017	255,456	113,619	53,768	31,287	33,536	32,263	30,979	24,234	23,766	23,184	19,694	20,618	32,443	29,539	25,451	21,921	21,018	15,124	14,086	19,146	17,036	22,145	21,040	21,040	20,841	18,300	16,379	14,800	11,000	12,000	11,800	3,000	4,200	3,800	3,400	2,400	2,900	2,200	2,000	2,200	2,200	1,900	1,700	1,800	2,400	-	-
Total Liab	2,194,104	2,160,150	2,094,441	2,067,461	2,085,355	2,082,599	2,091,945	2,056,800	2,097,579	2,142,778	2,137,806	2,212,223	2,100,269	-475,595	2,042,663	2,105,762	1,886,504	1,961,606	1,869,459	1,808,681	1,732,091	1,432,251	1,843,868	1,832,027	2,248,951	1,505,071	1,206,576	1,196,524	968,287	1,003,997	1,019,375	1,053,875	1,023,261	1,097,520	926,171	862,708	874,303	859,756	873,793	876,723	526,049	684,595	670,912	646,602	645,824	658,805	654,605	649,919	651,471	673,145	635,039	479,442	517,345	488,476	481,419	480,077	495,217	542,814	543,597	621,148	684,225	639,151	538,366	557,583	557,583	559,680	552,976	317,528	317,456	298,979	254,173	182,583	158,614	158,279	156,990	156,062	148,890	147,552	147,128	143,124	143,996	155,474	154,446	135,343	27,071	24,967	19,242	18,304	23,531	23,990	31,671	32,733	32,733	34,633	32,834	30,211	28,300	27,400	28,600	25,000	3,300	4,400	4,100	3,700	2,600	3,000	2,300	2,200	2,300	2,300	2,100	1,800	2,000	2,600	-	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Stockholder Equity	1,587,884	1,579,221	1,683,160	1,674,938	1,804,403	1,724,414	1,660,917	1,615,197	1,684,804	1,631,687	1,574,981	1,529,331	1,514,867	1,397,897	1,349,096	1,341,803	1,416,736	1,384,974	1,420,951	1,397,030	1,375,796	1,365,081	1,341,905	998,440	962,306	913,116	894,555	852,491	839,667	823,427	794,787	776,387	751,443	730,100	711,723	688,099	704,322	685,978	689,230	679,200	670,180	499,477	516,589	509,889	517,775	526,701	507,212	508,451	492,638	501,521	518,817	527,586	499,963	470,800	460,376	457,920	444,885	430,422	402,775	374,269	350,206	321,594	324,088	260,429	260,429	250,397	223,514	305,546	296,162	305,481	312,046	309,048	289,818	307,602	294,696	314,345	307,823	292,635	288,272	278,015	268,530	247,055	238,087	221,412	247,597	217,606	215,148	208,463	204,057	182,566	62,522	53,781	53,781	51,127	43,455	43,482	38,000	36,600	38,200	41,700	31,400	34,100	33,300	32,400	35,800	40,500	42,900	44,800	46,400	48,600	50,500	51,900	17,400	19,600	-	-
Treasury Stock	0	0	0	-481,678	-362,862	-362,863	-362,880	-362,886	-234,448	-234,449	-234,461	-234,461	-235,141	-235,224	-235,226	-202,506	-119,943	-120,101	-120,107	-120,109	-120,615	-120,727	-120,732	-120,734	-121,644	-121,816	-122,014	-123,051	-123,051	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-367,121	-352,669	-340,667	-287,978	-283,658	-283,658	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-252,380	-231,914	-231,914	-156,921	-145,846	-107,640	-91,002	-75,815	-75,815	-44,124	-44,124	-19,474	-19,474	-19,474	-5,236	-5,236	-5,236	-17,955	-21,204	-37,137	-1,812	-51	-51	-51	-51	-51	-180	-180	-180	-180	-180	-7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Begin Period Cash Flow	456,661	513,448	470,166	198,911	138,838	174,935	102,055	48,132	71,994	120,614	96,938	100,808	128,763	71,891	183,546	57,339	22,697	46,889	69,855	26,054	43,583	44,518	14,086	19,301	5,300	2,100	11,800	4,500	3,300
Capital Expenditures	66,865	47,085	48,080	63,890	134,532	77,741	43,503	47,328	33,413	42,396	47,851	69,031	38,425	37,138	27,569	13,401	22,572	11,520	8,053	8,508	3,843	2,254	2,860	3,268	17,300	1,200	800	1,200	2,900
Cash And Cash Equivalents Changes	0	-46,064	52,758	257,384	59,999	-36,097	72,880	53,923	-23,862	-48,620	23,676	-3,870	-27,955	56,872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	13,552	-136	38,735	95,596	6,489	-34,722	-28,363	-7	6,326	5,370	-33,310	10,571	-6,108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	-180,259	-56,787	43,282	271,255	60,073	-36,097	72,880	53,923	-23,862	-48,620	23,676	-3,870	-27,955	56,872	-111,655	126,207	34,642	-24,192	-22,966	43,801	35,396	-935	30,432	-5,215	14,000	3,200	400	36,500	700
Change In Working Capital	-81,574	-39,420	18,163	-41,314	-14,509	1,747	-1,323	-11,229	-16,903	-39,328	-33,863	-23,994	-15,088	-19,040	29,779	-23,517	-20,214	-2,164	-4,887	-20,183	-14,637	431	-5,077	-11,025	11,600	1,100	600	-1,700	-900
Change Receivables	0	-33,905	7,265	52,105	-9,428	-17,021	-89,698	-17,518	-16,231	-16,145	-2,892	3,783	-1,878	-3,783	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	4,593	-33,905	7,265	52,105	-9,428	-17,021	-89,698	-17,518	-16,231	-16,145	-2,892	3,783	-1,878	-3,783	9,808	-2,841	-2,841	-26,131	491	0	0	0	98	0	0	0	0	0	0
Change To Inventory	-59,773	-29,124	5,374	-48,348	-43,308	8,300	99	-9,576	-3,759	-27,006	-42,017	-711	1,702	-7,374	9,405	10,823	-18,591	3,461	-9,984	-9,738	-1,829	1,153	-6,987	-3,061	2,800	500	300	-1,300	-400
Change To Liabilities	0	12,905	18,764	-60,401	12,607	3,979	122,998	1,428	2,710	-2,503	5,676	-23,061	-14,892	-1,252	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	2,192	126,438	-43,597	10,913	20,135	-40,543	12,588	46,251	13,984	48,337	6,954	27,277	17,757	0	0	1,235	7,496	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	1,992	-27,378	12,478	24,168	5,376	-10,919	15,028	1,322	1,255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	123,512	118,299	119,836	116,031	109,462	110,730	88,945	72,665	58,863	61,128	47,010	52,611	50,172	39,172	39,688	33,148	27,039	21,478	13,221	11,592	9,043	7,162	6,257	5,176	2,200	1,300	1,800	2,000	1,400
Dividends Paid	-93,242	-5,465	-2,023	44,563	434	0	0	0	0	0	0	0	378,697	0	0	422,021	348,397	0	0	0	0	0	0	67	100	0	0	0	0
End Period Cash Flow	276,402	456,661	513,448	470,166	198,911	138,838	174,935	102,055	48,132	71,994	120,614	96,938	100,808	128,763	71,891	183,546	57,339	22,697	46,889	69,855	78,979	43,583	44,518	14,086	19,300	5,300	12,200	41,000	4,000
Exchange Rate Changes	0	0	0	0	0	-5,203	10,724	-4,744	-4,848	-7,550	1,685	4,556	-2,044	-4,809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	73,090	217,384	264,347	139,942	239,150	121,942	71,041	69,077	61,070	37,067	5,417	-10,316	65,903	68,433	115,666	59,189	24,454	60,182	48,795	30,467	30,983	29,731	12,841	-8,228	-14,800	-11,000	-8,700	-9,200	-8,500
Investments	-94,178	4,909	76	-7,840	2,336	910	17,434	-42,622	16,951	16,951	0	-2,967	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	349,590	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-107,800	-100,249	281,153	-9,200	-493,837	1,170,957	-20,746	74,721	226,185	-136,053	7,805	110,329	9,978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	67,741	180,550	169,075	133,892	50,201	60,801	64,743	74,564	6,851	34,004	-16,977	41,204	27,989	65,669	50,955	34,933	33,471	29,407	37,194	17,197	26,861	35,277	26,163	-10,955	-6,000	-12,300	-17,000	-7,500	-25,400
Other Cashflows From Financing Activities	180,621	21,597	27,274	766,873	310,560	129,538	1,285,947	681,100	507,697	438,389	31,561	159,330	750,178	117,930	6,663	845,632	698,018	99,805	-1,377	12,742	115,923	-3,600	-13,652	1,821	-1,100	9,200	-2,200	-21,300	-400
Other Cashflows From Investing Activities	0	-21,146	-161,443	-21,343	-95,467	27,126	-1,195,266	4,706	-338,597	-321,396	-2,445	-7,278	-151,951	-5,178	0	0	0	0	0	0	0	0	0	1,362	0	0	0	0	0
Other Non Cash Items	22,018	-18,100	-28,102	39,771	226,319	13,810	7,933	-30,431	30,573	9,518	57,534	-21,694	13,294	-1,567	6,685	57,527	20,674	21,081	1,425	24,268	1,202	2,516	443	11,844	100	100	6,700	-800	19,300
Sale Purchase Of Stock	-275,000	-125,000	-4,801	-100,000	-6,514	358,982	9,774	10,481	227,014	15,215	154,802	696	-83,463	-31,278	0	-106,534	-106,534	-70,031	-56,341	-14,238	-35,402	-1,761	0	-170	0	-300	0	0	0
Stock Based Compensation	20,143	27,725	36,210	19,590	21,255	20,779	21,550	17,310	15,450	15,105	10,393	9,051	26,805	17,209	15,580	-1,224	-1,224	-1,335	0	0	0	0	0	0	-3,600	0	0	0	0
Total Cash From Financing Activities	-229,925	-251,953	-98,226	121,625	64,460	-180,872	1,168,947	-15,116	258,513	242,784	19,019	12,135	60,137	-1,574	-171,342	153,536	108,485	45,641	-48,336	-8,115	94,673	-2,038	109,457	14,272	11,200	3,800	400	36,500	700
Total Cash From Operating Activities	139,955	264,469	312,427	203,832	373,682	199,683	114,544	116,405	94,483	79,463	53,268	58,715	104,328	105,571	143,235	72,590	47,026	71,702	56,848	38,975	34,826	31,985	15,701	-4,960	2,500	-9,800	-7,900	-8,000	-5,600
Total Cashflows From Investing Activities	0	-58,580	-161,443	-68,073	-162,668	-49,705	-1,221,335	-42,622	-372,010	-363,317	-50,296	-79,276	-190,376	-42,316	0	0	0	0	0	12,742	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31
Begin Period Cash Flow	273,732	309,192	307,367	456,661	511,937	447,152	407,092	513,448	470,231	397,414	408,976	470,166	396,279	360,981	357,712	198,911	207,981	176,084	157,025	138,838	205,991	183,771	189,396	174,935	481,943	154,600	124,113	102,055	107,598	86,803	77,086	48,132	79,311	131,296	79,871	71,994	140,231	137,160	129,038	120,614	118,868	98,636	89,691	96,938	125,718	75,470	58,642	100,808	110,991	137,279	104,354	128,763	82,832	93,618	81,674	71,891	106,747	138,717	185,630	183,546	109,339	77,338	199,013	129,498	129,498	120,838	29,329	22,697	24,322	27,533	22,393	46,889	37,352	29,020	32,763	69,855	34,912	42,540	76,052	78,979	83,951	116,153	105,089	43,583	50,142	51,195	46,764	44,518	59,333	8,602	15,392	13,011	13,011	5,676	23,366	19,301	12,900	12,000	7,600	5,300	2,600	4,700	800	2,100	4,100	0	12,100	11,800	0	200	40,900	4,500	0
Capital Expenditures	24,535	13,078	15,548	13,704	14,456	9,155	9,407	14,067	27,485	7,286	6,634	6,675	28,427	6,727	7,217	21,519	22,194	78,588	17,664	16,086	25,685	16,669	20,000	15,387	13,697	7,796	12,819	9,191	21,192	6,974	8,267	10,895	13,099	1,699	13,112	8,901	12,930	8,775	9,356	11,335	10,129	13,247	13,622	10,853	24,672	19,717	14,230	10,412	13,044	12,243	7,216	5,922	18,241	7,206	5,747	5,944	11,287	8,013	5,223	3,046	4,108	3,190	3,259	5,327	5,327	6,179	7,217	3,849	4,284	3,617	1,930	1,689	1,421	1,807	2,044	2,781	2,811	884	1,938	2,875	1,477	917	907	542	608	543	473	630	903	789	772	585	585	460	872	1,351	900	1,400	700	14,300	300	300	300	300	300	300	0	0	8,700	9,200	400	300	500
Cash And Cash Equivalents Changes	0	0	2,038	-150,231	-67,185	75,476	48,833	-103,188	42,313	76,047	-14,102	-51,500	65,563	29,872	615	161,334	-13,417	36,170	19,059	18,187	-67,153	22,220	-5,625	14,461	-307,008	327,343	30,487	22,058	-5,543	20,795	9,717	28,954	-31,439	-51,725	51,425	7,877	-68,237	3,071	8,122	8,424	1,746	20,232	8,945	-7,247	-28,780	50,248	16,828	-42,166	-10,183	-26,288	32,925	-24,409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-7,884	-5,023	-8,358	13,733	9,233	-1,056	-2,747	508	-7,902	10,005	16,609	7,112	2,747	12,267	38,614	70,913	-166	-13,765	4,565	4,319	-14,897	12,502	-18,054	-5,621	-8,738	-2,309	-28,862	-3,292	2,376	1,415	-8,270	17,383	-13,393	4,273	135	10,869	-2,969	-1,709	6,167	195	-5,614	4,622	-10,771	859	-28,393	4,995	4,059	1,813	109	4,590	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	2,670	-344,652	1,825	-149,294	-55,276	64,785	40,060	-106,356	43,217	72,817	-11,562	-61,190	73,887	35,298	3,269	158,801	-9,070	31,897	19,059	18,187	-67,153	22,220	-5,625	14,461	-307,008	327,343	30,487	22,058	-5,543	20,795	9,717	28,954	-31,179	-51,985	51,425	7,877	-68,237	3,071	8,122	8,424	1,746	20,232	8,945	-7,247	-28,780	50,248	16,828	-42,166	-10,183	-26,288	32,925	-24,409	45,931	-10,786	11,944	9,783	-34,856	-31,970	-46,913	2,084	74,207	32,001	-121,675	-72,159	-72,159	8,660	91,509	6,632	-1,625	-3,211	5,140	-24,496	9,537	8,332	-3,743	-37,092	34,943	-7,628	-33,512	-2,927	-4,972	-32,202	11,064	61,506	-6,559	-1,053	4,431	2,246	-14,815	50,731	-6,790	1,075	1,075	7,335	-17,690	4,065	6,400	900	4,400	2,300	2,700	-2,100	3,900	3,900	100	4,100	-4,600	300	3,800	-100	200	36,400	-100
Change In Working Capital	10,093	-34,064	-14,991	-20,366	10,256	-3,186	-16,720	-29,770	-25,247	5,950	11,487	25,973	9,494	-14,681	-3,694	-32,433	35,507	-1,667	-18,826	-29,523	-7,880	22,742	-11,419	-1,696	-1,800	12,706	-8,628	-3,601	-1,532	3,728	2,557	-15,982	-17,430	4,579	-6,529	2,477	-19,577	104	-8,575	-11,280	-13,558	2,765	-18,563	-4,507	-35,364	-3,036	7,006	7,400	-637	-8,306	-1,804	-4,341	-14,189	-879	-4,330	358	8,176	702	6,119	14,782	7,038	-3,557	-26,518	789	-43,914	-7,027	-12,183	-1,793	1,068	3,459	-1,229	-5,462	1,069	-5,988	1,785	-1,753	-9,114	-4,636	-3,950	-2,483	-13,577	-4,328	4,164	-896	1,608	1,757	-918	-2,016	-586	220	-5,845	-4,336	-584	-1,488	-4,224	-977	1,300	-2,100	100	700	-700	700	500	600	-500	400	600	100	-200	400	-1,000	-900	400
Change Receivables	0	0	-5,215	10,041	-10,035	-14,238	-6,516	-3,116	-10,172	6,635	-5,954	16,756	-5,758	-37,430	66,992	28,301	8,091	12,837	-16,651	-13,705	-18,201	9,600	9,980	-18,400	-79,837	1,442	-10,714	-589	-9,418	5,425	4,915	-18,440	-7,025	-4,726	-6,580	2,100	-12,298	-3,953	-5,565	5,671	-4,332	2,185	-2,854	2,109	5,116	-3,585	-2,548	4,800	-1,101	-76	-1,797	1,096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-457	224	-5,215	10,041	-10,035	-14,238	-6,516	-3,116	-10,172	6,635	-5,954	16,756	-5,758	-37,430	66,992	28,301	8,091	12,837	-16,651	-13,705	-18,201	9,600	9,980	-18,400	-79,837	1,442	-10,714	-589	-9,418	5,425	4,915	-18,440	-7,025	-4,726	-6,580	2,100	-12,298	-3,953	-5,565	5,671	-4,332	2,185	-2,854	2,109	5,116	-3,585	-2,548	4,800	-1,101	-76	-1,797	1,096	474	-6,944	-591	3,278	-1,856	1,758	765	9,141	-4,710	0	0	-2,841	0	174	0	-540	-26,131	0	0	0	491	2,975	3,596	0	0	0	0	0	0	0	0	0	0	0	0	0	98	0	0	393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Inventory	-16,423	-15,795	-2,132	-25,423	-4,681	-6,867	-6,015	-11,561	8,972	-6,491	5,225	-2,332	-2,817	1,510	-20,805	-26,236	-12,755	-8,995	-9,510	-12,048	11,741	155	-4,893	1,297	961	4,602	-257	-5,207	-515	-1,699	742	-8,104	4,246	1,870	-7,086	-2,789	-358	-9,281	-8,851	-8,516	-7,162	-10,889	-15,081	-8,885	-1,791	3,235	-1,302	-853	8,490	2,762	-4,780	-4,770	1,029	-649	-5,555	-2,199	2,650	518	3,544	2,693	11,502	4,758	-5,616	-1,270	-1,270	-7,489	-9,662	-170	3,988	-1,605	2,109	-1,031	1,521	-420	-5,074	-6,011	-2,044	-1,718	-2,649	-3,327	-820	546	-1,305	-250	1,328	495	-795	125	-249	-1,332	-3,194	-622	-622	-678	-1,865	104	300	0	0	500	700	100	0	0	-400	100	700	-100	400	-300	-700	-700	0
Change To Liabilities	0	0	2,155	-19,057	27,996	7,583	-10,344	-12,330	-33,858	-27,277	12,911	4,787	12,194	19,487	-49,563	-42,519	11,644	-16,533	7,501	9,995	-5,985	8,668	-1,609	2,905	95,130	12,283	11,081	4,504	-5,537	3,294	-5,476	9,147	-6,381	-10,332	20,530	-1,107	-7,056	2,469	8,810	-6,726	-8,231	11,274	3,121	-488	-27,413	-3,169	5,535	1,986	-8,613	-9,318	6,662	-3,623	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7,370	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	0	6,345	10,249	-2,030	-11,280	5,720	9,782	144,787	263,238	13,133	-34,743	-63,228	11,301	189	8,141	-913	4,659	9,366	-2,199	-3,564	12,867	7,212	3,620	-59,214	8,002	4,690	5,979	1,607	2,291	6,118	2,572	6,919	34,883	1,494	2,955	4,786	2,583	2,522	4,093	-433	42,677	5,099	994	3,938	1,633	22	1,361	13,674	3,727	7,876	2,000	0	0	0	0	0	0	0	0	0	0	0	4,755	1,235	0	0	1,872	7,496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	0	-22,246	5,076	2,416	5,339	-5,339	4,287	3,512	-695	-2,817	-4,586	-343	-470	5,399	25,083	9,959	-1,905	-8,969	2,795	184	-10,036	12,433	-10,919	3,606	-9,838	-2,309	15,028	-3,292	3,104	0	1,322	0	0	0	1,255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	30,521	30,558	30,826	31,143	29,496	29,467	29,612	29,724	30,746	30,122	29,754	29,214	26,178	31,027	29,675	29,151	27,878	27,599	26,892	27,093	27,677	29,051	26,906	27,096	26,664	20,969	21,595	19,717	18,312	18,086	18,014	18,253	18,267	9,437	15,745	15,414	16,023	15,941	15,203	13,961	11,315	11,670	12,636	11,389	13,489	13,314	13,232	12,576	12,869	12,852	14,493	9,958	10,504	9,714	9,523	9,431	12,572	9,973	8,467	8,676	11,204	6,682	7,579	7,008	7,008	6,598	7,678	5,755	6,023	7,370	4,389	3,696	3,190	3,216	3,552	3,263	3,252	3,105	2,486	2,749	2,767	2,080	2,283	1,913	1,977	1,965	1,641	1,579	1,698	1,704	1,424	1,406	1,406	1,327	1,337	1,106	-200	0	0	300	400	100	200	600	300	500	500	500	400	600	600	400	600
Dividends Paid	0	-655	-1,007	-2,326	3,873	0	0	0	0	0	0	0	318,048	0	0	690,503	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	47,013	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18,298	0	0	0	0	0	0	0	0	0	0	0	0	0	0	118,519	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	7	20	20	20	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	276,402	-35,460	309,192	307,367	456,661	511,937	447,152	407,092	513,448	470,231	397,414	408,976	470,166	396,279	360,981	357,712	198,911	207,981	176,084	157,025	138,838	205,991	183,771	189,396	174,935	481,943	154,600	124,113	102,055	107,598	86,803	77,086	48,132	79,311	131,296	79,871	71,994	140,231	137,160	129,038	120,614	118,868	98,636	89,691	96,938	125,718	75,470	58,642	100,808	110,991	137,279	104,354	128,763	82,832	93,618	81,674	71,891	106,747	138,717	185,630	183,546	109,339	77,338	57,339	57,339	129,498	120,838	29,329	22,697	24,322	27,533	22,393	46,889	37,352	29,020	32,763	69,855	34,912	42,540	76,052	78,979	83,951	116,153	105,089	43,583	50,142	51,195	46,764	44,518	59,333	8,602	14,086	14,086	13,011	5,676	23,366	19,300	12,900	12,000	7,600	5,300	2,600	4,700	6,000	100	4,100	-4,600	12,100	3,800	-100	200	40,900	-100
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,141	-884	-456	-849	-7,012	3,114	797	2,838	5,809	1,280	-4,693	532	-1,285	702	-1,501	-1,201	2,138	-4,284	-1,883	-6,037	39	331	665	2,634	649	-2,263	1,579	2,024	-958	1,911	-2,196	-5,596	1,035	4,713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	34,215	13,692	12,731	12,452	70,878	59,158	57,071	30,277	-118,579	235,864	84,656	62,406	105,762	8,985	25,900	-705	209,239	-43,831	60,344	13,398	17,003	62,582	16,213	26,144	-2,148	37,446	16,052	19,691	-14,663	39,793	35,671	8,276	12,293	21,048	5,011	22,718	7,827	22,300	7,021	-81	1,567	17,561	-10,704	-3,007	-28,460	8,192	-11,954	21,906	21,651	11,552	17,367	15,333	10,189	22,440	13,611	22,193	35,757	20,353	25,415	34,141	22,983	23,938	-5,234	9,266	9,266	4,493	-738	11,433	16,650	20,824	13,526	9,182	13,540	10,590	14,213	10,452	4,181	10,224	8,087	7,975	2,188	7,156	13,354	8,285	10,889	7,649	6,281	4,912	5,771	5,254	-2,338	-2,048	-2,048	1,136	-4,705	-2,611	600	-2,000	3,600	-17,000	-3,300	-2,400	-2,900	-2,400	-4,400	-1,800	-1,100	-1,200	6,600	-10,600	-2,800	-2,400	-1,700
Investments	-57,229	-7,697	-15,548	-13,704	-54,820	14,805	4,909	-14,067	-27,485	76	-7,917	-117,566	-7,840	-6,718	-3,949	-21,485	1,584	257	250	245	231	233	225	221	16,951	483	6,975	9,976	16,951	9,976	9,976	4,165	16,951	0	0	0	16,951	0	0	0	0	0	0	0	0	38,882	11,399	-53,248	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	-11,700	-9,778	-101,300	-6,500	500	-500	100,800	100,000	-98,400	-1,600	20,200	-32,983	-29,800	323,736	-81,750	76,350	-13,600	9,800	-79,449	-45,167	-359,221	-10,000	664,574	291,383	25,000	190,000	13,491	-20,164	-27,038	12,965	-17,407	72,524	34,782	-15,178	4,665	-13,235	-123	234,878	-155,000	-40	18,987	0	0	0	20,618	-12,813	-12,812	48,066	116,950	-41,875	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	19,834	19,497	4,184	24,226	52,946	49,915	44,788	32,901	45,384	43,229	35,068	45,394	92,744	32,337	-369	9,180	15,319	-27,610	29,736	32,756	25,138	13,295	11,376	10,992	44,355	3,158	10,836	6,394	28,248	20,143	14,525	11,648	14,980	-21,511	4,998	8,384	17,166	9,807	4,825	2,206	12,183	-28,550	3,440	-4,050	12,786	13,211	8,514	6,693	4,560	11,243	699	11,487	18,807	16,483	15,157	15,222	15,731	14,432	11,225	9,567	24,845	-15,291	13,814	5,382	5,382	9,673	9,342	9,074	10,131	2,594	7,977	8,705	10,614	10,482	7,655	8,443	9,839	-7,598	7,518	7,438	9,172	6,833	5,418	5,438	25,374	1,563	4,249	4,091	17,625	3,780	2,762	-11,693	-12,163	1,717	84	-1,063	-800	-2,000	-3,600	400	-2,900	-2,900	-3,200	-3,300	-10,700	-2,400	-2,100	-1,800	-2,300	-2,100	-1,500	-1,600	-2,200
Other Cashflows From Financing Activities	-314	132,141	6,007	-283	-114,899	11,250	-1,897	3,285	112,261	-86,697	2,525	-815	635,707	19,451	15,747	1,356,394	94,084	113,882	39,801	62,793	-233,654	5,170	343,908	14,114	716,214	321,370	43,324	205,039	660,742	367	2,145	17,846	-262	682,001	44,494	1,352	46,975	146,933	1,185	243,296	2,054	10,184	19,066	257	150,397	460	155,415	253	4	50,254	337,781	1,740	40,549	-37,004	77,571	5,536	4,019	2,045	568	31	179,786	80,703	-118,787	294,069	57,031	-334	174,165	240	13,538	21,639	33,451	15,990	-1,107	-221	-24,694	-5	78,818	-14,238	-45,778	-15,081	-40	-91	14,204	101,850	-1,761	-9,715	-24	-3,576	186	-9,842	-2,601	-63	-63	1,895	192	-278	-400	-400	-400	-4,900	5,600	200	3,900	6,000	-2,200	5,600	-3,500	-2,100	-100	-200	-100	100	-100
Other Cashflows From Investing Activities	0	0	0	0	-40,364	23,960	-18,565	-4,742	-161,519	-133,958	-125,483	-110,891	-19,654	9	3,268	-4,966	1	-95,503	250	35	124	93	21,041	5,868	-986,822	206	-24,698	-183,952	4,215	267	224	0	-24,719	-317,147	1,831	3,269	-86,396	0	0	-235,000	2	-147	-66	-2,234	-5,101	690	-2,692	-175	-2,531	-68,621	-80,799	0	0	0	0	0	0	0	0	0	0	0	0	0	0	403	371	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,362	1,600	1,600	150	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	7,357	4,083	3,216	-14,420	-7,071	-10,747	-1,936	1,654	-159,152	164,695	2,955	-36,600	69,438	-43,567	7,802	6,098	155,728	32,009	36,664	1,918	1,733	7,379	2,654	2,044	3,508	2,897	526	1,002	-39,481	2,211	5,775	1,064	38,842	-10,258	206	1,783	3,182	2,844	1,159	2,333	2,548	48,931	2,058	3,997	-1,839	2,773	-27,190	4,562	4,389	4,213	2,594	2,098	1,760	1,684	-4,663	-348	1,520	2,057	2,287	821	3,446	48,010	3,007	10,116	4,002	3,375	3,691	-86	4,400	9,209	3,926	3,310	197	988	67	174	293	23,607	380	-13	1,186	275	-46	-213	141	2,345	0	30	-12,063	339	93	13,160	0	40	-1,030	-326	1,200	3,500	7,800	-4,100	200	0	-100	0	6,800	100	-100	0	0	-300	-500	0	0
Sale Purchase Of Stock	0	-125,000	-104	-150,000	125,000	-1,142	-14,000	-125,000	236	2,985	1,381	2,222	100,000	223	1,296	-100,000	6,948	4,735	463	1,750	153	5,503	349,664	3,662	0	0	8,607	1,167	556	665	8,222	1,038	-219	219,888	7,114	231	6,898	0	562	7,755	154,382	186	0	234	0	446	0	250	-14,452	-12,002	-52,689	-4,320	0	0	0	0	0	0	0	0	0	0	0	-20,465	-20,465	0	-74,994	-11,075	-38,206	-16,638	0	0	-31,691	0	0	0	0	0	0	0	1	-78	0	-35,325	0	0	0	0	0	0	0	0	0	-40	0	0	0	0	0	0	0	-200	0	0	0	0	0	300	0	0	0	0	0
Stock Based Compensation	5,793	5,459	5,271	3,620	5,731	8,967	6,736	6,291	6,432	7,745	15,699	6,334	5,257	5,411	5,172	3,750	5,511	5,885	5,776	4,083	4,993	5,572	5,483	4,731	5,191	5,309	5,687	5,363	4,537	4,876	4,651	3,246	3,662	6,172	3,239	2,377	3,417	3,386	5,831	2,471	2,799	2,830	2,692	2,072	2,419	2,277	2,285	2,070	7,908	3,034	11,829	4,034	5,756	3,933	3,677	3,843	4,059	3,790	3,971	3,760	-1,590	0	0	-1,224	0	295	-73	3,356	-1,335	236	0	0	0	-1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-6,890	-49,659	-10,693	-162,683	-97,699	-7,642	-13,147	-133,465	101,011	-98,747	-97,475	-3,015	21,222	-33,049	-28,553	162,005	-8,766	75,632	-7,799	5,393	-84,055	-39,839	-36,092	-20,886	664,214	286,370	33,324	185,039	13,763	-19,797	-24,893	15,811	-17,512	245,575	44,276	-13,826	11,740	-13,192	1,062	243,174	-488	184	19,066	257	3,202	460	21,033	-12,560	-27,107	36,377	95,322	-44,455	38,674	-37,004	6,220	-9,464	-13,109	-54,013	-76,263	-27,957	62,539	86,268	-116,272	-17,794	-17,794	4,444	125,199	-3,364	-17,956	7,092	35,491	21,014	-28,784	1,269	-23,101	2,280	1,929	-13,546	2,266	1,236	5,557	1,311	19,065	68,740	-389	471	505	-2,625	3,542	105,378	498	1,014	1,014	6,580	548	6,130	1,900	-200	-500	10,000	100	-200	3,900	0	100	0	0	300	100	-100	200	36,400	-100
Total Cash From Operating Activities	58,750	26,770	28,279	26,156	85,334	68,313	66,478	44,344	-91,094	243,150	91,290	69,081	134,189	15,712	33,117	20,814	231,433	34,757	78,008	29,484	42,688	79,251	36,213	41,531	11,549	45,242	28,871	28,882	6,529	46,767	43,938	19,171	25,392	19,349	18,123	31,619	20,757	31,075	16,377	11,254	11,696	30,808	2,918	7,846	-3,788	27,909	2,276	32,318	34,695	23,795	24,583	21,255	28,430	29,646	19,358	28,137	47,044	28,366	30,638	37,187	27,091	27,128	-1,975	14,593	14,593	10,672	6,479	15,282	20,934	24,441	15,456	10,871	14,961	12,397	16,257	13,233	6,992	11,108	10,025	10,850	3,665	8,073	14,261	8,827	11,497	8,192	6,754	5,542	6,674	6,043	-1,566	-1,463	-1,463	1,596	-3,833	-1,260	1,500	-600	4,300	-2,700	-3,000	-2,100	-2,600	-2,100	-4,100	-1,500	-1,100	-1,200	-2,100	-1,400	-2,400	-2,100	-1,200
Total Cashflows From Investing Activities	0	0	-15,548	-13,704	-54,820	14,805	-4,498	-14,067	-27,485	-8,475	-7,917	-117,566	-35,921	-6,718	-3,949	-21,485	-20,609	-108,839	-17,414	-15,806	-25,330	-16,343	1,266	-9,298	-983,568	-7,107	-37,517	-193,143	-21,142	-6,707	-8,043	-6,730	-37,818	-315,448	-13,112	-5,632	-98,851	-8,775	-9,356	-246,335	-10,127	-13,394	-13,688	-13,087	-29,773	19,855	-5,523	-63,835	-15,575	-80,864	-88,015	-5,922	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12,742	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Cost Of Revenue	653,180	587,355	597,808	520,834	564,681	571,496	435,511	349,089	326,542	352,801	334,085	314,427	299,150	268,188	244,918	252,826	214,674	168,314	105,536	87,299	70,597	45,772	36,014	26,816	21,800	6,100	5,200	4,700	3,500
Depreciation And Amortization	123,512	37,806	42,958	41,488	27,028	21,160	20,370	13,862	9,953	12,400	47,010	18,536	16,433	39,172	39,688	33,148	27,039	21,478	13,221	11,592	9,043	7,162	6,257	5,176	2,200	1,300	1,800	2,000	1,400
Discontinued Operations	0	0	0	0	0	0	0	0	-10,370	-2,291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	174,076	238,920	197,230	151,370	178,977	122,086	46,404	116,209	84,188	64,946	41,736	74,266	55,377	98,919	98,455	48,316	64,317	60,754	56,844	20,770	17,672	18,643	8,667	-26,392	-16,700	-15,900	-21,000	-11,400	13,300
Ebitda	297,588	276,726	240,188	192,858	206,005	143,246	66,774	130,071	94,141	77,346	88,746	92,802	71,810	138,091	138,143	81,464	91,356	82,232	70,065	32,362	26,715	25,805	14,924	-21,216	-14,500	-14,600	-19,200	-9,400	14,700
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	-43,400	0	-10,370	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	888,393	970,311	944,640	851,034	952,876	900,945	752,725	642,986	556,192	575,504	502,129	516,444	480,928	463,880	437,569	401,778	335,785	250,983	172,399	142,526	115,002	66,853	57,428	38,171	20,700	11,400	9,500	8,400	6,700
Income Before Tax	81,069	213,894	214,677	93,520	60,104	57,403	11,385	90,406	60,671	42,979	-24,790	52,029	28,494	82,114	73,152	31,006	60,062	48,308	55,101	28,008	43,189	22,725	15,543	-10,847	-7,800	-12,300	-17,000	-7,600	-25,300
Income Tax Expense	13,328	33,344	45,602	-40,372	9,903	-3,398	-53,358	15,842	53,820	8,975	-7,813	10,825	505	16,445	22,197	-3,927	26,591	18,901	17,907	10,811	16,328	-12,552	-10,863	108	-1,800	-1,800	-2,000	-2,000	19,400
Interest Expense	71,832	49,594	50,395	71,581	53,957	64,683	35,019	25,803	23,517	21,967	19,788	22,237	27,640	18,356	23,227	17,614	13,749	10,620	0	0	0	0	0	0	0	0	0	0	0
Interest Income	17,202	11,917	6,737	9,297	10,779	2,800	255	24	23,504	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	67,741	180,550	169,075	133,892	50,201	60,801	64,743	74,564	-3,519	34,004	-16,977	41,204	27,989	65,669	50,955	34,933	33,471	29,407	37,194	17,197	26,861	35,277	26,163	-11,425	-6,000	-12,300	-17,000	-7,500	-25,400
Net Income Applicable To Common Shares	0	180,550	169,075	133,892	50,201	60,801	64,743	74,564	-3,519	34,004	-16,977	41,204	27,989	65,669	50,955	34,933	33,471	29,407	37,194	17,197	26,861	35,118	25,380	0	0	0	0	0	0
Net Income From Continuing Ops	67,741	180,550	169,075	133,892	50,201	60,801	64,743	74,564	6,851	34,004	-16,977	41,204	27,989	65,669	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	-34,175	-37,677	-43,658	-62,284	-43,178	-61,883	-34,764	-25,779	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	24,568	67,842	13,731	20,301	11,088	1,600	869	4,601	-595	-1,358	484	1,222	1,776	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	64,916	0	0	0	0	0	46,738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	174,076	238,920	197,230	151,370	178,977	110,998	44,804	115,340	79,587	65,541	-3,644	73,782	54,912	98,694	97,824	47,411	67,288	58,744	56,105	24,779	39,647	19,187	14,286	-18,383	-12,400	-14,100	-19,000	-9,500	-6,000
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	1,367,497	1,318,746	1,345,218	1,220,498	1,358,881	1,361,443	1,143,432	876,735	803,147	862,764	793,120	757,089	725,166	633,374	584,663	607,193	483,171	360,553	221,830	205,046	145,952	91,110	79,156	83,370	54,900	31,600	33,700	22,600	16,200
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	123,512	118,299	16,914	116,031	109,462	110,730	88,945	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	62,687	101,193	93,051	77,381	79,573	78,041	63,455	58,155	50,895	51,596	52,088	51,012	51,451	48,114	44,280	60,495	30,658	25,732	11,960	14,121	12,814	8,304	7,992	7,524	8,700	8,400	6,400	6,300	5,200
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	656,641	616,316	637,445	594,526	687,599	690,746	624,096	455,629	415,757	445,967	394,250	373,114	358,132	305,055	281,102	280,997	225,187	157,706	98,273	99,360	59,461	40,587	32,366	43,854	22,200	15,800	20,300	9,600	0
Tax Provision	13,328	33,344	45,602	-40,372	9,903	-3,398	-53,358	15,842	53,820	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	714,317	731,391	747,410	699,664	794,200	789,947	707,921	527,646	476,605	509,963	459,035	442,662	426,016	365,186	339,745	354,367	268,497	192,239	116,294	117,747	75,355	45,338	43,142	56,554	33,100	25,500	28,500	17,900	12,700
Total Other Income Expense Net	-93,007	-25,026	17,447	-57,850	-118,873	8,288	1,345	845	4,588	-763	-48,539	-721	757	1,551	-2,076	-905	2,971	-2,010	-739	4,009	21,975	2,872	5,619	8,009	4,300	1,800	2,000	1,900	-19,300
Total Revenue	1,541,573	1,557,666	1,542,448	1,371,868	1,517,557	1,472,441	1,188,236	992,075	882,734	928,305	836,214	830,871	780,078	732,068	682,487	654,604	550,459	419,297	277,935	229,825	185,599	112,625	93,442	64,987	42,500	17,500	14,700	13,100	10,200

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31
Cost Of Revenue	163,061	164,076	174,241	147,975	147,937	148,445	148,404	142,569	156,250	144,468	151,267	145,823	147,069	134,811	105,478	133,476	149,462	142,636	143,671	128,912	146,464	143,245	137,565	144,222	148,171	101,757	98,998	86,585	85,422	89,329	89,565	84,773	90,001	86,069	86,539	86,722	97,468	85,974	86,976	82,383	86,648	84,101	83,068	80,268	81,930	79,548	78,274	74,675	82,740	78,651	72,838	64,921	71,306	69,194	64,464	63,224	63,944	63,021	59,805	58,148	68,138	64,317	58,159	62,426	62,426	50,863	52,808	48,577	51,445	47,559	41,373	27,937	28,252	26,013	27,139	24,133	23,221	22,412	21,665	20,001	20,934	18,870	17,090	13,703	14,168	12,611	9,465	9,528	9,957	9,153	8,310	6,978	6,978	6,982	6,658	6,198	7,800	6,100	8,000	2,400	2,000	1,600	1,400	1,100	1,100	1,200	1,800	1,100	1,800	1,000	800	1,100	1,400	500	-	-
Depreciation And Amortization	30,521	3,208	3,026	8,604	12,805	35,379	33,556	34,530	4,076	4,113	4,198	4,527	4,364	8,343	29,675	29,151	5,688	5,056	11,004	5,279	5,216	5,268	26,906	5,390	5,394	20,969	21,595	19,717	3,452	18,086	18,014	18,253	3,535	2,942	3,104	15,414	3,387	2,995	2,985	13,961	11,315	11,670	12,636	3,551	4,551	13,314	13,232	4,720	12,869	12,852	14,493	9,958	10,504	9,714	9,523	9,431	12,572	9,973	8,467	8,676	11,204	6,682	7,579	7,008	7,008	6,598	7,678	5,755	6,023	7,370	4,389	3,696	3,190	3,216	3,552	3,263	3,252	3,105	2,486	2,749	2,767	2,080	2,283	1,913	1,977	1,965	1,641	1,579	1,698	1,704	1,424	1,406	1,406	1,327	1,337	1,106	-200	-100	-300	300	400	100	200	600	300	500	500	500	400	600	600	400	600	300	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-10,370	0	0	0	-2,291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Ebit	55,880	31,671	16,288	36,382	67,840	65,049	59,867	46,164	64,081	63,210	58,652	37,331	56,267	62,307	17,333	29,194	44,869	46,342	49,767	37,972	38,449	25,502	30,235	27,900	12,349	9,996	14,183	9,876	42,022	31,289	21,531	21,387	25,624	11,826	13,043	18,109	25,802	17,459	12,568	9,117	17,832	16,899	7,960	-955	18,267	19,836	18,436	17,845	7,860	18,445	8,127	20,945	24,216	27,368	24,631	22,704	27,900	24,017	24,039	22,499	26,520	-22,482	25,249	12,354	15,554	18,661	16,592	16,711	20,326	13,579	13,257	13,592	15,014	16,095	12,668	13,009	11,332	-12,759	11,460	10,738	-7,870	10,613	7,838	7,091	5,875	5,209	3,697	5,348	3,342	2,209	2,072	-15,017	-12,358	-3,427	-4,118	-3,830	-1,300	-2,700	-4,500	-8,000	-3,400	-3,500	-5,200	-4,000	-11,600	-3,400	-3,100	-2,800	-2,900	-3,200	-2,600	-2,200	-2,400	18,100	-	-
Ebitda	86,401	34,879	19,314	44,986	80,645	100,428	93,423	80,694	68,157	67,323	62,850	41,858	60,631	70,650	47,008	58,345	50,557	51,398	60,771	43,251	43,665	30,770	57,141	33,290	17,743	30,965	35,778	29,593	45,474	49,375	39,545	39,640	29,159	14,768	16,147	33,523	29,189	20,454	15,553	23,078	29,147	28,569	20,596	2,596	22,818	33,150	31,668	22,565	20,729	31,297	22,620	30,903	34,720	37,082	34,154	32,135	40,472	33,990	32,506	31,175	37,724	-15,800	32,828	19,362	22,562	25,259	24,270	22,466	26,349	20,949	17,646	17,288	18,204	19,311	16,220	16,272	14,584	-9,654	13,946	13,487	-5,103	12,693	10,121	9,004	7,852	7,174	5,338	6,927	5,040	3,913	3,496	-13,611	-10,952	-2,100	-2,781	-2,724	-1,500	-2,800	-4,800	-7,700	-3,000	-3,400	-5,000	-3,400	-11,300	-2,900	-2,600	-2,300	-2,500	-2,600	-2,000	-1,800	-1,800	18,400	2,300	2,300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Gross Profit	233,978	218,345	207,026	232,871	250,085	236,746	249,411	234,069	249,274	242,393	238,725	214,248	241,578	235,421	153,187	220,848	245,665	236,459	239,974	230,778	236,851	222,609	228,625	212,860	220,431	177,077	183,166	172,051	170,241	161,003	159,744	151,997	151,159	140,298	157,539	146,943	154,708	143,745	144,375	132,676	134,121	129,145	122,479	116,384	132,502	130,536	131,896	121,510	120,783	123,534	120,491	116,120	122,828	117,447	114,131	109,474	119,582	109,265	105,920	102,802	106,232	102,711	99,039	95,219	95,219	84,152	81,959	74,455	73,949	69,088	58,748	49,198	44,732	43,320	42,639	41,706	38,590	36,718	34,776	32,442	38,091	28,188	25,646	23,077	15,896	17,593	16,976	16,388	19,497	13,166	13,075	12,199	12,199	9,908	9,026	7,038	5,100	6,000	4,600	2,600	2,800	2,700	2,400	3,500	2,200	2,700	2,500	2,100	2,000	1,900	2,700	2,000	1,600	2,100	2,300	2,300
Income Before Tax	28,858	18,609	3,824	29,778	64,208	58,796	51,575	39,315	51,787	50,788	44,824	67,278	38,916	41,511	1,651	11,442	26,407	-27,509	36,383	24,823	24,516	11,024	12,731	9,132	-4,597	3,235	8,002	4,745	35,474	24,994	14,943	15,014	19,511	5,362	7,572	12,617	20,275	11,543	7,186	3,975	13,125	-35,155	2,995	-5,755	16,611	14,256	11,569	9,593	376	11,287	1,998	14,833	19,440	22,271	21,094	19,309	22,677	18,144	17,384	14,947	19,111	-27,150	20,530	16,075	16,075	15,666	14,561	13,759	17,668	6,062	11,580	12,998	14,828	15,694	11,687	12,890	15,976	-11,631	11,895	11,769	15,039	11,043	8,542	8,565	7,489	2,403	6,538	6,295	5,722	4,388	3,191	-11,888	-11,888	1,797	245	-1,001	-1,300	-2,500	-4,800	900	-3,000	-2,900	-3,200	-3,200	-10,600	-2,400	-2,100	-1,800	-2,300	-2,000	-1,600	-1,600	-2,200	-20,900	-	-
Income Tax Expense	9,024	-888	-360	5,552	11,262	8,881	6,787	6,414	6,403	7,559	9,756	21,884	-53,828	9,174	2,020	2,262	11,088	101	6,647	-7,933	-622	-2,271	1,355	-1,860	-48,952	76	-2,833	-1,649	7,228	4,850	2,188	3,366	4,531	37,243	2,574	4,233	3,109	1,736	2,361	1,769	942	-6,605	-445	-1,705	3,825	1,045	3,055	2,900	-4,184	44	1,299	3,346	633	5,788	5,937	4,087	6,946	3,712	6,159	5,380	-5,734	-11,859	6,716	10,693	10,693	5,993	5,220	4,685	7,537	3,468	3,603	4,293	4,214	5,213	4,032	4,447	6,137	-4,034	4,377	4,331	5,867	4,210	3,124	3,127	-17,885	840	2,289	2,204	-11,903	365	429	-195	-195	80	161	62	-500	-500	-1,200	500	-300	-300	-1,000	-300	-400	-400	-600	-500	-300	-500	-600	-300	-100	19,600	1,100	1,100
Interest Expense	18,871	13,062	12,464	12,100	12,894	12,809	12,236	11,655	12,125	12,192	13,149	12,929	17,351	20,796	15,682	17,752	13,462	13,962	13,384	13,149	13,933	14,478	17,504	18,768	16,946	6,761	6,181	5,131	6,548	6,295	6,588	6,373	6,113	6,464	5,471	5,492	5,527	5,916	5,382	5,142	4,707	5,316	4,965	4,800	1,656	5,549	7,103	7,929	7,862	7,587	6,722	5,469	5,125	4,390	4,300	4,541	4,876	5,493	6,174	6,684	17,614	4,249	4,261	13,749	3,853	3,863	3,273	2,759	10,620	2,870	2,073	1,682	1,071	1,345	822	927	997	784	823	871	771	922	1,024	7	0	0	0	0	0	556	0	0	350	327	320	280	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Interest Income	4,549	4,607	3,939	4,107	5,311	3,264	1,965	1,377	1,439	1,786	1,764	1,748	2,173	2,273	2,281	2,570	2,728	2,913	2,710	10,721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Income	19,834	19,497	4,184	24,226	52,946	49,915	44,788	32,901	45,384	43,229	35,068	45,394	92,744	32,337	-369	9,180	15,319	-27,610	29,736	32,756	25,138	13,295	11,376	10,992	44,355	3,159	10,835	6,394	28,246	20,144	12,755	11,648	14,980	-31,881	4,998	8,384	17,166	9,807	4,825	2,206	12,183	-28,550	3,440	-4,050	12,786	13,211	8,514	6,693	4,560	11,243	699	11,487	18,807	16,483	15,157	15,222	15,731	14,432	11,225	9,567	24,845	-15,291	13,814	5,382	5,382	9,673	9,341	9,074	10,131	2,594	7,977	8,705	10,614	10,481	7,655	8,443	9,839	-7,597	7,518	7,438	9,172	6,833	5,418	5,438	25,374	1,563	4,249	4,091	17,625	3,780	2,762	-12,163	-12,163	1,717	84	-1,063	-800	-2,000	-3,600	400	-2,900	-2,900	-3,200	-3,300	-10,700	-2,500	-2,000	-1,800	-2,300	-2,100	-1,500	-1,600	-2,200	-21,000	-1,100	-1,100
Net Income Applicable To Common Shares	0	0	4,184	24,226	52,946	49,915	44,788	32,901	45,384	43,229	35,068	45,394	92,744	32,337	-369	9,180	15,319	-27,610	29,736	32,756	25,138	13,295	11,376	10,992	44,355	3,159	10,835	6,394	30,017	20,144	12,755	11,648	14,980	-31,881	4,998	8,384	17,166	9,807	4,825	2,206	12,183	-28,550	3,440	-4,050	12,786	13,211	8,514	6,693	4,560	11,243	699	11,487	18,807	16,483	15,157	15,222	15,731	14,432	11,225	9,567	23,255	-12,277	12,277	9,050	5,382	9,673	9,342	9,074	10,131	2,594	7,977	8,705	10,614	10,482	7,655	8,443	9,839	-7,518	7,518	7,438	9,172	6,833	5,418	5,438	25,374	1,563	4,225	3,956	17,490	3,888	2,391	1,611	-1,339	1,339	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Income From Continuing Ops	19,834	19,497	4,184	24,226	52,946	49,915	44,788	32,901	45,384	43,229	35,068	45,394	92,744	32,337	-369	9,180	15,319	-27,610	29,736	32,756	25,138	13,295	11,376	10,992	44,355	3,159	10,835	6,394	30,017	20,144	12,754	11,648	25,350	-31,881	4,998	8,384	17,166	9,807	4,825	2,206	12,183	-28,550	3,440	-4,050	12,786	13,211	8,514	6,693	4,560	11,243	699	11,487	0	16,483	15,157	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Interest Income	-9,202	-8,455	-8,525	-7,993	-7,583	-9,545	-10,271	-10,278	-10,686	-10,406	-11,385	-11,181	-15,178	-18,523	-13,401	-15,182	-10,734	-11,049	-10,674	-10,721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Operating Income Net Other	0	0	3,784	5,496	9,262	6,556	3,944	4,806	5,689	6,541	6,119	49,493	3,622	4,765	3,253	2,091	3,789	7,040	3,808	5,664	4,341	1,825	2,601	2,321	5,131	-646	-2,802	-83	1,253	1,194	-846	-732	2,359	1,832	-911	1,321	-882	-268	176	379	-204	-225	-18	-911	-291	69	651	55	489	583	720	-570	0	-648	815	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5,027	59,889	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	46,738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Operating Income	55,880	26,593	12,504	36,382	67,840	65,049	59,867	46,164	58,223	56,439	51,854	30,714	52,645	57,542	14,080	27,103	36,080	-20,587	45,959	32,308	34,108	23,677	27,634	25,579	7,218	10,642	16,985	9,959	40,769	30,095	22,377	22,119	24,008	9,994	13,954	16,788	26,684	17,727	12,392	8,738	18,036	-29,614	7,978	-44	18,558	19,736	18,021	17,467	7,749	18,291	8,000	20,872	24,163	27,309	24,579	22,643	27,847	23,820	23,905	22,252	24,968	-22,891	24,798	15,554	15,554	18,336	16,895	16,503	20,148	11,814	13,158	13,624	14,913	16,091	12,143	12,956	13,631	-12,180	11,600	11,729	12,996	10,922	8,289	7,440	6,780	1,592	5,490	5,325	4,712	3,736	3,456	-13,402	-13,402	-713	-1,847	-2,421	-1,300	-2,700	-4,800	-3,500	-3,200	-3,200	-4,200	-3,600	-11,100	-2,900	-2,600	-2,300	-2,600	-2,600	-2,100	-1,900	-2,300	-1,400	2,300	2,300
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Operating Expenses	341,159	355,828	368,763	344,464	330,182	320,142	337,948	330,474	347,301	330,422	338,138	329,357	336,002	312,690	244,585	327,221	354,047	339,793	337,686	327,382	349,207	342,177	338,556	331,503	361,384	268,192	265,179	248,677	214,894	220,237	226,932	214,651	217,152	216,373	230,124	216,877	225,492	211,992	218,959	206,321	202,733	196,122	197,569	196,696	195,874	190,348	192,149	178,718	195,774	183,894	185,329	160,169	169,971	159,332	154,016	150,055	155,679	148,466	141,820	138,698	149,402	189,919	132,400	142,091	142,091	116,679	117,872	106,529	105,246	104,833	86,963	63,511	58,071	53,242	57,635	52,883	48,180	71,310	44,841	40,714	46,029	36,136	34,447	29,340	23,278	26,290	20,951	20,591	24,742	18,583	17,929	32,579	32,579	17,603	17,531	15,657	14,200	14,800	17,400	8,500	8,000	7,500	8,000	8,200	14,400	6,800	6,900	5,500	6,400	5,500	5,600	5,000	5,300	4,000	-	-
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Reconciled Depreciation	30,985	3,208	3,026	3,108	29,496	29,467	29,612	29,724	4,076	30,122	4,198	29,214	26,178	31,027	29,675	29,151	27,878	27,599	26,892	27,093	27,677	29,051	26,906	27,096	26,664	20,969	21,595	19,717	18,312	18,086	18,014	18,253	18,267	9,437	15,745	15,414	16,023	15,941	15,203	13,961	11,315	11,670	12,636	11,389	13,489	13,314	13,232	12,576	12,869	12,852	14,493	9,958	10,504	9,714	9,523	9,431	12,572	9,973	8,467	8,676	11,204	6,682	7,579	7,008	7,008	6,598	7,678	5,755	6,023	7,370	4,389	3,696	3,190	3,216	3,552	3,263	3,252	3,105	2,486	2,749	2,767	2,080	2,283	1,913	1,977	1,965	1,641	1,579	1,698	1,704	1,424	1,406	1,406	1,327	1,337	1,106	-200	0	0	300	400	100	200	600	300	500	500	500	400	600	600	400	600	-	-	-
Research Development	24,311	26,596	26,588	26,724	26,783	24,736	25,589	24,085	24,725	25,831	20,121	22,374	22,179	19,460	14,926	20,816	24,643	19,003	17,633	18,321	20,299	20,309	19,108	18,325	17,180	15,034	15,747	15,494	13,901	15,124	14,679	14,451	13,866	13,938	13,891	12,556	12,157	13,127	13,745	12,567	14,511	13,052	11,809	12,716	12,864	13,105	13,131	11,912	13,402	13,187	12,709	12,153	13,331	11,721	11,761	11,301	11,810	11,525	10,302	10,643	10,186	34,718	7,793	11,813	11,813	6,546	6,239	6,060	5,214	10,991	6,354	3,173	2,704	3,110	2,787	3,359	3,556	5,103	2,639	2,823	4,771	2,616	2,777	2,650	2,249	2,160	2,073	1,822	1,910	2,172	1,837	2,027	2,027	1,741	1,929	1,828	2,100	2,200	2,300	2,000	2,000	2,200	2,100	2,100	1,900	1,400	1,700	1,400	1,500	1,600	1,700	1,500	1,600	1,600	-	-
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0	0	0	0	3,562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5,148	0	4,751	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Selling General Administrative	163,128	161,948	164,908	166,657	151,919	143,820	160,651	159,926	162,250	156,010	162,552	156,633	165,952	150,076	116,108	165,952	174,254	173,098	165,378	174,870	177,228	173,355	176,597	163,566	190,639	145,945	145,015	142,497	112,119	112,317	119,217	111,956	109,750	113,424	126,590	114,064	112,480	109,896	115,253	108,338	98,537	95,933	99,619	100,161	96,529	93,077	96,097	87,411	94,808	87,508	95,732	80,084	82,590	75,738	74,216	72,511	76,484	69,915	68,252	66,451	67,373	87,660	63,475	64,861	64,861	56,241	54,980	49,105	45,936	43,431	37,219	31,120	25,663	22,653	26,041	23,916	20,264	42,600	19,488	17,007	19,356	13,877	13,818	12,410	11,553	11,094	9,049	8,891	7,918	7,905	8,588	22,168	22,168	7,553	7,607	6,525	4,500	6,500	7,400	3,800	3,600	3,600	4,300	4,400	11,100	3,700	2,900	2,500	2,700	2,300	0	0	0	-	-	-
Tax Provision	9,024	-888	-360	5,552	11,262	8,881	6,787	6,414	6,403	7,559	9,756	21,884	-53,828	9,174	2,020	2,262	11,088	101	6,647	-7,933	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Operating Expenses	178,098	191,752	194,522	196,489	182,245	171,697	189,544	187,905	191,051	185,954	186,871	183,534	188,933	177,879	139,107	193,745	204,585	197,157	194,015	198,470	202,743	198,932	200,991	187,281	213,213	166,435	166,181	162,092	129,472	130,908	137,367	129,878	127,151	130,304	143,585	130,155	128,024	126,018	131,983	123,938	116,085	112,021	114,501	116,428	113,944	110,800	113,875	104,043	113,034	105,243	112,491	95,248	98,665	90,138	89,552	86,831	91,735	85,445	82,015	80,550	81,264	125,602	74,241	79,665	79,665	65,816	65,064	57,952	53,801	57,274	45,590	35,574	29,819	27,229	30,496	28,750	24,959	48,898	23,176	20,713	25,095	17,266	17,357	15,637	9,110	13,679	11,486	11,063	14,785	9,430	9,619	25,601	25,601	10,621	10,873	9,459	6,400	8,700	9,400	6,100	6,000	5,900	6,600	7,100	13,300	5,600	5,100	4,400	4,600	4,500	4,800	3,900	3,900	3,500	-	-
Total Other Income Expense Net	-27,022	471	-155	-6,604	-3,632	-6,253	-8,292	-6,849	4,250	4,755	4,355	47,745	1,449	2,492	972	-479	-3,939	-55,762	1,098	3,236	1,866	1,750	2,427	2,245	5,036	-735	-2,866	-90	1,243	1,192	-852	-738	1,604	1,827	-919	1,316	-905	-293	118	317	-257	-47,001	-307	-974	-603	-31	236	-323	378	429	593	-643	349	-707	763	1,146	-347	-380	-481	-868	-1,552	-409	-451	3,200	3,200	-325	303	-208	-178	-1,765	-99	32	-101	-4	-525	-53	2,299	579	140	991	20,866	309	451	349	911	-1,295	1,793	-23	1,370	1,527	1,384	1,615	-1,514	2,714	2,271	1,409	0	100	0	4,500	200	300	1,000	400	500	500	500	500	300	600	500	300	100	-19,500	-	-
Total Revenue	397,039	382,421	381,267	380,846	398,022	385,191	397,815	376,638	405,524	386,861	389,992	360,071	388,647	370,232	258,665	354,324	395,127	379,095	383,645	359,690	383,315	365,854	366,190	357,082	368,602	278,834	282,164	258,636	255,663	250,332	249,309	236,770	241,160	226,367	244,078	233,665	252,176	229,719	231,351	215,059	220,769	213,246	205,547	196,652	214,432	210,084	210,170	196,185	203,523	202,185	193,329	181,041	194,134	186,641	178,595	172,698	183,526	172,286	165,725	160,950	174,370	167,028	157,198	157,645	157,645	135,015	134,767	123,032	125,394	116,647	100,121	77,135	72,984	69,333	69,778	65,839	61,811	59,130	56,441	52,443	59,025	47,058	42,736	36,780	30,064	30,204	26,441	25,916	29,454	22,319	21,385	19,177	19,177	16,890	15,684	13,236	12,900	12,100	12,600	5,000	4,800	4,300	3,800	4,600	3,300	3,900	4,300	3,200	3,800	2,900	3,500	3,100	3,000	2,600	2,300	2,300

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	1,541,573
Cost of Revenue	-653,180
Gross Profit	888,393	888,393

Operating Income (+$)
Gross Profit	888,393
Operating Expense	-714,317
Operating Income	174,076	174,076

Operating Expense (+$)
Research Development	62,687
Selling General Administrative	656,641
Selling And Marketing Expenses	0
Operating Expense	714,317	719,328

Net Interest Income (+$)
Interest Income	17,202
Interest Expense	-71,832
Other Finance Cost	-20,455
Net Interest Income	-34,175

Pretax Income (+$)
Operating Income	174,076
Net Interest Income	-34,175
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	81,069	267,083 EBIT - interestExpense = 102,244 81,069 139,573
Interest Expense	71,832
Earnings Before Interest and Taxes (EBIT)	174,076	152,901
Earnings Before Interest and Taxes (EBITDA)	297,588

After tax Income (+$)
Income Before Tax	81,069
Tax Provision	-13,328
Net Income From Continuing Ops	67,741	67,741
Net Income	67,741
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	1,367,497
Total Other Income/Expenses Net	-93,007	34,175

Technical Analysis of Integra LifeSciences Holdings
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Integra LifeSciences Holdings. The general trend of Integra LifeSciences Holdings is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Integra LifeSciences Holdings's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-100.0%)		Bearish trend (100.0%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Integra LifeSciences Holdings.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 33.24 < 35.49 < 35.57.

The bearish price targets are: .

Tweet this

Integra LifeSciences Holdings Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Integra LifeSciences Holdings. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
MA 100 trending down: The MA 100 is trending down. -1
Close < MA 100: The price is below the MA 100. -1
MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Integra LifeSciences Holdings Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Integra LifeSciences Holdings. The current macd is -1.74113189.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Integra LifeSciences Holdings price going down in the near term. -2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Integra LifeSciences Holdings. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Integra LifeSciences Holdings price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

Integra LifeSciences Holdings Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Integra LifeSciences Holdings. The current adx is 42.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Integra LifeSciences Holdings shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.

Integra LifeSciences Holdings Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Integra LifeSciences Holdings. The current sar is 31.91.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1

Integra LifeSciences Holdings Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Integra LifeSciences Holdings. The current rsi is 25.94. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Trending up: The RSI is trending up. +1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Integra LifeSciences Holdings Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Integra LifeSciences Holdings. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Integra LifeSciences Holdings price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

Integra LifeSciences Holdings Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Integra LifeSciences Holdings. The current cci is -156.73394637.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1

Integra LifeSciences Holdings Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Integra LifeSciences Holdings. The current cmo is -52.65343272.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

Integra LifeSciences Holdings Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Integra LifeSciences Holdings. The current willr is -77.95501376.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Integra LifeSciences Holdings is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

Integra LifeSciences Holdings Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Integra LifeSciences Holdings.

Integra LifeSciences Holdings Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Integra LifeSciences Holdings. The current atr is 1.06113043.

Integra LifeSciences Holdings Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Integra LifeSciences Holdings. The current obv is -25,677,172.

Integra LifeSciences Holdings Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Integra LifeSciences Holdings. The current mfi is 22.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

Integra LifeSciences Holdings Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Integra LifeSciences Holdings.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-12-01	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-05	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-11	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-15	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-26	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2023-12-29	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-01-03	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-12	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-01-16	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-17	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-18	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-19	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-23	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-30	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-31	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-02	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-05	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-02-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-08	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-09	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-02-12	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-14	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-15	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-02-16	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-28	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-29	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-03-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-06	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-07	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-03-08	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-18	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-21	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-03-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-25	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-03-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-03-27	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-28	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-02	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-05	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-04-10	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-11	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-12	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-16	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-04-17	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-18	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).

6.3. Candlestick Patterns

Integra LifeSciences Holdings Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Integra LifeSciences Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	25.938
Ma 20	Greater than	Ma 50	32.877
Ma 50	Greater than	Ma 100	36.405
Ma 100	Greater than	Ma 200	39.234
Open	Greater than	Close	29.050
Total			0/5 (0.0%)

Create your own Symbol Scanner

Get notifications about Integra LifeSciences Holdings

I send you an email if I find something interesting about Integra LifeSciences Holdings.

Integra LifeSciences Holdings Buy, Hold or Sell?

Let's analyse Integra LifeSciences Holdings together

Get notifications about Integra LifeSciences Holdings

Quick analysis of Integra LifeSciences Holdings (30 sec.)

What can you expect buying and holding a share of Integra LifeSciences Holdings? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Integra LifeSciences Holdings (5 min.)

$29.38

$20.27

$-26.00 - $26.04

$-5.73 - $46.31

2. Growth of Integra LifeSciences Holdings (5 min.)

Is Integra LifeSciences Holdings growing?

How much money is Integra LifeSciences Holdings making?

How much money comes from the company's main activities?

3. Financial Health of Integra LifeSciences Holdings (5 min.)

4. Comparing to competitors in the Medical Devices industry (5 min.)

Industry Rankings (Medical Devices)

What can you expect buying and holding a share of Integra LifeSciences Holdings? (5 min.)

What can you expect buying and holding a share of Integra LifeSciences Holdings?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Integra LifeSciences Holdings

About Integra LifeSciences Holdings

Financial Health

Valuation

1.1. Profitability of Integra LifeSciences Holdings.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Devices)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Devices)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Devices)

1.2. Operating Efficiency of Integra LifeSciences Holdings.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Devices)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Devices)

1.3. Liquidity of Integra LifeSciences Holdings.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Devices)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Devices)

1.4. Solvency of Integra LifeSciences Holdings.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Devices)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Devices)

2. Market Valuation of Integra LifeSciences Holdings

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Devices)

Integra LifeSciences Holdings
Buy, Hold or Sell?